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The open chain dipeptides, L-phenylalanyl-L-serine and 
E~seryl-Ir-phenylalanine were synthesised, radioactively labelled 
■with C and He Both precursors were poorly incorporated into 
gliotoxin, produced by Trichoderma vlride. The isotope ratio 
measured in gliotoxin was different from those of the precursors 
which suggested that the precursors were cleaved by the fungus 
to their constituent amino-acids. It is believed that the amino- 
acids were then incorporated separately into gliotoxin*
The stereoisomers of cyolo-(phenylalanyl-seryl) were synthesised 
labelled with ^C. A high incorporation of the LL-stereoisoraer
into gliotoxin was observed but the other stereoisomers were 
poorly incorporated,. cyolo-(h~PhenyIalanyl-h-~seryl), doubly labelled 
with 14C and was incorporated into gliotoxin with essentially 
no change in the isotopic ratio, which suggested that the 
precursor was incorporated intact. Degradation studies, carried 
out on doubly labelled gliotoxin from this experiment, demonstrated 
that the i'^ C label was in the expected position in the gliotoxin 
skeleton. Doubly labelled gliotoxin was converted to anhydro- 
desthioglioioxin with no change in either the specific activity 
or the isotopie ratio, which substantiated the radiochemical purity 
of the sample. Methylamine, derived from the N~metbyX group of 
gliotoxin, was shown to be non-radioactivo.
L-Phenylalanine, labelled with ^C, was fed to Trichoderma. 
viride and labelled cyclo~(L-phenylalanyl-h-seryl) was 
isolated in an intermediate trapping experiment. The fungus was
vii
shown, thus, to be capable of synthesising cyolo-(L-phenylalanyl- 
L-seryl).
oyclo-(L-Phenylalanyl-N-methyl-L-seryl) was synthesised, 
labelled with ^C. The precursor was poorly incorporated into 
gliotoxin.
The cyclic dipeptide3 mentioned above were fed to a 
Hyalodendrpn species. Only cyc 1 o- (L~pheny1alany1-L-sery1) was 
incorporated significantly into hyalodendrin and bisdethiodi- 
(methylthio ) hyalodendrin. cyclo-( L— Phenylalanyl~L~seryl), 
doubly labelled with and ^H,was incorporated into the metabolites 
with essentially no change in the isotopic ratio.
HJBliCATIQff.
Some of the work described in this thesis has been published 
in the following papers
G.W. Kirby, D.J. Robins, and G.L. Patrick, "oyclo- 
(L~Phenylalanyl“L“seryl) as an Intermediate in the Biosynthesis 
of Gliotoxin1', J. Chem. Soc. Perkin 1, 1978* 1336.
viii
NOTE ON NOMEITC LATTJRE.
The following abbreviations are used in the texts
Z Bensylosy carbonyl Phe> Phenylalanine
Bu^ * i~Butyl Ser Serine
Boc Butyloxycarbony1 Ala Alanine
BCC Dicyclohexylcarbodiimide Trp Tryptophan
DCU Dicycloliexylurea Pro Proline
KBS N-Bromosuccinimide Leu Leucine
Bz Benzyl lie' Isoleucine
p-TsOH p-Toluenesulphonic acid
pts p-Toluenesulphonate
Amino-acids which are mono-substituted on the amino and/or 
the acidic group are represented as shown5'
—  ORRTF-
CHgOH
R^-L-Ser-OR2
±x
Amino-acids which are disubstituted on the amino group 
and/or substituted on a side group are represented as shown;
R 
11
R N H OH
CHgOE'
H1-L-Ser(EE2,OR3)-0H
CHAPTER 1 GLIOTOXIN
1.1'. Introduction
The first indication that a biologically active compound 
was produced by'the fungus Trichoderma viride appeared in 1931,
when T.viride was found to prevent the decay of wood by
1 2 Coniophora cerebella. In- 1932 Wein&ling observed an antagonism
of T.viride against the soil fungus Rhizocionia solani, and in
1936^ he isolated an active compound, unstable to light or basic
solution, which was later named gliotoxin (l). The compound was
subsequently isolated from cultures of Gliooladium fimbriatum^
*5 6(later identified as T.viride), Aspergillus fumigatus ,
7 8
Pen!ciIlium terlikowskii , PeniciIlium obscurum (later identified
7 9as P.terlikowskii ), Penicillium cinerascens , Aspergillus
chevalieri^, Aspergillus terrens^", and Aspergillus 110-10.^
1.2 Biological Activity,
Gliotoxin was found to inhibit the growth of a wide range 
of organisms. It was found^ to have bacteriostatic properties 
which were stronger than those of penicillin, gramicidin, 
actinomycin, streptothricin, and pyocyanase, and fungicidal 
properties which were comparable to those of actinomycin. The 
growth of a range of pathogenic organisms was found to be halted 
by a gliotoxin level of 10 yvg ml  ^and some organisms were 
inhibited by as little as 0.2-0.3 //£ ml^.^ Antiviral 
properties were also observed^ against ENA viruses such as 
poliovirus, herpes and Asian influenza viruses. Gliotoxin is 
toxic to aphids, rabbits, rats, mice, and other mammals.
The mode of gliotoxin’s biological action is unclear. 
Certainly the disulphide bridge is crucial to its activity sinc-^  
all analogues and degradation products of gliotoxin without the 
disulphide bridge are inactive. Furthermore, the simple 
epidithiodioxopiperazine (2) has itself been found to have some 
biological activity '. The discovery of small quantities of 
thiopurines and thiopyrimidines in ribonucleic acids and their 
ready reaction with disulphides has led to the suggestion that 
gliotoxin reacts at these centres to play some biological role 
as yet unknown.
1.3 Structure and Stereochemistry of Gliotoxin.
The structure of gliotoxin was elucidated by chemical
-3~
0
(6)
OH ^ NMe
0
(7)
~4~
methods and the study of degradation products. This work has
17-20oeen covered m  several reviews and is merely summarised
here. The basic skeleton of the molecule was -established by
degradation of gliotoxin to three separate products (3)-(5)
whose structures were proven by chemical synthesis. The synthesis
of the thiohydantoin (6) from gliotoxin suggested that the sulphur
atoms wero linked to the noncarbonyl carbon atoms of che
dioxopiperazine ring. The position of tho secondary hydroxyl
group in gliotoxin was established by degradation of gliotoxin to
(7)* whilst the primary hydroxyl group was located by the u.v,
and n.m.r. spectroscopic data of other degradation products.
2]
X-ray crystallographic analysis confirmed the structure, 
established the absolute configuration and showed that the strained 
disulphide bridge has a twisted conformation, with a dihedral 
angle about C-S-S-C of 12°. The sulphur atoms lie closer to the
carbonyl groups of the dioxopiperazine ring than to the nitrogen
- 22 atoms.
1.4 Synthesis of Gliotoxin.
A total synthesis of gliotoxin was achieved in 1976 by Kishi
27
and co-workers (Figure l). Starting from glycine sarcosine
anhydride (8), the dithiol (9) was synthesised in four steps.
Formation of the tbioacetal (10) from (9) gave a mixture of
24diastereomers. Kishi and co-workers had already shewn that the 
thioacetal was a useful protected precursor for the disulphide 
bond of the epidithiodioxopiperazine structure and had alrea-
ms
Cphco2
coiA
4
CHO
0T5e
BF^-Et
CH^Cl^ 2 2
-5-
HN
^ 0
•EMe
CICHgOMe
But0K
But0H
MeOCI-I
(8)
MeOCH^ 1.KSAc/CH2C12 Me0CH2| 
2*HC1/CH^OH . >
• SH
^ y 1
5H
(9)
MeOCHJT § N ^
H
l.oonc.HCl mi
Ax
2*Separation
(10) (14)
Figure 1. Synthesis of Gliotoxin.
-6-
.C02Bu
(15)
CH2C12 
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At
H
(16) (17) B* COgBu
(18) R$ CH2C1
At
BC1
3
c h2c i2
o°c Ar
OH
(19) (20)
Cl '
HC10
(-)-Gliotoxin (l)
Figure 1, Synthesis of gliotoxin.
-7-
devised syntheses for dehydrogliotoxin sporidesmin A
(12) , and sporidesmin B (13) f from related intermediates.
OHCl
MeO
OMe
Me
OH •Me
(11) (12) X» OH
(13) X= H
Removal of the methoxymethyl protecting group of (10) gave a
mixture of diastereomers (14) which was separated by
chromatography of the H-benzoyl derivatives* The thioacetal (14) 
was obtained after aminolysis in 30$ overall yield from (8) with 
the aromatic residue antj to the NH group. Coupling of (14) with 
the benzene oxide (15) was achieved by a novel, solvent dependent 
Michael reaction to yield a 1:1 mixture of two products (16) 
and (17) of which the latter had the required stereochemistry.
The alcohol (17) was converted into the chloride (18) in seven
steps. The benzylgliotoxin adduct (19) was obtained in 45$ yield,
by alkylation of (18) (Figure l). The benzyl protecting group 
was removed to yield the gliotoxin anisaldehyde adduct (20) in 
50$ yield. Finally, the disulphide bridge was formed by oxidation 
to the sulphoxido followed by perchloric acid treatment which 
resulted in a facile carbon-sulphur bond fission. Th.e resulting
cax-bonium ion experienced resonance stabilisation from thev. 
j>-methoxybenzene ring. With the loss of anisaldehyde^the disulphide 
bridge formed spontaneously to yield a,l~gliotoxin.
1*5 Biosynthesis of Gliotoxin.
The biosynthesis of gliotoxin and related metabolites has
X3 23been reviewed recently. 9 Only a brief summary will be given
here to place the author’s own studies in context.
29-32
Labelling studies revealed that gliotoxin is derived
from the amino-acids L-phenylalanine (21) and J.-serine (22) and
that the W-methyl carbon is provided by L-methionin© (23).
A high incorporation of m-tyrosine into gliotoxin reported 
by Winstead and Suhadolnik^ led to the proposal that m-tyrosine 
is an intermediate in the biosynthetic pathway to gliotoxin.
3 ~j 5
This result, however, could not be confirmed by other workers
and rigorous labelling experiments showed that ni-tyrosine could
not be an obligatory intermediate. The most likely explanation
for the incorporation observed by Winstead and Suhadolnik is
that their m-tyrosine had been contaminated with L-phenylalanine.
The dioxopiperazine, c,yclo-(L-phenylalanyl--L-seryl) (24),
was studied by MacDonald and Slater^ as a possible biosynthetic
intermediate for gliotoxin. They observed only a low incorporation
Of cycj£-(L-[l-14c] phenylalanyl-L-seryl) into gliotoxin produced
ky PeniciIlium terlikowskii, even though the precursor was taken
up into the mycelium, and concluded that the cyclic dipeptide
- 37was not a .free intermediate. Bu’Lock and Leigh , on the other 
hand, observed a high incorporation (21$) of a mixtuxo of cyclo-
-9-
(L-rAr~3Hl pheny 1 al any 1-L- [l-’^ cjseryl) and cyolo-(L-{]Ar_-3lfj 
phenylalanyl~D~ [l-^cO seryl) into gliotoxin produced by 
Trichoderma viride. Furthermore the isotope ratios ^ C s 3H of
the precursor mixture and gliotoxin were the same within 
experimental error, implying that the precursor had been
incorporated intact. It was suggested/ ‘ that the high levels 
of (24) fed to the cultures by MacDonald and Slater had resulted 
in misleading results.
iittle research has been carried out into the later stages 
of the biosynthesis. At least three further steps are required5 
H-metbylation, oxidative cyclisation on to the aromatic ring, 
and incorporation of the disulphide bridge. N-Methylation has 
been shown already to involve methionine but it is not known 
at what stage it occurs. Oxidative ring closure is thought to 
involve a benzene oxide-oxepin intermediate which may also be
PhCH2 H
+
(21) R= CH2Ph
(22) R= CH20H
(23) R= CH2CH2SMe
(24)
(25) (Figure2)involved in the biosynthesis of aranotin
-10-
Fj/?ure 2
Oxidation
S J  iO ? 0
o m< x co
Gliotoxin
OR A
V//
0
(25) H= H
(26) R= Ac
, Postulated Mechanism for Oxidative Ring: Closure,
-li­
lt may be significant that both gliotoxin and acetylaranotin (26)
• -» a. -,11 ~were isolated from cultures of the same organism- Aspergillus 
terreus.
r35 *1L— L SJMethionine was incorporated into gliotoxin but when 
inactive L-cysteine was added, the incorporation dropped and the 
amount of gliotoxin obtained increased* This suggested that L— 
cysteine was a better sulphur source for gliotoxin than L-methionine.
Olefinic derivatives such as (28) were shown not to be
40
obligatory intermediates for gliotoxin by Johns et al. 
Stereoselectively deuteriated and tritiated (3R)— and (3S)~ 
phenylalanines' were fed to T.viride and, although stereospecific 
loss' of the (3h)-proton was observed in gliotoxin, the loss was 
not quantitative signifying that the observed loss was associated 
with extensive transamination of L-phenylalanine.
H3^  CO“
A
H CH2SH 
(27)
To conclude, at the outset of this work, phenylalanine and 
serine had been established as the basic biosynthetic precursors 
for gliotoxin but the status of cyclo-(Ir-phenylalanyl-L-seryl) 
was confused by conflicting results* It was proposed, therefore, 
to study the various stereoisomers of cyclo-(phcnylalanyl-seryl) 
as possible intermediates for gliotoxin and this work is described
'i
(28)
-  12-
in Chapter 4* No experiments using open chain dipoptides of 
phenylalanine and serine as precursors of gliotoxin have been 
published. The synthesis and results of feeding these compounds 
is the subject of Chapter 3. A study of c,yclo-(L-phenylalanyl~ 
N-methyl-L-seryl) (29) as a possible biosynthetic intermediate 
for gliotoxin is recorded in Chapter 6.
Finally, a biosynthetic study of hyalodendrin (30), a 
fungal metabolite closely related to gliotoxin, is described 
in Chapter 7* This metabolite differs from gliotoxin in that 
the disulphide bridge has the opposite absolute configuration 
and both nitrogen atoms are methylated. It was interesting 
therefore to investigate whether gliotoxin and hyalodendrin 
share common biosynthetic intermediates.
H CH0Ph CH0Ph
0
(29) (30)
CHAPTER 2 DIOXOPIPBRAZINES AS BIOSYNTHETIC INTERMEDIATES.
Since c,yclo~(L--Phe~Ir"Ser) (24) has been proposed as a key 
intermediate in gliotoxin biosynthesis, it is relevant to review 
cases where other simple dioxopiperaz.ines have been identified 
or proposed as biosynthetic intermediates for natural products,
2.1 Echinulin and Related Compounds.
Simple dioxopiperazines have been established as biosynthetic 
intermediates for such metabolites as echinulin (31), neoechinulin 
(32), and brevianamide A (33)^.
2.1.1 Echinulin and Neoechinulin. Echinulin (3l), isolated from
A -a
Aspergillus amstelodamr, was shown to be derived from tryptophan , 
alanine^* and mevalonic acid-. Slater ejfc al, subsequently 
fed, to this organism, cyclo-fh-alanyl-h- f3* -~^C 1 tryptophyl)
(34) which was incorporated into echinulin, thus demonstrating 
that isopreriylation is a late step in the biosynthetic pathway. 
Further evidence supporting (34) as an intermediate was provided 
by Allen r'/ who was able to isolate a partially purified enzyme 
from A.amstelodami, capable of transferring the isoprene unit 
from 3-methyl-2~butenyl~1-pyrophosphate (35) to the cyclic 
dipeptide (34)• No transfer was observed with tryptophan or 
either of the open chain dipeptides of rryptophan and alanine.
The product of the enzyme mediated isoprenylation of (34) was 
identified as preechinulin (36), a metabolite isolated from an
46
echinulin-producing culture of A.chevalieri. A sample of
-14-
preechinulin, prepared as above and doubly labelled with 14C 
and “#H.,was incorporated into echinulin without any change in the 
isotope ratio9thus establishing it and the dipxopiperazine 
precursor (34) as intermediates.^
U'eoechinulin (32) is a metabolite, closely related to 
echinulin*, Marchelli et a1 * ^  .have shown that cyclo-(h- [U-~^
Alar-L-[5?7- T-Pj was incorporated, without change in the 
*^C; ratio, into neoechinulin A (32) and related metabolites.
2mil* 2 Brcvianamf&cs and Austamides. A large range of metabolites,
KA
shown to be derived from proline, tryptophan, and mevalonic acid, " 
have-been isolated from Pentcillium brevicompacturn and Aspergillus
ustus. These metabolites, the brevianamides and austamides, all
contain an isoprene unit at position 2 of the indole nucleus.
The simple dioxopiperazine, cyclo-(l— f3—~^ Hl prolyl-h- f3-^Cl tryptonhyl)
(37) was incorporated intact into brevianamide A (33) and was
also identified as a metabolite of P«brevi compac turn. *
2.1.3 - Fumitremorgen and Verrucologen. Several motabolites related
to brevianamide have been isolated from Aspergillus fumigatus,
55
Penlcillium verruculosum, and Aspergillus caespitocus" , for
53 52example fumitremorgen B (38) (also known as lanosulin ) and
54verrucuiogen TR^ (39)« These compounds are interesting in that
the indole nitrogen is isoprenylated since N-isoprenylated
49intermediates have been proposed for the brbvianamides. y cyclo- 
(L-Pro-L-Trp) (37) is presumably an intermediate to these compounds 
but this has still to be proved.
-15-
m
Me
■m
mi-
Me
(31) (32)
m
m
H
Ea
(33) (34)
OH OH
Me
(36) (37)
- 1 6 -
OH OH
OH
MeO MeO
(38) (39)
2.1.4 Hoguefortine and Oxaline. Roquefortine (40), isolated
5 6from Penfcillium roqueforti^ , has been found to have neurotoxic 
57properties^ and is related to oxainne (41), an unusual alkaloid
58
from Penicillium oxalium.^  Mevalonic acid, tryptophan, and
59histidine were incorporated into roquefortine 7 but cyclo-(L- 
histidyl-L-tx^yptpphyl) (42) remains to be tested.
2.2 Bioyclomycin.
Bicyclomycin (43), a metabolite of Streptomyces sapporonensis?
is an antibiotic active against Gram-negative bacteria. It has
19 /been suggested that it might arise from oyclo-(L-leucyl-L-
isoleucyl) (44) but biosynthetic studies are still to be carried
out.
2.3 Sibromophakellin.
It has been suggested that c,yclo-(L-prolyl-L-prolyl) (45)
might be an intermediate for dibromophakellin (46) isolatod
from the marine sponge, Phakellia flabollata but research into
19the biosynthesis remains to be carried out.
-17-
mi
O
(40) (41)
Nil
NE
OH
NE
OH
•MeHO
I-OH
(42) (43)
Me,\  /  2
NE
mi
CH,2
,Br
CH(Me),
(44) (45) (4b)
2.4 Hydroxypyrazine Derivatives.
2«4»1 Aspergillio Acid and Related Compounds. Biosynthetic
studies on these compounds have been carried out by MacDonald
and his collaborators. Experiments*^ with Aspergillus sclerotlorum
revealed that L- [l-^C] leucine and flavacol (49) were
incorporated into neoaspergillic acid (48). Similar experiments
showed that leucine and isoleucine were incorporated into
6 "*aspergillic acid (47) isolated from Aspergillus flavuse x
Deoxyaspergillic acid (5^) incorporated into aspergillic
62acid when fed to A.sclerotiorum. Labelling experiments with 
c.yolo-(L- r14Cl Leu-L-Leu) (51) and o.yclo-(L-Leu-L- f14Cllie) (44) 
were not so successful however, and low incorporations into
neoaspergillic acid and aspergillic acid respectively were
62 36 observed. MacDonald and Slater suggested that the simple
dioxopiperazine was not an intermediate and that a linear dipeptide
was formed on an enzyme complex then modified before cyclisation.
However the amount of substrate fed was similar to the amount
of metabolite isolated, This may have resulted in the suppression
of equilibration with exogenous material as suggested by Bu'Lock 
37and Leigh in the case of the cyclic dipeptide precursor of 
gliotoxin,
2.4.2 Pulcherriminic Acid. Pulcherriminic acid (52) is an 
effective chelating agent and may have a function in nature as 
an iron chelate,- It was isolated from Candida pulcherrlma and 
was shown to be derived from two molecules of L-leucine. ^
Eadioactively labelled cfyclo~(L-Leu-L-Leu) (5l) "was also isolated 
from this experiment and a high incorporation of cyclo-(L- P^Cl
\ /C ■)
Leu-L—Leu) into pulcherriminic acid was observed,
2.4.3 Mycelianamide. Mycelianamide (53) is a metabolite of 
PeniciIlium grlseofulvin. Labelling studies have established 
mevalonic acid^’^  and tyrosine^ as precursors. c,ycLo-(L- 
Alanyl~L~ j^C]tyrosyl) (54) and c,yclo-(L-alanyl-D- C^Cltyros.vl)
•3 c
were not incorporated very well into mycelianamide but the 
dose levels were high with respect to the amount of metabolite 
isolated and the arguments put forward by Bu'Lock and Leigh‘S  
may apply as discussed previously,
2.5 Epidithiodioxopiperazines
2,5*1 Gliotoxin and Hyalodendrin. The biosynthesis of these 
metabolites has been discussed in Chapter 1'.
2.5*2 Aranotin and Eploorazine. cyclo-(L-Phenylalanyl-L- 
phenylalarjyl) (55) has been suggested as the intermediate for 
aranotin (25) and epicorazine A (56). The dioxopiperazine (55) 
has been isolated from epicorazine-produeing cultures^ 0f 
Epioocoum nigrum but biosynthetic studies remain to be carried out.
2.^.3 Sporldesmins. Sporidesmin (57) and related metabolites, are 
thought to be derived from cyolo-(L-alanyl-L-tryptophyl) (34)»
-20-
Me
R
OH
A ,  Me
R ‘N '0H
(47) R- Me'^'V*' 
Me
Me
R* Me>
Me v, 
(49) R= Me^—  \
(50) R= M e ^ ^ l  \
Me
H
Me
O ^ / K -
Me' ‘2 T ^ 0
H
X Me MeMe Me
Me1
(51) '(52)
Me
Me
OH
'Me
OH
OH
Me
H
(53) (54)
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Kirby and Varley6^ fed cy_cl_o--(L-[3-^h]Ala-L-[3-14c]Trp) to 
Pithornyces chart a rum and observed a good incorporation (2405 cjo 
based on ^C) into sporidesmin. The ^H:^C ratio was 51$ of that 
of the precursor however, which suggested that either the 
precursor was being degraded to its constituent amino acids or 
that a dehydroalanyl derivative was involved in the biosynthetic 
pathway.
H CH0Ph 
f  2
H CHgPh
OH
OH
0
(55) (56)
OHOH
Cl
tt
Me I
Me 0"
Me
(57)
2.5 «4 Other Epidithiodioxopiperazines. Chaetocin (53) and 
chetomin (59) may be derived from cyclo~(L--ser,yl~Ir-tryptopbyl) 
(60) as might the verticillins e.g. verticillin B (6l)» The 
newly discovered sirodesmins, e.g. siro&esmin A (62) may be
2.6 Conclusion.
Simple dioxopiperazines have been shown to be biosynthetic 
intermediates for a variety of natural products containing a 
dioxopiperazine nucleus as well as being natural products in 
their own right. However, much research still requires to be 
done on a number of natural products for which simple 
dioxopiperazines have been proposed as likely intermediates.
derived from cyclo-( L-seryl~.L~tyros.vl) (63).
*
CH2OH
(58) (59)
* Tyrosine has recently been shown to be a precursor for the 
sirodesmins, J.D.Bu’Lock, personal communication, to G.W.Kirby.
H(60)
Me
I L
CHgOH
(61)
m
m
OHAcO
Me
(62) (63)
CHAPTER 3 h'-PHPNYIALAFfL-h-SERINE AITD L-SERYL-L-PHEHYL A.LAHME'
AS POSSIBLE BIOSYNTHETIC PRECURSORS FOR GLIOTOXIN.
Introduction*
L~Phenylalanine (2l) and L~serine (22) have been established
/ \ 2°~32as biosynthetic precursors for gliotoxin (1)* ' It seemed 
feasible that an open chain dipeptide derived from these two 
amino-acids might be a biosynthetic intermediate and therefore 
the synthesis of the two possible combinations, L-phenylalanyl— 
L-serine (64) and L-seryl-L-phenylalanine (65)9 doubly 
radio?ctively labelled with and ^H^was planned. Feeding 
experiments and comparison of the incorporations of each precursor 
into gliotoxin would then be carried out*
3.1 Synthesis of lA-Seryl-L-phenylalanine (6*7).
H-L~Ser-L~Phe~OH (65) was synthesised by Miyoshi et al.^ 
by three different routes. The most convenient route is shown 
in Figure 3.
3*1*1 L-Phenylalanine Benzyl Ester Hydrochloride (66). The
ester hydrochloride (66) was synthesised by the method of 
70 'Patel and Price , by heating phenylalanine in bensyl alcohol 
in the presence of thionyl chloride. High yields (90$) were 
obtained of the crude product (66). However, the recovery from
L—Sex' —-----
(22)
L—Phe    —
(21)
H-L-Ser-L-Phe-OH 
(65)
Figure 3 Synthesis of H~L-Ser-L-Phe-OH (65)*
crystallisation, carried out in ethanol rather than ethanol-ether^,
was low (ca. 60$) and crystallisation of the mother liquors was
usually necessary. Although the molting point was consistently
70low, the i.r. spectrum was in accord with .the literature and 
the n.m.r. spectrum was consistent with the structure (66),
3.1.2 N-Benay 1 oxyearbonyl-X,-~serine (67). Z-H-Sor-OH (67) was
71synthesised by the method of Guttman and Boissonas by stirring 
a solution of L-serine (22) in aqueous sodium bicarbonate with
benzyloxycarbonyl chloride (Figure 3). The ScLotten—Baumann 
72conditions involving sodium hydroxide as base could not be 
used in this case since a mixture of (67) and H-benzyloxycarbonyl-
0—benzylaxycarbonyl-I<-serine (69) was obtained* High yields 
were obtained as long as the solution was vigorously stirred.
The optical rotation and melting point agreed with literature 
values. I.r. and n.m.r. spectra were in accord with the structure (67)
10$ Pd/C >
Z—Ir—S er*“0H
(67) 1)00
NEt ^  Z-L-Ser-L-Phe-OBz.,
H-L-Phe-OBz.HCl CH j* (68)
(66) 2 2
3.1.3 Coupling Procedure. The two protected amino-acids (66) 
and (67) were coupled by the DCC method (Figure 3) to give the 
protected dipeptide (68)* The major contaminant was DCU (?0).
W  H j|
PhCH2OCN \  C—  OH
Cfi'0C0CHoPh2 n 2
(69) (70)
This was removed by precipitation from a solution of (68) in 
acetone, by crystallisation, and by ether trituration of solid
(68). The melting point and optical rotation of the protected 
dipeptide (68) agreed with literature values*^ The i.r, spectrum 
was consistent with the proposed structure. The n.ra*r, spectrum 
was complicated, but several signals sharpened after addition 
of PgO to the solution thus allowing the assignments shown in 
Figure 4 to be made* Complication of the signals arises from the
4.3 5-4.’'10 4.99-4,68
ABX
Ph— CH— O — C— IP H / C  N. H . C ~~ 0 -  CE0— Pha
5. J. 5.S7 .
a 7.42-6*88 m, “ 4.11-3.47 Z* '3.28-2*70
7.30 s y  2 ABX /  2 ABX
b 6.90-6.80 m Tin vha
5.80-5.60 br d 2.70-1.00
br s
Figure 4 N.m.r. Spectrum of (68) in CPC1^ (S values)
fact that the methylene protons adjacent to a chiral centre are 
not in identical environments and are therefore diastereotopic.
Of the two AB methylene multiplets, the one at lower field is. 
most likely to arise from the methylene group adjacent to the 
hydroxyl group* Confirmation of this was provided hy the sharpenin 
of this multiplet when the hydroxyl proton was exchanged for 
deutepium. The methine signals were assigned on the basis of 
decoupling experiments and comparison of vicinal coupling 
constants measured after the sample was shaken with
The mass spectrum of (68) was dominated by fragmentation 
of the benayloxycarbonyl group (Figure 5)* The parent ion was 
weak and the base peak was due to the tropylium ion at m/e 91*
Figure 5 Fragmentation of the Benzyloxycarbonyl Group*
3*1.4 Formation of Linear Bipeptide (65). Both protecting 
groups were efficiently removed by hydrogenolysis (Figure 3) 
as long as the solvent ratio of ethanol to water was 2si. With 
any other composition, either starting material or product was 
found to crystallise out and coat the catalyst, thus stopping 
the reaction. The triturated linear dipeptide (65) was identical
0
i l l 'Hi— — rO —i~ C
, I »
H
NR
79,65
-28-
with a sample crystallised from methanol-water ( l s l ) . T.l.c, gave 
one spot when developed in three different solvent systems*
The optical rotation, (jxjp +51*0? was comparable with the 
literature value of +53.8°.^ The i.r.spectrum was characteristic 
of a switterion and closely resembled a literature spectrum of 
L-alanyl-L-phenylalanine (71). Fragmentations observed in the 
mass spectrum are outlined in Figure 6. The base peak at m/ie 60 
resulted from a well known amine fragmentation route. A 
MacLafferty rearrangement to give a peak at m/e 222 was observed 
but this was weak as was that of the parent ion. The n.m.r. 
spectrum of (65) was assigned as shown in Figure 7* Assignments 
were based on the sharpening of signals observed when was 
added to the sample and on decoupling experiments.
CH3 CH2Ph
(71)
3«2 Synthesis of IT-i'.— Ser-L-Gl'—iuPhe-OH.
It was decided to label both halves of the dipeptide (65)7 
using 14C and so that any hydrolysis of the dipeptiae by 
the fungus would be detected by a change in the isotopic ratio 
measured in gliotoxin. The synthesis, starting from L“ [3-14Q] 
serine and L- [4*-^Hjphenylalanine, was carried out on a 1 mmol
T i'+ -i •+
 > H2HCH=C(OH)R 1
\ £ a  ~CH2° b/jl 222
0
3. R-CH2-Ph
T + -B* , C J
* 7 7
m/e. 91
* .C5H5
m/e 65
4.
H.
O H  0
li I I
,C— 35L /\ C-OH
0 H
CHgOH
LSI -CO,
CH2Ph
H/Cn-H
CHCH2Ph
CHgOH
HgH ==rCHCH2Ph 
ny(e 120
Figure 6 Maes Spectrum of H-I-Ser-L~Phe-OH (65).
7.53 br s 4.82-
+ 4.45 m }j
H.N _ .C
3^ \ H
7.82 br d
H 4*q?" 0I 4.90 ra 1
•K C—  0
HO'
,CH2 -4.60-4.12 
m
CH0 3.60-3.00 ABX
\  —Ph 7*50-7-10 m
Figure 7 N.m.r. Spectrum of H-L-Ser-ii-Phe-OH (63) in CF-,C02H.
scale, H-L~[4t3H]~Phe~OBz,HCl and Z-L- [3-1 V]Ser-~OH were synthesised
in high yield as previously described (Figure 3) and coupled
to give the protected dipeptide (68) in 56# yield with l4C and 
3.
H specific activities essentially unchanged. Only one band was 
observed on Panax scanning and autoradiography of an analytical 
t.loC. plate, Hydrogenolysis of doubly labelled (68) gave the 
linear dipeptide (65) in 86$ yield with unchanged specific activity, 
Panax scanning and autoradiography of t.l.c, plates run in five 
different solvent systems established that neither eye 1o-(L-Phe- 
L~Ser) (24) nor any other contaminant was present. However, 
this did not reveal whether epimerisation had occurred since 
H-L-Ser-D~Phe-OH (73) was found to have the same R^ value as 
the LL-isomer in all solvent systems tried. Dilution analysis 
was carried out to test for possible epimerisation by diluting 
a small quantity of labelled dipeptide (65) (usually ling) with- 
unlabelled carrier (usually 50mg) crystallising to constant 
activity. The' results (Table l) show that the radiochemical 
purity was not less than $>6$ and that not more than 0#2$
H-L-Ser-D-Phe-OH (73) or H-D-Ser-L-Phe-OH (74) was present*
3.3 Synthesis of L-Seryl-D-nhenylalanlne (73) and D-Seryl-
L-phenylalanine (74)»
The Linear dipeptides (73) and (74), required for dilution 
analysis (see above), were synthesised as described for the LL~ 
isomer (65) (Figure 3),
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Jbii,*.-*- J^ I~Song,ylox.ycarbonyl-D-seryl-L-T3henylalanine Benzyl Es tor 
_(,75),..and its Enantiomer (76). Z-D-Ser—OH (77)? synthesised from 
D-serine (78) in 90$ yield, was coupled with H-L-Fhe-OBz.HCl (66) 
to form Z-D-Ser-L-Phe-OBz (75) in 54$ yield, The i.r. and mass 
spectra were very similar to those of the LL-isomer (68) and 
the n.m.r. spectrum of the benzyl ester was consistent with the 
structure (75) •
The LD-isomar (76) was similarly synthesised from Z-L-Ser-OH 
(67) and H-D-Phe-OBz.HCl (79) in 49$ yield and had identical 
physical properties to (?5) with the exception of optical rotation.
3.3.2 Formation of Linear Dipeptides. Hydrogenolysis of 
Z-L-Ser-D-Phe-OBz (76) gave H-L-Ser-D-Phe-OH (73) in 44$ yield 
after recrystallisation. The i.r. and mass spectra were 
virtually identical to those of the LL-diastereomer (65). The 
n.m.r. spectrum of (73) was similar to that of (65)* Multiplets 
due tc- methine protons were again assigned by decoupling 
experiments,
H~D-Ser~L~Phe~OH (74) was "synthesised in the same fashion 
in better yield (61$) and had identical physical properties to 
those of (73) except for optical rotation, Mjj, +25 .8° compared 
with -29.3° for the enantiomer (73)0
3,4 Synthesis of L-Phenylalanyl-L~serineLiterature Routes.
The only reported synthesis of H—L—Phe—L—Sor—OH (64) was
75carried out by Suzuki jet al. and is shown in Figure 8. The
acid (80) (Figure 8) was also synthesised by Bodanzky and 
76 77
coworkers 9 as shown in Figure 9- Both routes were carried 
out to compare yields and applicability to small scale synthesis.
Z Cl
k-Phe ________ Z-L-Phe-OH 0
(21) Na0H ' % L Ph T . nutv . Z— — e~L—Ser—OMe
sorji 3 (82)
L-Ser ______ 2 . H-L-S e r-rOMe • HC1 CHo01o
(22) MeOH (g3) 2 2
_y Z-L-Pho-L-Ser-OH ^2  ^ H—L—Phe—L-PJ or-OJI
He0H (80) ~ ~ W °  (g4)
Figure 8 Synthesis of H-L-Phe-L-Ser-OH (64)f~*
Z-L-Phe-OH £-nitrophenol g-L-Phe-O-/ Q  )~m 2
(81) BCC ^ — 4
(85)
L-serine _ ^ T e nrr_________  Z-L-Phe-L-Ser-OII
(80)
Figure 9 Synthesis of Z-L-Phe-L-Ser-OH (23) . ^ 9 ^ ^
3.4*1 Benzyl oxycarbonyl-L-phenylalanine (81) Z-L-Phe-OH (8l)
H O
was synthesised by the Schotten-Baumann procedure  ^(Figure 8) 
with certain modifications. It was found that better yields were
obtained if che reagents were added dropwise over the renuired 
time period rather than in portions* In addition* the solution
*•>
was acidified to pH 1 since acidification to Congo Red^2 had
resulted in precipitation of (8l) contaminated with its sodium 
78
salt. With vigorous stirring yields of 90$ or more were achieved.
3.4.2 Benzyloxyoarboayl-L-phen.ylalanyl~L-ser1.n9 Methyl Ester- (82). 
(82). L—Serine (22) was converted into H-L-Ser-GMe.HCl (83)
in high yield by the method of Brenner and Huber^ (Figure 8).
The ester (83) was coupled with S-L-Phe-OH (8l) by the mixed
Q-j
anhydride method described by Hicolaides and Be Wald (Figure 8) 
to give.the protected dipeptide (82) in 70$ yield. The major 
absorptions in the i.r. spectrum were due to the primary 
hydroxyl group with bands at 3310 and 1060 cm 5^ the 
moncsubstituted aromatic rings with bands at 750 and 700 cm 
and amide* urethane and ester carbonyl stretching absorptions.
The n.nur.spectrum was consistent with the structure (82). The 
mass spectrum was again dominated by fragmentation of the 
benzyloxycarbonyl group.
753.4.3 Removal of the Ester Group. Suzuki jet al. saponified 
the methyl ester (82) with 1*1 equivalents of base in aqueous 
methanol and achieved a 62$ yield of the acid (80) (Figure 8).
Since the release of an acidic group during the reaction should 
account for 1 equivalent of base, the reaction was tried with
2. equivalents of base. The crude yield was high (91.4$) but the 
product was found on t.l.c. to consist of 2 compounds,presumably
-34-
re suiting from epimerisation. The recovery from crystallisation 
was poor and the optical rotation of the product (80) was very -» 
low compared with the literature value: Ilowever, the melting
point and spectroscopic data were in accord with the structure
(80). The possibility exists that the reported"^ optical rotation 
was a mistake since Boda.nzky _et al. ^  reported a low optical 
rotation for the same compound closer to our .observed figures.
A variety of reaction conditions* including those followed 
75by Suzuki et.al. , were tried but epimerisation still occurred 
to some extent and crystallisation was inefficient.
Some attempts were made to cleave the ester enzymatically.
Q 2
Walton et_ al. had succeeded in hydrolysing the ester of 
benzyloxycarbonyl-L-valine-L-tyrosine methyl ester (84) using 
ehymotrypsin? without cleaving the amide bond. Unfortunately 
the procedure failed with Z-L-Phe-L—3er~0Me (82) since 
chymotrypsin is selective with repect to the substrate and prefers 
araino-acids with an aromatic side chain. In the case of (82) the 
aromatic residue is too far away from the ester group* The 
same procedure was tried with a pig liver esterase but no reaction 
was observed.
An attempt to remove the benzyloxycarbonyl group of (82):1 
in methanclic hydrogen chloride, such tha.t the resulting amine 
salt could be treated with the enzyme, was unsuccessful. Several 
spots were, observed on t.l.c. after hydrogenolysis of (82) and 
it was presumed that side reactions, involving the chloride anion 
and the seryl moiety of the starting material (82), were occurring. 
Hydrogenolysis in methanol could not be used since some
-35-
dioxopiperazine was formed.
PhCH^OC C  OMq
CH(Me)
OH
(84)
3»4«4 Synthesis of Z-L-Phe-L-Ser-OH (80).^  Attention was
76switched to the procedure employed by Bodansky et al, , to
synthesise the acid (80) (Figure 9). The £~nitrophenyl ester
depended crucially on maintaining the pH at 8.7 hy the controlled
addition of sodium hydroxide. It was found that the addition
was best done automatically but this presented practical
difficulties when the reaction was carried out on a small scale.
The synthesis was attempted on 3*75 mmol of starting material but
76
the reaction mixture failed to go clear after l6h as described , 
and remained cloudy after 40h. A final yield of 42$ was obtained, 
20$ below the literature yield. The product was impure, 
failing to give a satisfactory analysis or well resolved spectra,
(85) of Z-L-Phe-OH was synthesised as described by Bodansky and 
77
Vignoaud ' in 71$ yield, then coupled with L-serine by the
rj C
literature method. The success of the coupling reaction
3«3 Synthesis of L—Phen.ylalanyl—L—serine (64)
Neither of the literature routes'^7 ^  were considered 
suitable for a small scale radioactive synthesis due to 
epimerisation in one case and the need for rigid pH controls 
in the other. It was decided therefore, to synthesise the 
dipeptide (64) in a similar fashion to that adopted for 
H-L-Ser-L-Phe-OH (65) (Figure 3)> namely via Z-L-Phe-L-Ser-OBz 
(86) (Figure 10).
L~Serine 
(22)
H-L-Phe-L-S er-OH 
(64)
Figure 10 Synthesis of L-Phenylalanyl-L-serine (64).
3,5.1 L-Serine Benzyl Ester p-Toluenesulphonate (87)* The ester
O-n
salt (87) (Figure 10) was synthesised by the method of Foelsch , 
modified to a 1 mmol scale. The procedure involved heating a 
solution of the amino-acid and ^ -toluenesulphonic acid in benzyl 
alcohol and azeotroping off the water formed with carbon 
tetrachloride. g-ToluenesuIphonic acid was required both as a 
catalyst and as a means of dissolving the amino-acid. The reaction
2
Pd/C
BzOH > _ Z-L-Phe-OH
 Hp~L-Ser~0Bz.pts  ** Z-L-Phe-L-Ser-OBz
*-Ts0H (87) ® t 3 (86)
CHgCXg
depended crucially on dissolving the reagents completely and 
keeping them dissolved during the addition of carbon tetrachloride. 
More solvent was required than, reported (for benzenesulphonic
tetrachloride initially added was also crucial, If too much was added 
the starting materials were precipitated but if too little was 
added then the water was not azeotroped off efficiently. It was 
discovered that refluxing the carbon tetrachloride through a 
Soxhlet apparatus containing molecular sieves i?as a far more 
efficient procedure on small scale than continuous distillation* 
After several minutes reflux, more carbon tetrachloride could 
be added without risk of precipitation. Applying these conditions 
on a 1 mmol scale, the ester (87) was obtained in 79^ yield with 
a satisfactory n.m.r. spectrum, It failed to crystallise from the 
recommended solvent due to the presence of small quantities
83
of dibenzylated serine derivative (88).
. \83
acid) for total dissolution. The amount of carbon
0
(88)
3,5.2 Coupling Procedure The protected amino-acids Z-L-Phe-OH
(81) and H-Ir-Ser-OBz.pts (87) were coupled by the PCC procedure 
(Figure 10) to give a crude product contaminated with DCU and
one other impurity. This impurity, purified by preparative t.l.c., 
was believed to be benzyloxycarbonyl-L-phenylalan.yl-'O-bensyl- 
L~serine benzyl ester (89) on the basis of the n.m.r. spectrum. 
Both impurities were efficiently removed in solution by filtration 
after cooling a suspension of the crude product in ether for 
several days. The final yield (43$) was low compared with the 
crude yield (89$) but further product could be obtained by 
preparative t.l.c. of the ether filtrate. A sample ox Z--L-Phe~ 
L-Sor-OBs (86) was crystallised and fully characterised. The i;3r. 
spectrum, outwith the fingerprint region, was similar to that 
of Z~L-Ser-L~Phe~OBz (68) with characteristic hydroxyl, carbonyl 
and aromatic absorptions. The n.m.r. spectrum (Pigui'e 11) ... 
contained a complicated multiple! dxie to both methine protons. 
Doxiblets due to the methylene protons were observed rather than 
the ABX patterns observed in spectra of similar compounds (68)7 
(•75)? and (76)* These patterns were altered when D^O was added 
but no conclusions could be made. Bo parent ion was observed in 
the mass spectrum of (86) due to rapid dehydration and loss 
of the benzyloxycarbonyl group*
The product (86) showed unusual melting properties. Hhen 
the crystals were warmed quickly the melting point was 116-119°C. 
However on slow heating a mixture of needles, m.p. 136-138°C, 
and prisms, m.p. 210°C, were formed. Possibly decomposition of
(86) occurred on slow heating before the m.p. was reached.
O H O  H
EhCHgOC--------- C---- ®----------- OCHgPh
9
CHgPh CHgOCH Ph
(89)
t 4.75- b 4.75-
0 H 4.30 m 0 H 4.30 m 0
Ph“—  CH2-  0 — cl —  H jj —  Hv H £  —  0— CH°— Ph®
£ __ C
,CH_ 3.15-2.95 CH„ 4.00-3.78 br d 
2 br d y  2
Ph® OH 3.10-2.50 br 3
a 7-28 a, 7-23 s, 7-14 s b 7-10-6.78 m, 5.6O-5.4O br d 
c 5-14 s, 4-99 s
Figure 11 JTom.r. Spectrum of S-Cr-Phe-h-Ser-OBs (86) in CDC1-,
(S values).
3-5-3- Formation of Linear Dipeptide Hydrogenolysis (Figure 10)
rapidly cleaved the protecting groups of Z-L-Phe-L-Ser-OBz (86)
and H-L-Phe-L-Ser-OH (64) was obtained as a white solid (t.l.c,
showed a single spot) which failed to crystallise. The melting
point and optical rotation of (64) agreed with those of the 
75literature. ^ The solid did not analyse correctly but the results 
which were obtained were moro in line with a monohydrate, in
-40~
agreement with the results obtained by Suzuki ejt .al.^ The i.r, 
spectrum showed characteristic absorptions of a zwitterion and 
the n.m.r. spectrum was consistent with the structure (64). ITo 
parent ion was observed in the mass spectrum due to rapid 
dehydration* The amine fragmentation described previously (Figure $ 
was observed again, giving a fragment ion peak at m/e_ 120 
which was also the base peak,
3.6 Synthesis of H~L~ [4 ’ ~3H] Phe-L- f3-14C]Ser-0PT*K20*.
H-L- [3-‘^ C]Ser~0Bz.pts was synthesised in 66$ yield and 
coupled with an equivalent of Z-L~ [4f- II] Phe~0H which had been 
synthesised in 90 $ yield (Figure 10). Z-L- ^ '-^HjPhe-L- [3~^^C]~ 
Ser-OBz was obtained in good yield (82$). Panax scans and 
autoradiography of an analytical t.l.c. plate revealed the 
presence of a small quantity of diberzylated derivative (89). 
Hydrogenolysis (Figure 10) gave H-L-[4f-^H]Phe-L-[3-^CjSer-OH#
HgO in 97$ yield* The overall yield from L-serine was 52$ compared 
with an overall yield of 72$ from L-phenylalanine, The 
specific activity was 88$ of the original value when dilutions 
were taken into account, whilst the specific activity of 3H was 
89$ of the original value. The radiochemical purity was checked 
by scanning and autoradiography of t.l.c. plates which had a single 
radioactive band corresponding to (64)® The extent of 
epimerisation was estimated by dilution analysis since H-L-Phe- 
D-Ser-OII (30) ( see below) had the same value as that of the 
product in all solvent systems tried. The results of the
-41-
dilution analysis (Taole 2) showed that conta.min9.tion by 
H—L—Phe—B-Ser—OH (90) and H-D-Phe-L—Ser—OH ($l) was not more 
than 0*3 and 0.2$ respectively*
7 Synthesis of h-Phenylalan.yl—B—serir.e and its Enantiomer*
3.7»1 « Bftnsyloxycarbonyl-B-phenylalan.yl-Tj-sQrlno Benzyl Ester 
(92) and its Enantiomer (93) The protected dipeptides (92)
and (93) were synthesised from their respective protected amino- 
acids as described for Z-L-Phe-L-Ser-OBs (86) (Figure 10). Yields 
of 41-47$ were obtained ar.d samples were purified by preparative 
t*l9c* and crystallisation for analysis, Bands, characteristic 
of the primary hydroxyl group, the ester, amide, and urethane 
carbonyls, and the aromatic ring, were observed in the i*r. 
spectrum. The n.nur. spectrum of (92) is shown in Figure 12. Both 
amide protons exchanged very slowly with deuterium when the 
sample was shaken with B20. nultiplets due to the methine
protons overlapped and could not be distinguished* The multiplets 
due to the methylene groups adjacent to a methine group were 
more complicated than the simple ABX system and could not be 
analysed. Fragmentation of the benzyloxycarbonyl protecting group 
again dominated the mass spectra of (92) and (93)*
3.7.2 Formation of Linear Bipeptides (90) and (91)* Bue to 
the insolubility of the protected dipeptides (92) and (93) in 
ethanol-water, hydrogenolysis was carried out overnight on a 
suspension of the reactant. H-L-Phe-B~Ser~0H (90) and H-B-Phe-
-42-
Carrier
X-*
LL LD
■
DL
Isotope 14c 3h l4c 3H 14c 3h ■
S.A* Initial 
s.a. istxtn 
S.A. 2ndxtll
0*91
0.91
0.93
11.21
11.59
11.53
0.76
5.25xiO~3
undetec
9.34
0.11
ted
0.76
1.98xlO~2 
4.00x10""^
9,55
0.27
0.02
Table 1 Dilution Analysis Results for 
■14C] Ser-L-[4;-3HjPhe-QH.
Carrier LD DL
Isotope 14c 3E 14c 3E
S.Af Initial 0.71 9.64 0.56 7.79
S.A. lStXtll 0.02 0.26 0.03 0.56
S.A. 2ndxtll 1.13xlO”3 0.08 1.23xl0~3 0.06
S.A. 3rdxtll 1.9xlO~3 0.06 unde4;ected
Table 2 Dilution Analysis Kesults for
H-L- T41 -3H] Phe-L- f3-14ca Ser-OH. H^O.
* Specific activity (yvCi mmol ).
** The configurations^ or D) of components are given in the
order, Ser-Phe* - _
*** The configurations (L or D) of components are given in the
order, Phe-Ser.
L-Ser-OH (91) were obtained in ca. 75$ yield after- crystallisation. 
The melting points of (90) and (91) were broad and, as melting 
took place, needles were formed which in turn decomposed over 
a large temperature range. Possibly the d5peptides were cyclising 
in the molten state to the dioxopiperazine which decomposes at 
258-268°C (page 136). The i.r. spectra of (90) and (91) showed bands
PhCHo0C  N
CH2 3.20-2.98 CH2 4.00-3.57 m 
v m
Phb OH 1.95-1.70 m
a. 6.78-6.49 m, 5.50-5.30 m. b. 7.29 s, 7*21 s. 
c. 5*15 s? 5*^5 a
Figure 12 N.m.r. Spectrum of Z-D-Phe-L-Ser-OBz (92) in CDCl^ 
(& values).
characteristic for a switterion. The n.m.r. spectra o± (90)and 
(91) were consistent with the structures and the mass spectra 
were closely similar to that of the LL-isomer (64).
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3.8 Feeding Experiment3 .
The doubly labelled dipeptides, L-phenylalanyl-L-serine (64) 
and L—seryl-L—phenylalanine (65)} were fed In aqueous ethanol to 
one day old cultures of T.viride at a concentration of 6-14 mg I*"1, 
The cultures were grown for a further three days then worked up 
as described in the Experimental Section. Incorporations of 
radioactivity into the total chloroform extract and the crude, 
crystalline gliotoxin obtained from the extracts by trituration 
with methanol, are recorded in Tables 3 and 4- The latter figures 
are more accurate as a measure of precursor incorporations into 
gliotoxin since the specific activity of the crude crystalline 
gliotoxin remained reasonably constant after several crystallisations,
Neither of the labelled dipeptides were incorporated very 
well into gliotoxin and the isotopic ratio (^Hr^C) in gliotoxin 
was quite different from that of the dipeptide precursor in all 
the experiments carried out, These results strongly suggest that 
the dipeptide precursors were cleaved by the fungus into their 
constituent amino-acids. It would be reasonable to assume that 
the pool sizes of L-phenylalanine and L-serine would be different, 
Therefore, the efficiency of uptake of the two amino-acids into 
gliotoxin would be different o’-This would result in a different 
isotope ratio in gliotoxin compared with that of the precursor, 
which would account for the results obtained.
H-L- [4*-^H] Phe-L- p-^CjSer-OH (64) was also fed to two day 
and three day old cultures. The cultures were grown for four days 
in all as above, then worked up in the normal manner. The results
Incorporation (%) '
Age of Culture when fed 1 day 1. day
Concentration (mg 1*"^ ) 11 6
Isotope ¥ c 3H 14C 3H
Chloroform Extract 2,23 5-40 5.80 15.8
Triturated Extract 0,86 • 4.45 1.20 6.4
Aqueous (Extracted) 12.6 35.2 16.0 30.0
Mycelium (Calculated) 85.2 59.4 78.2 54.2
r 1/1 , t ^
Table 3 Feeding of H-L- [3- C] Ser-L~ £4 ~ EQPhe-OH
Incorporat i on (*)
Age of Culture when fed I day 2 days 3 days
Concentration (mg 1 ^) 14 14 14
14n 3,t 14n 3 TT 14^ 3tjIsotope C H C H C H
Chloroform Extract 3.40 8.60 6.90 6.50 8.80 7.10
Trifurated Extract 0.60 3.10 2.90 3.90 4.40 4.90
Aqueous (Extracted) 0.00 42.0 0.00 38.0 9.30 40.8
Mycelium (Calculated) 96.6 48.4 93.1 55.5 81.2 52.1
Table 4 Feeding of H—Ir~ [41 -“3H] Phe-L— [3- 4C] Ser-OH«E^O>
(lable 4) indicate that cleavage of the precursor was occurring 
as explained above. However,it is interesting that the isotopic 
raoio in gliotoxin was almost the same as that of the precursor, 
and the incorporation value for vias greater, when the dipeptide 
was fed to a three day old culture* These results could he 
accounted for hy variation of the pool sizes of L—phenyl alanine 
and L~serine with the age of the culture* Another possibility 
is that some incorporation of the linear dipeptide into gliotoxin 
is talcing place, and that this incorporation occurs more readily 
with increasing age of the culture*
3 o 9 Conclusions
Clear evidence for the involvement of linear dipeptides 
in the biosynthesis cf gliotoxin could not he obtained* In fact, 
the results obtained suggest that the dipeptides were cleaved 
by the fungus to their constituent amino-acids, which were then 
incorporated separately into gliotoxin* It is possible linear 
dipeptides are enzyme hound biosynthetic intermediates for 
gliotoxin* Therefore, equilibration between these intermediates 
and added linear dipeptides may be prevented*
CHAPTER A T.iPL flPEB OF CYCLIC PIPEPTIDES 
.CT GLIOTOXIN BI0S7HTHESIS *
Introduction,
As described in Chapter 1, the status of cyolo-(L-Phe-L- 
Ser) (24) a biosynthetic intermediate for gliotoxin had 
been placed in doubt by the results of MacDonald and Slateiv^ 
The incorporation into gliotoxin obtained by Bu'Lock and 
Leigh^ on feeding cyclo-(L-[Ar-^HI Phe-DL- Ser) to
Trichoderma viride could have been partly the result of 
incorporation of cyclo~(L-Phe-D-Ser) (94)• It was decided to 
synthesise and feed the four possible stereoisomers of cyclo- 
(Phe-Ser) to settle the issue. The labelled structures selected 
were cyclo— (L - P h e ~ L ~ S e r ) 9 cyclo-(L- Phe-Q-Ser),
oyclo-(L- [41 ~^H] Phe-L- [ 3 C^] Ser), and cycle-(D-Phe-DL- D-^C] 
Ser), The last compound was a mixture of two diastereomers? one 
of which was the DD-isomer. .This isomer could not be synthesised 
separately since neither radioactively labelled D-phenylalanine 
nor D—Berine was commercially available and so it was planned 
to synthesise the mixture from DL— [3— C] serine and to separate 
the two diastereomers if necessary.
4 . 1  Synthesis of o y c l o - (  Whenylalanyl-L-aeryl) J^4}_and_cyolo-
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The synthesis of cyj^o-(L-Phe~L~3er) (24) and the DD~ 
enantiomer (95) was carried out as shewn in Figure 13 and was 
basically The same route used by MacDonald and Slater. The 
only deviation from their procedure was the final step where 
ammoniacal methanol, was used to encourage cyclisation.
Me OH
I-Phe — SObT " H-L-Phe~OMe.HC1
(21) 2 (97) DCG
Z-Cl
Ir-Ser — NaHCO"^ Z-L-Ser-OH CH.CI.
(22) 3 (67)
Z-L-Ser-L-Phe-OMs 
(96)
H CH0Ph 
'*.S 2 
0
H2 . H-L-S e r-Ix-Piis-OMe NH3 W  , x
W T “  ( 3) Me OH * (24)
MeOH-HOAc Kyj 0 bt<
H • CH^OH
Figure 13 Synthesis of cyclo-(L-Phe-L-Ser) (24)»
4.1*1 ff-Bensy I oxyearbony 1-L-sery1-L-phenyialan ine Methyl Ester (96), 
H-L-Phe-OMe.I-ICl (97) was synthefsised in good yield by the method 
of Brenner and Euber^ and was coupled with Z-L-Ser-OH (67) as 
described by MacDonald and Slater ' (Figure 13) to give the 
protected dipeptide (96) as an oil contaminated with DCU* A sample 
was purified for analysis by preparative t.I.c. and crystallisation* 
The i*r. spectrum was closely similar to that of Z-L-Phe-L-Ser- 
OBz (86). It was not possible to analyse completely the n.m.r. 
spectrum run at 60 MHz. However signals due to the aromatic, 
methyl ester and bensyloxycarbonyl groups were clear. Fragmentation
of the benzyioxycarbonyl gr0Up waa the dominant feature of the 
mass spectrum#
Z—D-Ser-D-Phe-OMe (97) was similarly synthesised#
4#3.#2 Deprotection and Cyclisation Procedure. Normally the
crude protected dipeptide (96)was used for the next step in the
synthesis, namely hydrogenolysis of the benzyloxycarbonyl group
(Figure 13)# Hydrogenolysis was superior to treatment with 45$
KBr/HOAc since it was found that side reactions involving
acetylation and elimination of the hydroxyl function occurred
by the latter method. This behaviour of serine derivatives has
3s
been recorded in the literature, v An oil was obtained after 
hydrogenolysis and was shown by t#l,c. and n«m.r. spectroscopy 
to be a mixture of (24) and the open chain methyl ester (98)# 
Acetic acid was also present in the product and it was concluded 
that the acid had protonated the amino group of (98) thus 
halting cyclisation which should have occurred readily in the 
absence of acid.^^ Several methods were tried to induce 
cyclisation, the best being treatment of the crude product with 
ammoniacal methanol. There was an added advantage in that the 
cyclised product crystallised from this solution# The crystals 
were contaminated with DCU but this cculd be removed by 
thoroughly washing the crystals with ether. Crystallisation from 
methanol usually resulted in a recovery of 65$ but more product 
could be obtained from the mother liquors. The overall yield 
from L-pheny 1 a 1 anine was in the order of 30~40^» Coupling was 
the stage with the lowest yield in the synthesis.
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cyclo-(L-Phe-L-Ser) (24) did not 3ho?/ up on t.l.c. under
u.v. light, or with iodine and required a multiple spray procedure,
(see Experimental Section) for detection. The optical rotation
( —105 ) was high, five times the reported value^^, and
melting was observed to occur ?/ith decomposition at a lover
temperature than that recorded.Nevertheless the product
analysed correctly and the spectral results confirmed that the
correct product had been obtained.
The i.r. spectrum contained absorptions characteristic of
the dioxopiperazine ring. Amide N-H stretching was at 3200 cm""1,
shifted to lower frequency compared with the normal trans value 
1 86
of 3300 cm” . Carbonyl stretching gave a band at 1670 cm
which was at higher frequency than the normal absorption of ca
—1 86 I65O cm for trans amides. The amide II absorption at 1550
—1 8 bcm , characteristic of trans amides , was absent in the spectrum
of (24).
Due to the complicated multiplets observed in the n.ra.r.
spectrum of (24)> spectra were run in three different .solvent
systems. Cyclic dipeptides containing an aromatic side chain
generally prefer the dioxopiperazine ring in a boat conformation
19?/ith the aromatic ring hanging over the boat, This conformation 
is thought to be the result of dipole induced dipole interactions 
bet?/een the aromatic ring and the amide groups of the . 
dioxopiperazine ring. One result of this conformation is that 
protons in the axial position at the opposite end of tne boat 
from the aromatic residue experience a shielding effect from 
tho aromatic ring current. Therefore in cyolo-(L-Phe-L-Ser) (24)
the me fchylene pi o tons adjacent to the hydroxyl group might be 
expected to be at higher field in 'the n.m.r, spectrum than 
normal, This was found. to be the case in (Cih)pSO where a widely
J ^
spread ABX multiplet was observed for these protons (Figure 14). 
When the sample was shaken with D O  this multiplet sharpened 
appreciably due to the exchange of the hydroxyl proton with 
deuterium* The methine protons were assigned on the basis of 
decoupling experiments.
7.40-7.02
3.38-2.72 ABX
82 t
8.10-7.75 m
H
Figure 14 N.m.r. Spectrum of oyclo-(L-Phe--L-Ser) (24) in (GD^/^O 
(& values).
When the spectrum was run in CD^OD, hyperfine splitting 
(J= lllz) of the multiplets due to the methine protons was observed. 
This splitting was the result of long range coupling between the
methine protons analogous to homoallylic coupling.b8 The fact 
that this splitting was oh serve cl suggests that there is 
significant double bond character in the amide bonds and that 
the molecule exists more as a flattened boat in order to satisfy
oo
the stereochemical requirements for homoallylic coupling.
Three characteristic fragmentations have been observed for
19simple dioxopiperazines in their mass spectra. One of these 
was observed in the mass spectrum of cyclo-(L-Phe~L~ Ser) (24) 
(Pathway 1, Figure 15).
cyclo-(H-Phe-H-Ser) (95) was synthesised in a similar fashion 
and had identical’ physical properties to (24) except for an 
optical rotation of [^3^ + 104° compared with -105° for (24)*
W H +
■ v  - a
H
R'
R1® CHgPh m/e 120
R1  ^CH90H ' m/e 60
Ph
_ j
HN
115
77 m/e 65
s
I3
m/e 11.5
l-H2
$/e 113 
1-co
m/e 85
CH2Ph 1
HR:
f
m
O^r
D ^ C H 2
m* 178 
1Ci7 Ph
BN T
m/e 206
Figure Mann Spectrum of cyolo-(L-Phe-Ij-Ser)_(_24)_.
53-
lil Sgithosig, of cyolo-fL-Fhegylalanyl-B-seryl) (94) and its
Enantiomer (99).
The procedure described earlier was used to synthesise 
Z-L“Ser-D-Phe-OMe (100) and its enantiomer (101) as oils, A 
sample o'f (100) was purified by preparative t.l.c. for analysis.
Hydrogenolysis and cyclisation of the protected dipeptides 
was successfully carried out as described for the LL-stereoisomer 
(Figure 13). Samples obtained by trituration of the crude product 
and by recrystallisation were compared but no difference in purity 
was observed. The cyclic dipeptides (94) and (99) had the same 
Hf value on t.l.c. as that of the LL-stereoisomer (24) in all 
the solvent systems tried. This is probably not too suprising 
since (24) and (94) both exist in a boat conformation with the 
aromatic ring over the dioxopiperazine ring and a hydroxyl group 
presumably spending most of its time exo to the ring. The i.r. 
spectrum was characteristic of the dioxopiperazine ring. The 
n.m.r. spectrum of (94) mun in CF^CO^H is shown in Figure 16.
The multiplet due to the methine proton derived from serine is 
shifted upfield by 1.1 p.p.m. compared with the same signal for 
the LL-stereoisomer* Assignments were made on the basis of 
decoupling experiments and comparison with spectra run in 
different solvents. The mass spectrum was virtually identical 
to that of the LL-stereoisomer.
The blr-isome.r (99) showed the same spectral characteristics 
as those of (94) except for an optical rotation of [px]^ -10.2° 
compared with +11.2° for (94).
7*50-7.10
3*53- 
3.14 ai
3.53-3.14 H2C
Hm
4.90- 
4.65 m
H
/
C
0
.•OH
8.11
Figure 16 N.m.r. Spectrum of cyclo-(L~Phe-D-Ser) (94) in
treating L-phenylalanine with 2,2-dimethoxypropane and 
concentrated hydrochloric acid. This method was more convenient 
for small scale synthesis. The cyclised product was obtained 
in 33$ overall yield based on L-phenylalanine with a specific 
activity 85$ of the original specific activity. One radioactive 
band was observed by Panax scanning and autoradiography of t.l.c. 
plates run in two different solvent systems. Dilution analysis 
showed that the LD- and DL-icorners were present in not more than
GF-'CO H ( Svalues)
4.3 Synthesis of Hadioactively Labelled Precursors *
T 1
oyclo-(L-[U- c]Phe-L-Ser)was synthesised by the route 
described above (Figure 13) with one exception. H~L-[U-'^C]Phe 
OMe.KCl (97) was synthesised by the method of Eachel^ by
0.3$ (Table 5).
0^ “" C]Phe-D~Sflr) wag synthesised in 30$ overall 
yield wioh a specific activity of 90$ of the original value andv'"' -f
found to contain not more than 0*5$ of the 1L—stereoisomer (Table 5^, 
£Z9_l2'“(I)“plie“’I)L“,[3~1^C]Ser) was synthesised in 15$ overall yield 
from Dlr-[3~^CJ serine, The mixture was found to have a DLjDD 
ratio of'68s28 and to contain less than 0.1$ of the LL-isoraer 
(Table 5). The specific activity was 87$ of the original,
Z-L~[3-^C]Ser~0H, synthesised from L-[3-™^C]serine in 91$ 
yield, with a specific activity 97$ of the theoretical value, 
was coupled with H-L-L4-^H]Phe-0Me.HCl and converted into the 
cyclic dipeptide in 28.6$ overall yield with the specific 
activity 98$ and the specific activity 97$ of the expected 
value* Dilution analysis (Table 5) showed the presence of not 
more than 0,2$ of the LD- and DL-isoraero.*
All the radiolabelled samples wer-a shown to contain a single 
radioactive compound by Panax scanning and autoradiography of 
t*l*c* plates*
4*4 Feeding Experiments with gyclic Dipeptides*
The radiolabelled cyclic dipeptides, normally 16 mg (3//Ci) 
l"1 3 were .added in dimethyl sulphoxide (iml) to 1 day old, shake 
cultures of T. vxride* The cultures were incubated-for a further 
thfee days, then worked up as described in the Experimental 
Section. cyclo-(L~ [4-3H] ?he-L-[3~14C]Ser) was fed as a separate 
experiment but all the other precursors were fed in parallel 
with cyclo-~(L-[U-^C JPhe-L-Ser) as reference* The results (Table 6)
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Precursor by ?,3
Composition
diodilution
W
Andy s i s •
cyclo- (lr~ [U-~4C] Phe-L-Ser) 109 LL*, 0*3 DL, 0.3 LD
cyclo-(L- [IJ-14C] Phe-D-Ser) 109 LD, 0.5 LL
cyclo-( D-Phe-m.- [>14C] Ser) 68 DL, 28 DD, 0.1 LL
jG2aXa-(L- [4! ~3Hj Phe-L- [3—14CJ Ser)100 LL, 0.2 DL, 0.2 LD
* The configurations (ir or ])) of components are given in the 
order, Phe-Ser.
Table 5 Dilution Analysis on Radiolabelled Cyclic Dipeptidesf
Exp« No.a Pre curs or
Incorporat;L< 
{%) in 
Chloroform 
Extract
m
T/i
S.A., 4C 
Gliotoxin0 s.x. 0
(1 oyolo-(L-[U-14C]Pha-L-Ser) 40 6.19 .1 o d i r 1
\ 2 cyclo~(L— [U-l4C]Phc-D-Ser) 0.43 0.06
-3l-DxlO0
f3 cyclo-*(L- [U-14C] Ph e -L-S e r) 58 7.17 3 4x10 3
{4 cyclo-fL- [U-14C]Phe-D-Ser) 0.43 0.03 4*3:<10~5
j5 oyclo-(L~ Qlt—14C]Phe-L-Ser) 49 11*7 2.6XIO"*1
1^6 cyclo-( D—Phe—DL— [3~J’4C3 Ser) 1.1 0.06 1 .2:xlO“3
7 cyclo-“( T.i“" [3 ■ Hj Elie-i-£3“ C3 Ser j 59 3d3 1,5x10
a Incubations braci-ceied were conduc cod m  parallei*
■b Specific „ Specific Activity (Gliotoxin)/Speaific Activity (.'Precursor)
T^ejsronTab ion
O
Inco pomH
S.A.- Specific Activity (/'Ci mntoi- )
Tat-,la 6 roofting BosnltPlor
showed that only cyolo~(L-Phe-L-Ser) (24) was incorporated into 
gliotoxin significantly. Incorporations of 40-50$ of the radio-
—9
activity fed in the form of the LL-cyclic dipeptide were observed
in the crude chloroform extract, double the incorporation
37observed by Bu’Lock and Leigh. Radioscanning and autoradiography
of t.l.c.' plates run in four different solvent systems revealed
that the vast majority of the activity was present in gliotoxin.
Gliotoxin, after crystallisation to constant activity., normally
—1had a specific activity of 6-12//Ci mmol . In contrast, poor 
incorporations (0.4-1.1$) of the other isomers were observed 
into the crude chloroform extract and the specific activity of 
the crystallised gliotoxin was very low, 0.03-0.06//Ci mmol""^ 
less than 1$ of the specific activity of crystallised gliotoxin 
from a parallel LL-cyclic dipeptide feeding.,
A more accurate incorporation figure for an LL-cyclic 
dipeptide feeding was obtained in the following manner. A sample 
of the mother liquors from the crystallisation of gliotoxin was 
diluted with inactive gliotoxin by a factor of fourteen and the 
mixture crystallised to constant activity. From this figure it 
was possible to calculate how much labelled gliotoxin was present 
in the sample taken and hence in the total sample. This procedure 
was also carried out for the mother liquors obtained from the 
trituration of crude gliotoxin. In this way it was shown that 
at least 43$ of cyulo-(L~[U-14C]Phe-L-Ser) had been incorporated 
into gliotoxin in the experiment tested, and that very little 
gliotoxin was lost during trituration.
Having es tablrshed that cyjslo—(n—Pho—L—Ser) (24-) was 
incoiporated eilicienLly into gliotoxin, we needed to show that 
the incorporation observed was not due to cleavage of the cyclic 
dipeptide by the fungus into its constituent amino-acids, 
which would then be incorporated separately. To surmount this 
problem, the LL-cyclic dipeptide was fed, doubly labelled, with 
in the phenylalanyl .moiety and in the seryl moiety, and 
the derived gliotoxin was crystallised to constant activity as 
before. It was found that the hlt^G ratio in gliotoxin (11*1) 
was essentially the same as in the precursor (10,9). This is 
good evidence that the precursor was not cleaved to it3 
constituent amino-acids, since it is unlikely that both amino- 
acids would then bo taken up into gliotoxin with the same 
efficiency. The pool sizes of L-phenylalanine and L~serine would 
be expected to be quite different. This assumption was supported 
by the results obtained from feeding doubly labelled open chain 
dipeptides, where cleavage did appear to occur and the 
ratio did change (Chapter 3),
This experiment did not disprove the possibility that the 
cyclic dipeptide was an unnatural precursor which was converted by 
the fungus into the true intermediate. This possibility was 
tested by means of an 5intermediate trapping* experiment* Eon 
radioactive LL-cyclic dipeptide was incubated with T.viride and,
2 hours later, L~ [u-^C]phenylalanine was added to the medium, Aften 
a further 2 hours,, the organism was harvested and the culture ilitre 
was extracted with chloroform to remove gliotoxin, and tnen was 
extracted continuously with ethyl acetate to give the cyclic
dipeptide (24). This was diluted with unlabelled (24) and the 
mixture was crystallised to constant activity. The residual 
activity in (24) corresponded to 1.3^ of that administered as 
L-tF- phenylalanine. This demonstrated that the fungus had 
indeed converted some of the fed phenylalanine into (24) under 
normal.conditions of growth.
A further check was carried out whereby the doubly labelled 
gliotoxin obtained above was degraded to prove that the ^ C  label 
was in the expected position. Details of this and other 
degradation experiments are given in Chapter 5.
4«3 •Conclusion.
cycle-(L-Phenylalanyl-L-seryl) (24) was shown to be a 
biosynthetic intermediate for gliotoxin (l)* Incorporations of 
labelled cyclo-(L-Phe-Lr-S.er) into gliotoxin were high, Doubly 
labelled cyclo-(L-Phe-L-Ser) was incorporated into.gliotoxin 
with the isotopic ratio unchanged. It was shown by
an * intermediate trapping* experiment that the fungus was capabl 
of synthesising the cyclic dipeptide (24) from L—phenylalanine, 
•The other stereoisomers of cyclo— (phenylalanyl—seryl) were 
poorly incorporated into gliotoxin.
CHAPTER 5 DEGRADATION STUDIES OW GLIOTOXCT.
Introduction.
The incorporation of cyclo-(L-r4l-3HlPhe-L-[3-14ClSer) into 
gliotoxin with an essentially unchanged ratio, backed by
the intermediate trapping experiment described in the previous 
Chapter, provided strong evidence that the LL-cyclic dipeptide 
is. a true intermediate for gliotoxin, It was decided to strengths] 
the case further by degrading the gliotoxin derived bio- 
synthetically from cyclo-( L- [41 -^H.lPhe-L- f3— Ser). The 
degradations were aimed at finding out a) whether the H-methyl 
group was labelled with ^ C  and b) whether the "^C label was 
completely located as expected in the hydroxymethylene unit,
5.1 Degradation Studies to Isolate the N-Methyl Group,
The possibility that the LL-cyclic dipeptide (24) was
degraded by the organism to its constituent amino-acids, followed
by uptake of the latter into gliotoxin, had already been shown
to be unlikely since the isotope ratios in precursor and metabolit<
were identical. However there remained the outside possibility
that both amino—acids were incorporated with exactly the
same efficiency. This possibility could be ruled out if the N~
■L 4
methyl unit in gliotoxin was shown to be free from C, for 
the following reasons. It is well known that serine and glycine
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are biosynthetically interconvertable and.that, in this process, 
"the C—j ol serine (the position laoolled in the cyclic dipeptide), 
enters the one-carbon pool. This same pool supplies the S-methyl 
group of L-methionine which in turn has been shown^ to be a 
good precursor for the N-methyl group in gliotoxin. Evidence 
of this biosynthetic process was supplied by Winstead and 
Suhadolnik30 who, by feeding [3~14C]serine to Triohoderma 
viride, demonstrated that 25$ of the radioactivity incorporated 
was contained in the N-methyl group. They hydrolysed gliotoxin 
with sodium hydroxide thus generating methylamine, derived 
from the N-methyl unit, which was trapped in hydrochloric acid 
and counted as the salt. This procedure was modified for the 
degradation of doubly labelled gliotoxin on account of the small 
scale employed. A sample of the labelled gliotoxin was diluted 
with inactive gliotoxin and methylamine was generated and trapped 
as described.-'' The basdc solution was then steam distilled to ' 
ensure that all generated metkylamine had passed into the traps. 
The methylamine hydrochloride obtained (ca 3®5mg) contained only 
1.16$ of the original radioactivity. The hydrochloride salt was 
converted into the phenylisothiourea derivative of methylamine 
by treatment with phenylisothiocyanate under basic conditions#
The derivative was purified by preparative t.l.c. Very little 
radioactivity was observed m  the derivative, and it wa.s 
calculated that the specific ac»■ ivnty wau not more than 0 
of the original specific activity of the diluted gliotoxin.
Thus it was shown conclusively that degradation of tne precursor 
(24) to its constituent amino—acids was not occurring.
5.2 The Location of the 14C Label in Doubly Labelled Gliotoxin -
part 1«
Having shown that the label was not in the N-methyl
group we needed still to prove its location.The expected position 
for tb« label was the hydroxymethylene group of gliotoxin (Figure 
17) which, it was planned, could be isolated by conversion of 
gliotoxin into anhydrodesthiogliotoxin (3) followed by ozonolysi; 
of (3) to produce formaldehyde which could be trapped and 
counted as its dimedone derivative(103)•
3ET^
Alumina
ch2oh CH,2
(i) (3)
*
ch20
Dimedone
->
(103)
Figure 17 Degration Scheme.
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JLiJAiiL ana Ozonolysis of Anhyd.rodesthi_oo;li o t ox in (3) •
Anhydrodesthiogliotoxin was synthesised hy a method of Johns90 
using a modified work up procedure* The yields obtained were not 
very good and varied considerably (10—25$)* The melting point 
and i.r* and mass spectra agreed with the literature,90 The n.m.r- 
spectrum was closely similar to that of the literature90 except 
for the N-methyl singlet which was at ,S 3*45 (lit.,90 & 4,00).
5.2.2 Degradation of Gliotoxin-1. Samples of doubly labelled 
gliotoxin were converted into anhydrodesthiogliotoxin (3) as 
described above, with essentially unchanged specific activity 
(105-109$) and isotope ratio (10,.7-11*5) expected. This
result further confirms the radiochemical purity of the gliotoxin 
isolated. The olefin (3) was ozonised and the product worked 
up with zinc to produce formaldehyde, trapped a3 its dimedone 
derivative, which was crystallised to constant activity. The 
results were suprising since the specific activity was less than 
half of the expected value. Variation of the temperature and time 
of ozonolysis made little difference to this result. A different 
work up procedure involving dimethyl sulphide resulted in lower 
specific activities since it was found that formaldehyde was 
being generated from dimethyl sulphide itself.
Two explanations for the results obtained were possible; 1) 
the label had been scrambled within the molecule or 2) 
formaldehyde was being generated from another part of (3)^ 
diluting the labelled formaldehyde and thus lowering the specific 
activity.
The lacter explanation seemed more likely and of all the 
carbon atoms present only that in the N-methyl group was at the 
correct oxidation level to generate formaldehyde*
5*2*3 Degradation of Gllotoxin-2* ^C-Labelled gliotoxin derived 
biosynthetically from cyclo-(L-|u-14clPhe-L-Ser) was converted 
into anhydrodesthiogliotoxin (3). The product was ozonised 
and the reaction mixture treated with dimethyl sulphide-to 
give unlabelled formaldehyde (Figure 18)* This is in accord with 
the above theory since none of the carbons in the uppt^r half of 
gliotoxin should be capable of generating formaldehyde* However;- 
the yield of dimedone derivative obtained from this experiment 
was poor and could in fact have been derived from dimethyl 
sulphide.
*
*
CH,2
0H I s r W
0r < Y  
caoh
(1) "(3)
Figure 18 Degradation Scheme.
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The location of the 14C Label in Gliotorin-part 2.
It would have been extremely informative if the trioxopiperazin<
(5) could have been isolated from the ozonolysis described above, 
since it should have contained 3H but no 14C if this latter label - 
■was confined to 3a-carbon, However, due to the scale of the reaction 
and the suspected break up of the molecule, this isolation was not 
attempted,
A search of the literature revealed that (5) and another 
trioxopiperazine (7) had been synthesised from gliotoxin* These 
syntheses were studied to see whether they' were suitable for 
small scale degradation of.gliotoxin.
0
(5) (7)
5,3.1 Synthesis of the Trioxopiterazine (7)« Compound (7) had
91been synthesised by Taylor and co-workers' by the route shown 
in Figure 19. Gliotoxin was dehydrogenated to give dehydrogliotoxin 
(11) in 69$ yield, Acetylation of (11) gave an uncharacterised 
acetate in 55$ yield, which was converted into the phenol (104) 
in 85$ yield. Finally oxidation of (104) gave (?) via the glycol 
(105) in 23$ yield. This route was impracticable due to the low 
yields obtained during acetylation and oxidation. A modified route 
was planned (Figure 20) whereby it was hoped uhat treatment of
dehydrogliotoxin (ll) with HGAc/ACgO would give the phenol (104) 
directly in better yield and that chromic aoid oxidation of (104) 
would give the trioxopiperazine (j) in an analagous fashion to 
the chromic acid oxidation of anhydrodesthiogliotoxin (3) described 
later.
5*3*2 Dehydrogliotoxin (ll), Gliotoxin was dehydrogenated to 
dehydrogliotoxin (ll) with 2,3™-diehloro-5j6-dicyano-l,4- 
benzoquinono (106) (Figure 20) in an improved yield of 81$. 
Unreacted gliotoxin (7$) was recovered by chromatography. The i.r. 
spectrum contained absorptions characteristic of the dioxopiperazine 
ring and of the aromatic and hydroxyl groups. The parent ion peak 
in the mass spectrum of (ll) was weak due to the rapid loss of 
the disulphide bridge and subsequent dehydration to an ion of 
m/<e 242 which gave the base peak*
5.3.3 The Phenol (104), Dehydrogliotoxin was converted into the
phenol (104) (Figure 20) in 60$ yield after preparative,t*i.e.
and crystallisation, an improvement on the 47$ yield from the
91original two step process.7' The i.r, spectrum corresponded closely
with that reported^1 showing the absence of the hydroxyl group
and the presence of the cis-amide carbonyls in conjugation with
double bonds* Since the base peak in the mass spectrum of
dehydrogliotoxin corresponded with the composition of (104) it
was expected that the spectra of both compounds would be closely
similar and this was found to be the case. The n.m.r*. spectrum of
91
(104) agreed exactly with that of the literature.
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91Figure 19 Synthesis of Trioxopiperazine (7)»
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H0Ao/Ao„0: CrO.
-> (104) *  (7)
PiKuro 20 Planned Synthesis of Trioxopiperazine (7)
5.3*4 Oxidation of the Phenol (104). The phenol (104) was oxidised
gowith chromic acid by the method of Ali et al. However, the product
obtained was a black 3olid which could not be characterised and it
was concluded that the phenol had been too reactive and that it
had been degraded.
In, an attempt to reduce this reactivity a sample was acetylated
92
as described by Ali et al. and treated with chromic acid as above 
but again no simple product could be detected and so this approach 
was discontinued,
5.3.5 Synthesis of the Trioxopiperazine (5). The trioxopiperazine 
(5) had originally been obtained by treating gliotoxin with 
selenium. However, the yield was very low. More recently (p) was 
synthesised from anhydrodestkiogliotoxin (3) by several routes 
(Figure 21), the best of which involved oxidation with chromic acid.
(3)
CH,
1. OsO
2. H23
3. PTSA
1. OsO.
h 2s2.
3. HalO
(5)
Yield
13.4#
(5) <40.i
CrO.
(5) 65.0#
Figure 21. Syntheses of Trioxopiperazine _(5) *
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This procedure was carried out on a sample of doubly labelled 
anhydrodesthiogliotoxin, synthesised from doubly labelled gliotoxin-'
^ "I yj
as before with unchanged H: C ratio and specific activity* The
isolated trioxopiperazine was crystallised to constant specific 
activity and found to be identical (103$) in content to the 
original, diluted gliotoxin* Fo activity could be detected at 
all proving that it must have been totally in the 3a-position 
The melting point and the i.r* and mass spectra of the 
crystallised product corresponded closely with those of the
92
literature* ' In the mass spectrum, a peak at’ in/e 88 with an 
accompanying metastable ion at m/je 67*3 was observed, whereas the
peak at s/s 89? the literature value, was relatively weak* A metastable
/ / 92ion at m/e_ 92*5 was also observed rather than at ra/jj 91*5 but
the former value fits the fragmentation m/e 143 to m/je 115- much
better and the literature value was considered to be a misprint*
5*4 Analogue Synthesis - 1*
The results obtained above demonstrated that the anomalous 
ozonolysis must have involved generation of formaldehyde from 
another* part of (3) which, as already stated, was most likely to 
be the N~methyl group. It was decided to synthesise an analogue 
of (3) having the structure shown in Figure 22, with the IT-methyl 
group labelled in order to detect if this group could form formaldehyde 
on ozonolysi3.
Figure 22 Analogue Structure.
An attempt to synthesise the analogue (107) was made following 
the route shown in Figure 23. Glycine anhydride (108) was
ethylene
glycol BE Y  Ac 0 AcH Y ’
2 x Glycine — ---- —?
(108); (109)
CHTgO *C&,I 0
Bu "OH
*■ Acf  Iu I EH HaH *•V
CH2
(110)
Figure 23 Planned Synthesis of Analogue (107)'
(107)
. 04
synthesised in 74$ yield by the method of Schott ejb al. I.r. and
mass spectra were characteristic of the dioxopiperazine structure.
Acetylation of the anhydride yielded the di-acetylated product
(109) in 84$ yield. It was planned to condense (109) with
formaldehyde to give (110) which could then be methylated with
radioactivoly labelled iodomsthane. It had been shown that (109)
could be dialkylated with aromatic aldehydes and monoalkylated
Q r
with aliphatic aldehydes.yo The mechanism (Figure 24) frees a lone 
pair on nitrogen which reduces the electron withdrawing power
of the neighbouring carbonyl group making dialkylation possible 
only with reactive aldehydes. If formaldehyde could be condensed 
with (l09)9 it would then be possible to label the desired amide 
nitrogen as shown (Figure 23)* Unfortunately,all attempts to 
synthesise (110) following the literature procedure'*^ were 
unsuccessful, the only product being a plastic like film showing 
several spots on t.I.e. It was decided therefore to abandon this 
approach.
AcN
J0
. o f 13U — LC‘ Me 
/
qn— h
R -
AcR
o^1 NH
fHOAc
R
AcI'T
m
CHR
Figure 24 Mechanism of Alkylation.95
5c5 Analogue Synthesis—  2,
Following the failure of the above synthesis it was decided to
synthesise the literature compounds (ill) and (112), ozonise both,and
compare the yields of formaldehyde generated* If the H—methyl group
was being converted into formaldehyde then a greater yield might be
expected from (ill). It was also proposed to label (ill) radioactively
9 6
in the N-methyl group. The literature synthesis was employed for both 
compounds with slight variations (Figure 25)*
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L - P r o l i n e --------- > H~L~Pro-OMe.
(113) HC1
H E
CH,2
(115) E= Me (111) E =  Me
(116) B- E (112) E= H
Figure 25 Analogue Synthesis - 2.
5«5«1 N-Ifrruvoyl-L-prolina Methyl Ester (114)» L—Proline was
methylated as its hydrochloride salt by the method of Brenner 
79and Huber, The product was an oil which failed to crystallise
and was coupled to pyruvic acid by the PCC method to give an
oil, heavily contaminated with BCIJ, Fractional distillation gave
(ll4) but the recovery was low due to decomposition or
polymerisation of the product in the distillation flask. The
optical rotation of (114) was suprisingly high, almost twenty
96b
degrees higher than the literature value. However, the i.r. 
and n,m«r spectra were identical with reported spectra. 
n,ra.r, spectrum was interesting in that two singlets were observed 
for each methyl group due to .hindered rotation about the amide bond.
DCC
pyruvic
acid
HEt.
>Me
M e
(114)
The mass spectrum, which was not reported^, showed a very weak 
parent ion peak, the base peak being at n/e 128 with other strong
•9
peaks at m/e 70 and m/e 43. A fragmentation scheme is given in 
Figure 26*
ra/e
/ H ' \ ' " I 7 JL
E /< U _ _ j.  » ijjje + OK0
128 m/e 128 m/e 70
a jn/fi 140 b m/e 43 
Figure 26 Hass Spectrum of ff-Pyruvoyl-B-proIine Methyl Ester (63).
5»5»2 Cyclisation with Hethylamine*. Cyclisation of (114) with
96bmethylamine was carried out as described by Lee to give the
dioxopiperazine (l!5)« The yield was half of that expected and
the melting point was low* The elemental analysis was correct
however and the optical rotation and n.m.r. spectral data were
q dh
identical to literature values. The i.r. and mass spectra, 
which were not reported, were also consistent with the structure 
(115). The hydroxyl group was revealed in the i,r.spectrum by 
0~H stretching and C-0 stretching bands. Two carbonyl absorptions 
were present. The parent ion peak in the mass spectrum was weak 
due to rapid dehydration. Fragmentations, characteristic of the 
dioxopiperazine and proline rings, wsro present (Figure 27).
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5o5.3 Dehydration Procedure, Dehydration of th© dioxopiperazine
(115) in trifluoroacetic acid was followed by n.m.r. spectroscopy 
and found to be complete within a few minutes. The olefin (ill) 
obtained failed to crystallise and decomposed after e, few hours.
5«5*4 Cyclisation with Ammonia. The dioxopiperazine (ll6) (Figure 
25) was synthesised by treating (114) with ammonia in dimethoxyethane
as described by Lee to give prisms with a decomposition point, 
20°C higher than the reported melting point.However, the 
elemental analysis, was cori-ect and the optical rotation was
QjC-U
identical to the reported value. The n.m.r. spectrum was 
similar to that reported^b and the i.r.spectrum, showed the 
characteristic absorptions for a dioxopiperazine ring.
Fragmentation pathways, analagous to those for the methylated 
compound (115) were also present in the.mass spectrum of (116).
5»5»4 Dehydration Procedure. Dehydration of the dioxopiperazine •
(ll6) was carried out as described by Lee"^b to give the olefin 
(112) which analysed correctly and gave i.r. and mass spectra 
which were consistent with the structure (112). The mass spectrum 
was closely similar to that of the reactant as expected, since 
dehydration of the latter was an important process..
5*6 Ozonolysis Experiments.
5.6.1 Ozonolysis of methylated dioxopiperazine (ill). Due to 
the instability of the dehydrated dioxopiperazine (ill), ozonolysis 
was carried out as soon as the product (ill) had been freed uf 
trifiuoroacetic acid. The same reaction conditions were used as 
for the ozonolysis of anhydrodesthiogliotoxin (3). A dimethyl 
sulphide work up was used to generate formaldehyde which was 
trapped in dimedone solution. The yield varied from 45—54$*
5*6.2 Ozonolysis of Dioxopiperazine (112).. The same conditions 
were applied to the unmethylated dioxopiperazine (112) using 
ethyl acetate as solvent since (112) was insoluble in ethyl 
chloride. The yield of dimedone derivative obtained was 48$.
The yields were essentially the same but this does not disprove 
the theory that the N—methyl group was contributing to the 
recovered formaldehyde to some extent.
5sl Radiolabelled Synthesis of the Analogue (ill).
More detailed studies were pursued on the cyclisation reaction 
to produce the methylated dioxopiperazine (115) with methylamine, 
since it was proposed to introduce the radioactive label at this 
stage with [^C] methylamine. This, in turn, had to be generated 
from C^c]methylamine hydrochloride. In order to get as high 
an incorporation of radioactivity into the product as possible 
it was necessary, ideally, to treat the reactant with one 
equivalent of methylamine. The reaction was studied to see if 
this was possible with unlabelled methylamine hydrochloride.
It was found that methylamine could be generated by refluxing the 
salt in sodium hydroxide solution and could then bo passed in 
a slow stream of nitrogen into the reaction flask which was cooled 
to -40 to -50°C to ensure efficient trapping of the gas. Usually 
5~8h was required for the process.
The amount of methylamine hydrochloride used and the reaction 
times were varied. Reaction solutions were evaporated to dryness 
and studied by n.m.r. spectroscopy in CD-^ OD.
Using one equivalent of methylamine, the reaction failed
to go to completion since some methyl ester was still in
evidence in the n.m.r. spectrum. It was calculated that the yield '
was 66$. With two equivalents of methylamine the reaction went
to completion hut, as with the previous experiment, two products
were present on t.l.c. and two N-methyl singlets were present
in the n.m.r.spectrum. The singlet of lower intensity was due to
the desired product and the other, presumably, was due to the
2S, 5S-diast0reoaer•- It was estimated that the 2S,'5Rs2B,53 ratio
was 1:3. When more than two equivalents of methylamine
hydrochloride were used a solid was obtained with the 2S,5Rs2S,5S
ratio nearer 1:1. These results implied that the 23,53-diastereomer
was formed kinetically and was then equilibrated in the presence
of excess base to a 1:1 mixture of the two forms. This was at
96
odds with the results obtained by Bycroft and Lee and it must
be concluded that the methylamine was not sufficiently dried by
the potassium hydroxide and soda, lime columns included in the
9oapparatus. Bycroft and Lee reported-that 1:1 mixtures of the 
two diastereomers were obtained in pro tic solvents. Bigger drying 
columns were impracticable and so it was decided to carry out 
the radiolabelled synthesis as follows, I-Byruvoyl-I^-prolino 
methyl ester (114) would be treated with one equivalent of P^c] 
methylamine at 0°C for two days to produce a non-quantitative 
mixture of the two diastereomers, mostly 23,53. Ten equivalents 
of unlabclled methylamine would then be added to equilibrate the 
mixture* Before this procedure was attempted, it was necessary 
to show that equilibration did not release methylamrne. This
was demonstrated by treating a solution of a 1:1 mixture of the 
diastereomers with ammonia, generated by refluxing an ammonia 
solution. If equilibration required the loss of methylamine then 
ammonia would take its place resulting in the loss of the M- 
methyl singlets in the n.m.r. spectrum. This was not observed*
'The radiolabelled synthesis was carried through by the method 
described to give a diastereomeric mixture of 2Sf5S:2S,5R (ratio 
5:3) containing 68.5$ of the radiolabelled methylamine added* 
Crystallisation of the mixture yielded 36mg (l8$) of the 23,5R- 
diastereoraer and a further 9$ was obtained by diluting the mother 
liquors with unlabelled product (115) &ad recrystallising,
Panax scanning and autoradiography of t.l.c* plates of (115) run in 
three different solvent systems showed the presence of a small 
quantity of the 2S,5S-diastereomer. Dilution analysis of a sample 
of the labelled product, with unlabelled product 
showed that the product was 94*4$ pure and it was decided not 
to purify further since both diastereomers would yield the same 
product on dehydration.
Dehydration of labelled (115) was followed by n.m.r. 
spectroscopy and the crude product (ill) was ozonised. The 
ozonide was worked up as before. Formaldehyde dimedone was obtained 
in 51$ yield with a negligible specific activity corresponding 
to 0*2 - 0.4$ of the original value.
It appears that the N-methyi group in this particular 
molecule (ill) does not form formaldehyde on ozonolysis. This 
result cannot, however, rule out the possibility of this occurring
with anhydrodesthiogliotoxin (3) and it may be that- the indole 
double bond has some important function to play.
The obvious experiment to try is an ozonolysis of 
anhydrodesthiogliotoxin labelled specifically in the H-raethyl 
group. However, the synthesis of this derivative Would not be 
s t raightforward.
5.8 C o n c l u s i o n . ■
1 j
The position of the " C label in doubly labelled.gliotoxin, 
derived biosynthetically from cyclo~(L~ [4 !-^h1 Phe-L- [~3~^^cISer), 
was shown to be at carbon-3a by degradation of gliotoxin to the 
trioxopiperazine (5)* The JT-methyl group of gliotoxin was shown 
to be inactive. These results demonstrate that the label 
was not scrambled within the molecule d^nring incorporation of 
the cyclic dipeptide.
Doubly labelled gliotoxin was converted to anhydrodesthio- 
gliotoxin with.essexitially the same isotope ratio and-specific 
activity. Ozonolysis of the latter compound gave formaldehyde 
with less than half of the expected specific activity in •* C.
Since the label has not been scrambled,formaldehyde is being 
formed from another part of anhydrodesthiogliotoxin apart from 
the exo methylene group. The N-methyl group is the most likely 
contributor. However,this has still to be proved since experiments 
with model compounds did not show that formaldehyde is generated 
from N-methy! groups of the model compounds on ozonolysis.
CHAPTER 6 THE ROLE OF CYCLO~( L-PHEigYLALAJTYL ~H”?ffiTHYL~Tj~SERYL)
AS A POSSIBLE BIOSYNTHETIC JJTTBRMEI)IATE FOR GLIOTOXIN. ’
Introduction»
Following the confirmation of cyclo -(L~phenylalanyl-L- 
seryl) (24) as a biosynthetic intermediate for gliotoxin (Chapter 
4)* attention was turned to other possible intermediates* At 
least three further stages are required to convert cyolo-(L-Phe— 
L-Ser) into gliotoxin; IT-methylatiori, incorporation of the 
disulphide bridge, and ring closure to form the dihydroaromatic 
system* The order of these steps is unknown but several possible 
intermediates can be formulated. The most accessible intermediate 
in terms of synthesis is cyclo-(L—phenylalanyI-H-methyl-L-seryl) 
(29), which could be formed in the biosynthetic pathway by H- 
methylation of cyclo-(ir-Phe-L-Ser),
Specific methylation of cyclo-(L-Phe-L~Ser) did not seem 
feasible since experiments with cyolo-fL-Phe—L-Ala) (117) had 
given the M-dimethylated cyclic dipeptide with no evidence of 
the mono-substituted product, even when less than one equivalent 
of methylating agent was used. Racemisation, O-methylation, and 
elimination might also occur on the L-seryl portion of cyclo- 
(L-Phe-L~Ser) and so it was decided to synthesise (29) by 
coupling an ester derivative of N-mathy 1-Ir-s er ine with Z-B~Phe«~QH 
(8l) such that hydrogonolysis of the protecting group would 
release a primary amino group necessary for subsequent cyclisation.
Earlier work had shown that secondary amino groups did not cycliee 
97readily*
Attempts to methylate Z-L-Ser-OH (67) to give II- 
benzyloxycarbcnyl-N-methyl-L-serine methyl ester (ll8), which 
could then he hydrogenolysed to the desired M-sethyl-L-serine 
methyl ester (119)* were unsuccessful. Using iodometbane and
q O
silver oxide in dimethylformaraide ’ at room temperature, a mixture 
of the unsaturated derivative (120) and the serine derivative
(121) was obtained in a ratio of 1:2 in agreement with the 
literature.^ The same result was obtained at 0 ° C .
PhCH2 sH Me g
SB. H  tv C  (MeV, I v'
\
m
(29) H1* Me H2» CHgOH (118) H=» Z
(117) H^= H S2« Me , ( 1 1 9 )  H
(120) (121)
A recent paper by Cheung and Benoiton' reviewed, several
methods of B-methylating amino-acid derivatives» The method 
involving least racemisation was the treatment of 11- 
ben zyl o:cy carbonyl or N-t-butyloxycarbonyl derivatives of amino- 
acids with eight equivalents of iodomethane and three equivalents 
of sodium hydride in tetrahydrofuran with or without 
dimethylformamids. In the absence of diraethylformamida the acid 
group was not methylated- These workers also reported"**^ that 
the serine derivatives (122) and (123) underwent elimination 
under these conditions at room temperature, but by reducing the 
temperature to 5°C and increasing the reaction time to three 
days, the IT-methylated products were obtained in high yield.
It was decided to synthesise N-b en zy1 oxycarbonyX-0-t~butyl»- 
L-serine (122) rather than the O-benzylated compound (123) since 
the t—butyl group could be retained until the final stage of the 
synthetic route to (29)0 The benzyl protecting groujp^  which was 
difficult to introduce, would be lost during hyorogenolysis.
The planned, synthesis is shown in Figure 28, including the known 
literature route to (122).
0
il
H C OH
(122) R1® Z, R2« OBu’b
(123) R1® Boc, R2® GBz
L-“Serine H-L--3e:r~0Me«HCl --> Z-~L~Ser-~OMe^0C±o NctriOO*
(22) - (33) - (124)
isobutene , MeOH ,
 --  — > Z-L-Ser(OBu )-OMe -"t t Tux---- * Z-L-Ser(OEu )-OHcone, ilaOH
HgSO (125) (122)
SaH +
■ v  = ; — > Z-L-3sr(0Eu ,Ittfe)-OH  Z-L-Ser(OBu ,NHo)-OMe
Mel, THP 7
(128) (130)
H_ , Z-L—Phe~0H ,
 i> Ne-L-Ser(OBu )-0Ke ----- — > Z-L-Phe-l-Ser(0BuC,NT-!s)-0
(129) CH:2C12 (136)
Pd7c" HOAo— * H-l-Phe—L-S er(OBu'*'«HMe) -OMe --------- :----- >
° (137).
cyclo-(L-Phe~l~Ser(OBu \ffle)) 
(138)
c.yclo-(li-Phe-L-Ser(HK3)) 
(29)
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6 «„1 Synthesis and N~Mothylation of flT-Benz,y 1 oxy c a.rbonyI-0-t~buty 1 
L-serine (122), -•»
6.1«1 N—Benzyl oxycarbonyl-L—serine Methyl Ester (124). 
H-L-Ser-OMe.HCl (83) was converted into Z-L-Ser-OMe (124) in 
good' yield (80$) by the method of Guttman and Boissonas^ (Figure 
28). The product failed to crystallise due to the presence of 
benzyl chloride as an impurity* The success of the reaction 
depended on neutralisation of the hydrochloride salt with ice 
cold sodium bicarbonate solution and vigorous stirring throughout 
the reaction. A sample of the oil was purified by vacuum 
distillation for analysis. The i.r.spectrum showed absorptions* 
characteristic of the urethane*ester, aromatic, and hydroxyl 
groups. The presence of the benzyloxycarbonyl group was clearly 
indicated by the n.m.r. and mass spectra of (124).
6.1.2 IT-Methylation of L-Serine Ester Derivatives. The substrates 
used by Cheung and Benoiton10^ for Jf~methylaticn were free acids 
and therefore it would be necessary to hydrolyse the methyl ester 
of (125) to obtain the same starting material. Since, however, 
the methyl ester group would have to be reformed afterwards, 
attempts wera made to N-methylate the methyl ester (125) directly, 
using the reaction conditions cf Cheung and Benoiton.
N~Methylation did take place but so did elimination of 
t—butanol and hydrolysis of the ester. At —20 C, IT—methylation 
failed to proceed but hydrolysis was still found to occur. Similar 
experiments with N-benzyloxycarbonyl-fi-t-butyl-L-serino t-butyl
-85-
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ester (126), prepared by the method of Callahan jet al*"' ~9 were 
equally unsuccessful, and a yield of 57$ was obtained of the -» 
unsaturated product (127) at 5°C.
These results showed that the methine proton of the serine 
ester derivatives was too acidic to allow selective H-methylation 
and that the free acid had to be synthesised*
TT 0 „ 0
H 1 + 1 + 
ZSH H .C— OBu ZIT. .C-OBu
CH OBu* CH2
(126) (127)
6*1*4 ff-Benzyloxycarbonyl-O-t—butyl—L-serine (122)* Hydrolysis
of the methyl ester (125) was carried out by the method of Callahan
et (Figure 28) to give the acid (122) as an oil, which
was purified by preparative t»l»c. The optical rotation was less
101than half of the reported value ‘ 9 implying that racem.isation 
had occurred* Haeemisation was reduced by replacing methanol as 
solvent with ethanol, by increasing the watersethanol ratio as 
much as possible within the limits of solubility, and by decreasing 
the reaction time. The acid (122) was obtained as a solid in 
bettor .yield (8p$) with no more than 10$ racem.isation, Only 0,8$ 
of the starting material was recovered showing that hydrolysis 
was virtually completes. The melting point was broad due to partial
racemisation, The i.r. sx>ectrum showed the characteristic broad 
acid 0—H stretching absorption as well as absorptions due to the 
acid and urethane carbonyl and C-0 stretching vibrations. The 
n.m.r. spectrum was noticeable for the ABX multiplet due to the 
seryl methylene group. Benzyloxycarbonyl and t-butyl 
fragnlentations dominated the mass spectrum*
Unsuccessful attempts were made to remove the methyl ester 
of (125) using other procedures e.g. lithium iodide in 
dimethylformamide^^, and sodium thiomethoxide in hexamethyl— 
phosphoramide.^^^ A different approach using the t-butyl ester 
(126) was tried whereby selective removal of the t-butyl ester 
was attempted with benzene and p-toluenesulphonic acid. However, 
both ester and ether t-butyl groups were removed.
-Methylation Procedure. N-Methylation of the free acid
(122) was carried out as described by Cheung and Benoiton^^ 
(Figure 28). However, it was observed that a certain amount of 
elimination (11-15$) was still taking place and that the reaction 
proceeded better at 0°C with no elimination. Furthermore it was 
discovered that the reaction failed to go to completion if more 
than five mmol of starting material was used. Under the revised 
conditions the IT-methylated compound (128) was obtained in high 
yield (94-98$), as an oil which showed one spot on t.l.c. and ' 
analysed correctly. Since the urethane group was tertiary, no 
urethane II absorption was observed in the i.r. spectrum. Both 
monomer and hydrogen bonded dimer, acid carbonyl stretching
absorptions "were seen. The raultiplet due to the methine proton 
in the n.m.r. spectrum was shifted downfield by ca4 0,25 p,p*m,
"9
compared with that of the reactant, Benzyloxycarbonyl and t-butyl 
fragmentations were again the dominant features of the mass 
spectrum,
6,2 S?/nthes.is of 0-t-Buty 1 ~I\F-methy 1 -L*~serine Methyl Ester (129),
Two steps were required to convert the acid (128) into the 
desired methyl ester (129)? namely* formation of the methyl ester 
and hydrogenolysis of the benzyloxycarbonyl. group. Since these 
steps could be carried out in either order (Figure 29)? the two 
alternatives were tried and compared with respect to yield and 
ease of synthesis,
Me-L-Ser(OBu^)-0H 
a ) /  (132) \ b )
Z-L-Ser( 0Bu%Me)-0H Me-L-Ser(OBu"t )-0Me
A \  (129)
Z-L-Ser(OBu^,HMe)—OMe 
(130)
a) B2, Pd/c b) CHgMTg
Figure 29 Synthesis of Methyl Ester (129),
6.2,1 N-Benzyloxycarbonyl-0-t-butyl-U'-methyl-L~serine Methyli—I, n i ,  nui n r  ■ ii m i ,r w n g inmiiirfwiMi m um  ih i n ii i i n  * ■ 1 " T ~ -----------------------* ■—<—  ■ «» n»w — * »i w h»ilh  i . i . i ......................................, ....... 1/  ......
Ester (l30). 'The mothyl ester (130) was formed quantitatively
(128)
by treating the acid (128) with a slight excess of diazcmethane.
The ester was a slightly hygroscopic oil which showed a single 
spot on t.l.Co and analysed correctly, Evidence for the methyl 
ester group was clearly seen in the i.r. and n.m.r.spectra*
One interesting feature in the n.m.r. spectrum (Figure 30) 
was the extremely broad singlet observed due to the ester methyl 
group, caused by hindered rotation about the urethane bond. The 
same situation was found with H-benzyloxycarbcnyl-N-metbyl— 
glycine methyl ester (131)* which at +35°C showed broad doublets 
in the n.m.r. spectrum due to the methylene and ester methyl 
groups and broad singlets for the phenyl and adjacent methylene 
groups.'^''* At +60°C, rotation was rapid and every signal was a 
sharp singlet whilst at -30°C the methyl ester,phenyl, and
105glycyl methylene groups showed doublets due to hindered rotation. J
The mass spectrum was dominated by benzyl oxy carbonyl and 
t-butyl fragmentations as expected. Other peaks of significance 
were at m/sk 162, 146, and 102 which might be produced as shown 
in Figure 31.
?\ Me
PhCELO— C —  2T
0
C  OMe
CH,2
(131)
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Ph GH2—  0
7.40 5-20 
s s
3 #90- H9C \
3.50 m
OBu 1.15 s
Figure 30 N.m.r. Spectrum of Z-L-Ser(.0Bu'b.NMe)-0Me (130) in 
CDCl-^ ( S values).
Me Me
HO.C-N ^ + C0J1 H0oCN + C0oMe
2 - V  /  2 2 %  /  2
c c
I I
CBLOH H
m/e, 162 m/e 146 m/e 102
Figure 31 Possible Ions in the .Mass Spectrum of the Ester flBO/.
6.2.2 O-t-Butyl-N-methyl-h-serlne Methyl Ester (129).
Z-Ip-Ser(OBu^,NMe)-OMe (130) ?as easily converted into Me-L-Ser(OBu% 
OMe (129) by hydrogenolysis (Figure 29). An oil, giving a single 
spot on t.l.c,was obtained in high yield. After several days at 
room temperature, the compound was found to have decomposed slightly 
and was therefore best stored at 0°C. Absorptions due to the 
methyl ester and t-butyl other groups were clearly seen in the
Me
H N *  C0oMe
X  2
C
I
H
3.05 s
0
IIc —  sr
Me 4.90-4.50 0
I!.
H Me 3*75 br- s
\
i.r. spectrum. A sharp singlet was observed in the n.m.r. spectrum 
(Figure 32) due to the ester methyl group® The multiplet due to 
the methine proton and the singlet due to the H-methyl group had 
shifted significantly upfield compared with the equivalent signals 
in the n.m.r* spectrum of the reactant (130).
2.05 
br s
2.45 s
Me
3.75-3.20 m■IT
C
3.75-3.20 H2C’ 
m
0— Me 3*95 s
OBu 1.15 s
Figure 32 N.m.r. Spectrum of Me-L-SerfOBu )—QMe (129) in CDCl  ^
(S values).
6.2.3 Q-t-Butyl-N-mathyl-BB-serine (132). The alternative 
route was attempted whereby the acid (128) was hydrogenolysed 
(Figure 29). The amino-acid (132) was obtained as a solid in 85$ 
yield. The i.r. spectrum revealed that the product existed as a 
zwitterion. The t-butyl group was obvious in the n.m.r. and mass 
spectra.
6.2.4 Methylation of the Amino-acid (132). The amino acid
(132) was treated with diasomethane (Figure 29) but the reaction 
failed to go to completion. The previous route where esterification 
preceded hydrogenolysis (Figure 29) was therefore favoured.
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6.3 Synthesis of cyclo~(L-Fhsnylalanyl-Ib-mo thyl~L~seryl)) (29).
"9
6*3*1 Coupling Procedure, Mo--L-Ser(OEu'fc)~OHe (128) and 
Z-L-Phe-OH (8l) were coupled by the DCC method (Figure 28) for 
twenty four hours rather- than five hours since coupling was slower* 
This was presumably due to steric hindrance from the H-methyl 
group* Triethylamine was not required since the free base (129) 
was used* In fact, the presence of triethylamine resulted in the 
formation of an impurity, identified by n.m.r. spectroscopy 
(Figure 33), as the F-acyl urea (133) of Z~L~Phe~OH present at 
a ratio of 3 i4 with respect to the desired product* F-Hydroxy— 
succinimide (134)? known to inhibit the formation of H-acyl 
derivatives, was found to be very effective in eliminating 
formation of (l33)« However, the active ester (135) which it 
formed with Z-L-Phe-OH was not sufficiently reactive to react 
completely with Me~L-»Ser(OBu^)”OMe (129)* After twenty four hours 
a mixture of the product to active ester of 35? was obtained.
In the absence of triethylamine and N-hydroxysuccinimide,, 
a high yield (8855) of the crude- product, benzyloxycarbonyl-E- 
phenylalanyl utyl”H-methyl-L“serine methyl ester (136).
was obtained, contaminated slightly with DCIT. A sample was purified 
by preparative t*l*c* and analysed* The LD—isomer, Z—L—Fhe—D— 
Ser(OBut,HMe)~OMe, had the same Rf value as that of the LL~ 
isomer and the only indication of its presence was a small 
shoulder on the singlet due to the t-butyl group in the n.m.r. 
spectrum*
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5*75-5*40
m 6*95—6.65m
II l 4*95-4.45^ %
Ph CH0~ 0 — C —  IT ABX c  ----   1 — —  Q
7*32 _ fL \  r
s 5.05 \  J, /  I 4.40-
x  1 /  I H 3.80 H
h O
o
11 3*95-3.35
m
■CB2 3.35-2.20
ABX
7*27 s ph _
2.20-0.63 = cyclohexyl 
- methylenes
Figure 33 n.m.r. Spectrum of If— acyl urea derivative (133) in 
CDG1-. (& values)*
A " i  P h C H g O — ^ — H  B  C—  0 —"V Nt/ rH O
(134)
(135)
6.3.2 gydrogenolysis of the Protected Bipeptide (136). The 
benzylorycarbonyl group of the protected'dipeptide (136)- was 
removed quantitatively by hydrogenolysde (Figure 28) to give 
I^^enylalanyl-O-t-butyl-M-mefhsrl-Ir-seiTine methyl ester (137)* 
which cyclised spontaneously once residual acetic acid had been 
removed completely. Two impurities were observed on t.l.c., 
one of which was BCD. Purification by crystallisation,
preparative t.I.e., and column chromatography gave cyclo- 
(L-phenylalanyl-O-t-butyl-N-methyl-L-seryl) (138) and the 
impurity, C£clo-.(L-phenylalanyl-0-t-butyl-N-methyl-])-seryl) (139)* 
Both compounds were recrystallised and analysed.
The optical rotations for both compounds were large and 
negative. The i.r. spectra of both compounds showed absorptions 
characteristic of the dxoxopiperazine structure. The amide II 
absorption was absent and the absorptions due to the secondary 
amide C=0 stretching modes were at high frequency (ca. 1680 cm"’ ) 
compared with the normal trans-value (ea. I65O cm~^). An 
absorption due to the tertiary amide C=0 stretching mode was 
present at ca. I65O cm ~ in both spectra. The n.m.r. spectrum, 
of the LL-isomer (138) run in CD^OD (Figure 34) was compared 
with that of cyclo-(L-Phe-L-S er) (Figure 14)* The ABX multiplet 
due to the methylene group derived from serine was again widely 
spread and shifted upfield due to the influence of the aromatic 
ring. However, both the shift and the spread of the multiplet 
was not so great as observed with cyclo-(L~Phe-L~Ser) which implies 
that the boat might bo flatter thus decreasing the influence of 
the aromatic ring on the methylene group. The n-m.r. spectrum 
of the LL-isomer (138) was also run in CDC1-, and compared with 
the n.m.r. spectrum of the LB—isomer (139) (Figure 35)* The 
multiplet due to the methine proton derived from serine was 
shifted ca. 1.2 p.p.m. upfield in the n.m.r.spectrum of tne 
LB-isomer (139) compared with the equivalent signal in the spectrum 
of the LL-isomer (138). An extremely large combined vicinal
splitting was also observed in the former spectrum for this multiple 
The fragmentations observed in the- mass spectra of (138) and 
(139) are shown in Figure 36. Fragmentations whereby the charge 
resided in the dioxopiperazine ring were favoured for the LL- 
isomer (138), whereas the strongest ions res\ilting from the LB- 
isomer (139) contained the charge on the side groups.
6.3.3 Beprotection 'Procedure. Several methods of removing the
+
t-butyl protecting group from cyclo-(L-Phe--L-Ser(OBu M l e )) (138) 
were attempted. Refluxing (138) in benzene with ^toluenesulphonic- 
acid, heating with trifluoroacetic acid or chloroform-hydrochloric 
acid had no effect, and starting material was recovered in every 
case. Refluxing (138) in benzene-concentrated sulphuric acid 
resulted in degradation, leading to many spots on t.l.c. The only 
method which worked was treatment with 45$ HBr-HOAc. The acetyl 
derivative (140) of cyclo—(L—Phe—L—S.er(NMe)) was also formed 
as a by-product but the extent of this reaction was reduced by 
short reaction times. Beprotection was virtually complete but 
unfortunately, the crude produbt required to be purified by 
preparative t.l.c. and the recovery of cyclo—(L-Phe—L—Ser(llMe))
(29), was not good. The overall yield after crystallisation was 
37$. The acetyl derivative was obtained in 6$ yield when the 
reaction mixture was allowed to stand for thirty minutes.
The i.r. spectrum of (29) contained absorptions, characteristic 
of the hydroxyl group, the dioxopiperazine ring, and the tertiary 
amide group. The base peak (m/e 218) in the mass spectrum of (29)
-95 ~
7.29 ra
J= 7Hz
4.14 
br t 
J= 7Hz
3.81-3.31
A33X
d
3.01
H
4.02 t 3Hz
Figure 34 ff.m.r. Spectrum of eye1o~(L-Phe-L-Se r (OBu .Hie)) 
in CH^OH (& values).
7.25 m
3*90-3.47 H2C 
m
4.45- H
4-28
ABX
2*96 s
H
5.88 br s
2. f 5-2.62 JJB1 
JAX+ JBX” 25Hz
GBu
3.90—
3.47
1.12 s
JU
Figure 35 H.m.x. Spectrum of cyclo-(L-Phe— )
in CDCl^ (6 Tsluea),
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m/e 65
> ~
\ a/g 91
fl/e <" 
157 0
m/e
218
(136)
m/ e
a/i 91 3/e-65
a/e 57
(139)
l) m/e 304
CH,2
m/e 231
CH2*C*SBKe
m/e 56
2) m/j£ 304 -3> PhCH CS=OT m/e 120
3) m/e 304
h2>?/ V "'Y5° -go
r^ote m/e 99
5 /e 127
Figure 36 Mass Spectra of cycle—(L-Phe—Ir-Ser(05u “,Blfe)) (138) 
and cyclo—(L-Pfae-B-Sgr(OBu >H?fe)) (l39).
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PhCH.
me
(140)
corresponded to a McLafferty rearrangement and an associated 
metastable ion peak at m/e 191*5 was observed. The remainder of 
the spectrum was similar to that of the reactant (138). Two new 
peaks were observed and these were thought to be due to the ions 
shown in Figure 37* The n0m.r. spectrum run in (Cb^J^SO was
m/e 248
m/e 129 m/e 101
Figure 37 Possible derivation of Ions in' the Mass Spectrum of 
(L-Phe-L-Ser(HMe)) (29)*
complicated but several multiplets sharpened after the solution
was shaken with D^O and assignments were made as shown in Figure
c d
38. The ABX> multiplet due to H and H was again widely spread 
and shifted upfield although not so much as the equivalent
PhCH,
•98.
multiplet 121 the n.m.r* spectrum of cyclo-~(L-Fhe■-L-Ser) (24).
The acetyl derivative (140) had a large negative optical
rotation,, Strong absorptions due to the ester group ire re present
in the i.r* spectrum and thore was no 0-H stretching absorption.
The mass spectrum contained many of the ion peaks discussed
already. A peak at m/o 230 was either the result of elimination
or a McLafferty rearrangement. The n.m.r. spectrum is shown in
c clFigure 39* The multiplet due to H and H was at lower field 
due to the increased electron withdrawing influence of the acetyl 
group. An AI3X multiplet, thought to be due to Bf was suprisingly 
shifted upfield and experienced large vicinal coupling.
6.3.4 cynlo-(L~Phenylalan.yl--H-methyl-L-sery 1) (141)* cyolo- 
(L—Phe-D-Ser(lTMe)) (l4l) was synthesised from tho protected 
cyclic dipeptide (139) as above. The reaction proceeded cleanly 
with little evidence of the acetyl impurity. The recovery from 
preparative t-.l.c. was again poor and the final yield was 9»5$>»
It was found that the melting; points of the LL- and LI)-isomers, 
(29) and (l4l), were virtually'identical and that booh compounds 
had the same Rf value on t.l.c* The mass spectrum of (141) was 
very similar to that of (29) but there were differences in the 
i.r. spectra. The n.m.r, spectrum of (141) was confused by solvent 
peaks but It was clear that the methino proton of the soryl moiety 
had been shifted upfield as expected.
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H
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Figure 38 N.ra,r> Spectrum of cyclo-(L-Phe-L--Ser(Me)) (29) 
in (C!D^ )j50 ( & values)*
7.35 br s
m
4*40—
3.95
m
H
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Me
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ABX
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N .m.r. Spectrum of cyclo-(L-Phenylal,anyl-Q-aoetyl-» 
N-methyl-L-seryl) in (6 values).
The discovery that the diastereomers (29) and (141) had similar 
R^ values on t.l.c. presented a problem in the radiolabelled 
synthesis. Since recovery of the protected and free cyclic 
dipeptides from preparative t.l.c. had been poor, it had been 
hoped that the Lf-diastereomer (141) could have been separated 
from the product by preparative t.l.c. after the final step. 
Separation of the diastereomer had been achieved to some extent 
by eluting four times with ethyl acetate~methanol? 10 si but the 
separation was still quite small. It was decided, therefore, tc 
carry out a total synthesis on a one ramol scale in order to see 
whether crystallisation of the final product was sufficient to 
remove the Lb-dias tere omer *
6.4.1 Tria1 Synthesis. Coupling of Me~l—Ser(OBu\)~QMe (129) 
with Z-L-Phe-OH (8l) was achieved in 8.1% yield (figure 28) and 
hydrogenolysis gave a crude oil which was estimated by n.m.r. 
spectroscopy to consist of a 9 si ratio of LL ; Lb diastereomers.
The crude product took longer to dissolve in 45$ HBr/fiOAc than 
the pure compound but the rest of the deprotoction procedure 
was carried out as normal to give the recrystallised product 
in 24$ overall yield from Z-L-Phe-OH. (8l). There was no evidence 
of the Lb-cliastex’eomer from t.l.c. and it was concluded, therefore;, 
that one crystallisation had been effective in removing the 
impurity.
6*4*2 Hadiola.be!led Synthesis. The radiolabelled synthesis
was carried out as above* L—[U—^cn Phenylalanine was converted into
Z-L-tU-^cjPhe-OH in 97$ yield with 87$ of the total .
radioactivity retained* The product was coupled with Me—L—Ser 
*b
(OBu ) —OMg (129), then hydrogenclysis and deprotection gave 
cyclo—(L- [U-^C] Phe-L-Ser(IH<!e)) in 16$ overall yield with a 
specific activity 98*8$ of the expected value. Only one 
radioactive band Tsras observed on t.l.c.* carried out in three 
different solvent systems. Multiple elution revealed the absence 
of the LD-diastereomer (l4l) as did dilution analysis, carried 
out with (29) as diluent. Dilution analysis revealed a radio­
chemical purity of 98*2$.
6.5 Feeding of cyclo-(L- QJ-'l C]Phenylalanyl-F-methyl-L-scryl) 
to Trichoderma Viride.
cyclo-(L-[U-14C]Phe-E™Ser(MMe)) was fed, in dimethyl
sulphoxide, in parallel with cyclo-( h- Phe-L-Ser) at a
-1 -1 "level of 11 mg 1 ' , 2 fJ Ci 1 , to a one day old culture of
T.viride. The culture was grown a further four days and worked 
up as described in the Experimental Section.
A significant quantity of radioactivity was incorporated 
into the crude chloroform extracts from both precursors but it 
wa,s shown-by radioscanning and autoradiography of t.l.c. plates 
of the crude extracts that, whereas most of the radioactivity 
incorporated from feeding cyclo-(L-Phe*-L-Ser) resided in gliotoxin,
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14,Precursor 2 Incorporation (f$) into X4C S.A^ of • >
Chloroform
Extract
Triturated
Extract
Pure
Cliotoxin
cyclo-(L- DJ-1'4C3 Phe-L-Ser) 84 55 2.91
cyclo-(L- LU-14C]Phe-E-Ser (lIMe)) 22 3.7 1.8x1
—1
a S.A. ~ Specific activity (//Ci mmol“ ).
Table 7 Feeding of cyclo-(L~CU-^4C]Phe-L~Ser(:NMe)).
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the vast majority of the radioactivity present from feeding 
£Z22i2'_(l'“'l’lie~lJ'"28r(i'n;/le)) was in recovered precursor0 Auto— 
radiography showed.that a very small amount of radioactivity, 
too small to be detected by radioscanning, had been incorporated 
into gliotoxin and other metabolites.
After trituration of the residue from the chloroform extract
with methanol, the radioactive incorporation dropped dramatically
to 3.7$ due to the loss of most of the H-methylated precursor.
Similar treatment carried out on the extract from the reference
feeding resulted in a drop of radioactive incorporation to
55$ (Table 7). Furth ermore, after repeated crystallisations, the
specific activity of gliotoxin isolated from the IT-methylated precursor
feeding dropped sharply to level off at a very low value of
0.002 /'Ci mmol”^. In contrast, the specific activity of gliotoxin
from the reference feeding rose slightly to a constant value 
—1of 2„91//j,Ci mmol . The ratio of specific activities was ca.
1500. Thus, the N-methylated precursor had been incorporated 
into gliotoxiu with less than 0.1$ the efficiency of oyclc--(L— 
Phe-L-Ser)•
These results, however, cannot be taken to prove that the 
E-methylated precursor is not a biosynthetic intermediate since 
other factors such as cell wall permeability or presence of the 
N—methylated cyclic dipeptide as an enzyme-bound intermediate 
may have prevented incorporation.
CHAPTER 7 ir/ALQDEHDRBT AMD
BISDETHIODlf METHYLTKIQ) HTALQHETJHRIH .
Introduction.
Hyalodendrin'*'^ (30) and the related fungal metabolite"*^
(142) are closely similar to gliotoxin. They appear to be derived 
from phenylalanine and serine and both nitrogen atoms of the 
epidithiodioxopiperazine ring are methylated. Ring closure to 
the dihydroaroraatic system has not occurred but it is not known 
whether this is due to the lack of the necessary enzyme required 
for this step or whether both nitrogen atoms are methylated 
before ring closure has a chance to occur.
It seemed likely that cyclo~(Fhe-Ser) would prove to be an 
intermediate for these metabolites and it was decided to study 
hyalodendrin specifically, since the disulphide bridge was of the. 
opposite stereochemistry to that of gliotoxin. There existed, 
therefore the possibility that cyclo-(D-Phe-D-Ser) was the 
intermediate rather than cyclo-(L-Phe-L-Ser).
7.1 ' Bisdethiodi(methylthlo)hyalodendrin (143)*
106
The conditions of growth used by Struns ot al. were 
followed but it was not possible, with the facilities then availabl©, 
to grow the culture at the required 20-21°C, the lowest possible 
temperature being 25°C. At this temperature bisdethiodi(methylthio)~
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hyalodendrin^^ (143) was produced in greater quantities than 
hyalodendrin. This compound (143) is, most likely, a degradation? 
product of hyalodendrin, analogous to bisdethiodi(methylthio)- 
gliotoxin (l44)» which has been shown'*'^ to be derived from gliotoxin. 
The fact that (143) also crystallised much more easily than 
hyalodendrin made it a more attractive compound to study. Chemical 
correlation with hyalodendrin had been achieved by Strunz et al. 
by treating hyalodendrin with sodium borohydride in the presence 
of methyl iodide and pyridine at 0°C to produce (144)* Therefore, - 
any results obtained from studying (144) should also hold true 
for hyalodendrin.
7*2 Feeding of cyclo-(Phenylalanyl-seryl) hiastereomers.
Growth conditions for the Hyaloden^ron species and the work 
up procedure are described in the Experimental Section. The 
Precursor® listed in Table 8, dissolved in dimethylsulphoxide, 
were fed at a level of 8-10 mg 1 \  activity 2.8-3*0j^Ci 1 ^
of medium. The results are summarised in Table 8.
7.2.1 Feeding of cyclo-(L-[U-^Cj Phe-L-Ser). On feeding the
radiolabelled LL-cyclic dipeptide (24),20$ of the radioactivity
fed was incorporated into the chloroform extract. Radioscanning
and autoradiography of t.l.c. plates run in three different
solvent systems showed;that the majority of this activity was
present in (143), whilst a smaller quantity was present in
hyalodendrin.
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1 3 4C Incorporation (fo) 
into
Chloroform Metabolite 
Exp„Ho.a Precursor Extract (143)
S.A.C
(143)
ds,r,
1 cyclo-(L-Cu-14Gp Phe-L-Ser) 20 10 3 *00 , 3*6x10™2
2 r cyclo~(L- DJ-14C_'I Phe-L-Ser) 63 28 7*95 1.2x10
( cyclo-(P-Phe-PL-r3-14clSer) 2.2 0.36 0.05 8,OxlO"4
3 cyclo-(L- [4»-3h1Phe-L-f3-14clSer) 63 42 7.60
—2
8.3x20
4 f cyclo-(L- [U-14C]Phe-L-Ser) 44 33 3.30 3.8xl0~2
fcyclo-(L- IjJ-14C]Phe-L-Ser(M e )) 12' 3.0xl0-3 j oxlO~4 7vlxlO“6
a Incubations bracketed were conducted in parallel, 
b The metabolite was bisdeihiodi(methylthio)hyalodendrin.» 
c Specific activity (juCi mmol of purified metabolite (143)*
^ i^ or^ rthion’'3 Specific Activity (Metabolite^3)/ Specific Activity 
(Precursor)
Table 6 Feeding Results of Cyclic Dipeptides to Byalodendrrn 
Species (FSC-6OI),
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m e
(30)' (142)
/
MeN
HeS L-
SMe
0
IJMe
CHgOH
(143)
m e  
,l> SMe
'cr2o k
(144)
The extract was purified by preparative t0l.c. and the S— 
methyl derivative was found to contain 10$ of the radioactivity 
fed. On repeated crystallisation the specific activity of the 
metabolite soon reached a constant value of 3.0/^Ci mmol and 
it was shown by radioscanning and autoradiography of t.l.c. plates 
run in different solvent systems, that the metabolite was radio— 
chemically pure. The physical properties of (143) were identical 
to the literature values.
7.2.2 Feeding of cyclo-(D~JbJhe-bL~ L3-~^cQ Ser). The radiolabelled 
mixture of DD- and DL-diastereomers were fed in parallel with
14
cyclo-(:L- [U~ C] Phe-L-Ser) • The latter was incorporated efficiently 
whereas the former. mixture was poorly incorporated into the
*•>
SU-methyl. metabolite. The specific activity of the pure metabolite 
was 0,6$ of that value measured for* the reference feeding. 
Measurement of the radioactivity of the aqueous broth demonstrated 
th,at ca* 20$ of the radioactivity fed as the diastereoraerio 
mixture had probably been incorporated into the mycelium.
It was concluded that cyclo—(L-Phe—L—Ser) and not cyclo— 
(b-Phe-JD-Ser) or cyclo-(D-Phe-L-Ser) was the biosynthetic 
intermediate for bisdethiodi(methylthio)hyalodendrin and therefore, 
also for hyalodendrin,
2*2-3. Feeding with Doubly Labelled cycIo-(h~Phe-h-5er), 
cyclo-( L- [4•-%] Phe-L- [>14CjSer) was incorporated extremely 
well (ca. 42$) into the jS-methyl metabolite (143) and the isotope 
ratio of the crystallised metabolite (ll'.l) mis essentially 
unchanged from that of the precursor (l0,9)* This result, as 
explained in Chapter 4>demonstrates that the precursor was not 
degraded into its constituent amino-acids which might then have 
been incorporated into the metabolite.
An attempt was made to isolate hyalodendrin itself by feeding 
the precursor to a five day old culture and working up two days 
later. The chloroform extract contained 28$ of the radioactivity 
fed with the isotopic ratio (ll,2) relatively unchanged from 
that of the precursor (l0.9). Radioscanning showed that the 
activity was almost evenly divided between hyalodendrin and the 
dimethylthio-metabolite (143). Preparative t.l.c. gave a small
quantity of “both compounds as solids. Hyalodendrin had a 
activity of 16.3/'Ci mmol*”1 and a ^Ht^C rati© of 11.2 while 
the corresponding figures for bisdethiodi(methylthio)hyaiodendi’in
r „ . -1
were 16.1 //Ci mmol and 10,6. In both cases the isotope ratio 
was essentially unchanged and the activities were virtually 
identical, as expected. Unfortunately,*, there was insufficient 
metabolite for further crystallisations to constant activity.
7«»3 Fe ofling of cyclopL~ TjJ-^C]Phenylalanyl-H-methyl-L-scryl)«
cyclo-(h~ rU~14C 1 Phe-L-Ser(ITMe)) Was fed in parallel frith labelled 
cyclo-(L-Phe-L-Ser) on the same scale described above. Incorporation 
of .the former precursor into the dimethylthio metabolite proved 
to be extremely small, and the radioactivity measured in the 
chloroform extract was due to unchanged precursor. Only 0.003$ 
of the activity fed was present in bisdethiodi(methylthio)- 
hyalodendrin after preparative t.l.c. From the radioactivity 
of the aqueous broth after chloroform extraction it was concluded 
that ca. 16$ of the radioactivity fed was probably incorporated 
into the mycelium.
137.4 Biosynthetic Studies with C.
Degradative studies require to be carried out on doubly 
labelled bisdethiodi(methylthio)hyalodendrin, derived from 
cyclo-(h- f4t~^5l Phe-L-D-^ClSer), to prove that the labels are 
in the expected positions. As an alternative to chemical
-1X0-
degrad^tion it was proposed to synthesise and feed cyclo—
(L-Plie-DL-[3- "'Cjser). The dimothylthio metabolite isolated from
11such a feeding would then be studied by C n.m.r. spectroscopy 
which should demonstrate whether the label was in the expected 
position.'
cyclo-(L-Phe-DL-[ 3 C] S er ) was synthesised from DL— {3— 
serine by the method described in Chapter 4® However, t.l.c# 
showed two compounds in the final product and it was concluded
that the impurity was cyclo~(glycyl-L-phenylalanyl) on the basis
1 I"*
of H n.m.r.spectroscopy and t.l.c., A sample of DL-[3~ JC]serine
was checked for purity by n.ra.r. spectroscopy and found to
contain glycine. Several unexplained peaks were also present in
the n.m.r. spectrum. Due to the difficulties involved in purifying*
the final mixture of products this research was terminated*
7*5 Conclusion.
Since cyclo-(l~Phe~L-Ser) appears to be the biosynthetic 
intermediate for bisdethiodi(methylthio)hyalodendrin rather than 
cyclo-(P-Phe-P-Ser), inversion of the chiral centres of the cyclic 
dipeptide must occur during biosynthesis. This is contrary to 
the situation ini gliotoxin biosynthesis where the chirality of 
the LL-cyclic dipeptide is retained in gliotoxin*
Inversion would most likely take place during the incorporation 
of the disulphide bridge. A reaction scheme (Figure 40) for the 
incorporation of sulphur was suggested by Kirby and Bobins „
RN
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Figure 40 Postulated Reaction Scheme28
in their discussion concerning gliotoxin biosynthesis. Structure 
(145) might be common to both gliotoxin and hyalodendrin 
biosynthesis. The opposing stereochemistry of the disulphide 
bridge in these metabolites would then arise from the sulphur 
source attacking opposite sides of the structure (145)*
CHAPTER 8 EXPERIMENTAL
8.1 General Notes
Melting points are corrected and were measured with a Kofler,
hot stage apparatus. Infra red spectra were recorded for KBr discs,
unless otherwise stated, with Perkin-Elmer 197*257 or 580 Infra
red Spectrophotometers or a Perkin-Elmer 225 Grating Infra red
Spectrophotometer. Nuclear Magnetic Resonance Spectra were recorded for
CLCl^ solutions,unless otherwise stated, with Varian T-60, Perkin-
Elmer R32, or Varian XL-100 spectrometers. Tetramethylsilane was
used as internal standard. Mass spectra were obtained with an
AEI MS 12 spectrometer. Analytical t.l.c. separations were carried
out on precoated, silica GF254 plates and preparative separations
on GEVjf^ (type 60) plates. Open chain dipeptidos were detected
with a ninhydrin spray. Cyclic dipeptides were detected by the
following procedure. The plate was sprayed with bleach then allowed
to stand for thirty minutes before spraying with absolute ethanol.
After ten minutes, the plate was sprayed with a 1:1 mixture of
1$ potassium iodide solution and a 2% solution of o-toluidine
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in 10$ acetic acid in water. All concentrations were carried 
out by rotary evaporation under reduced pressure. Organic solutions 
were dried over magnesium sulphate or sodium sulphate and sQlid 
samples were dried over phosphorus pentoxide in vacuo.
The following t.l.c. systems arc referred to in the text 
and are quoted as superscripts (R^)s A) n—outanol—acetic acid-
watery 4:1:1 B) n-butanol-acetic acid—pyridine—water; 15:10:3:2 
C) methanol-water; V t3 D) toluene-acetone; 2:1 E) ethyl acetate 
chloroform-diethylamine; 1:1:0.1 F) ethyl acetate-petrol ether 
(40-60°C)-acetic acid; I:l:0.1 G) di~isopropyl ether-chloroform- 
acetic acid; 6:3:1 H) chloroform-acetic acid; 3 si I) methanol- 
ethyl acetate; 1:1 j) toluene-acetone; 5»2 K) ethyl acetate— 
methanol; 10:1 L) chloroform-methanol: 15:1 M) chloroform- 
methanol; 15:2 B) ethyl acetate-methanol; 6:1 O') toluene-acetone 
94:6.
The following'abbreviations are used in the text: pet. ether 
(petrol ether 40-60°C); br (broad); £ (delta value in p.p.m. 
for n.m.r.); exch. (exchanged).
8.2 Radiochemical Methods.
and activities were measured with a Philips liquid 
scintillation analyser using toluene-metlianol solutions. Open 
chain "dipeptides were measured using methanol-triton X100—toluene 
(0.06:1.0:2.0) solutions. A Panax Thin Layer Scanner RTLS-1A 
was used for the radioscanning of t.l.c. plates and Ilford Red 
Seal 100 Fff X-ray film was used for autoradiography.
8.3 Fermentation Conditions
1Triohoderma vlride1 (Gliocladlum deliouescens, strain no.
-114-
1828 NRRL) was maintained on potato dextrose agar and grown in 
shake-culture at pH 3.0-3.5 in a defined medium4 at 24°C.
Precursors were added to 1 day old cultures of T.virid.e through 
a sterile syringe. After 4 days, the mycelium was filtered off 
and treated with methanol. The filtrate was neutralised with 
sodium hydroxide, saturated with sodium chloride, and extracted 
(x6) with chloroform (10$ by volume). The extracts were dried 
and evaporated. Gliotoxin (ca. lQOmg 1  ^of medium) was crystallised 
from methanol..
Hyalodendron sp. (FSC-601) was grown as a shake culture at 
25°C as described by Stillwell et al.^^ Radiolabelled precursors 
(ca. 8-10 mg 1 \  ^4C activity 2.8-3.0//Gi 1 ^) dissolved in 
dimethylsulphoxide (lml) were fed to 5 day old cultures and growth 
continued for a further 9 days. Mycelia were filtered and killed 
with methanol. The aqueous filtrate was extracted (x6) with 
chloroform (10$ by volume) and the organic extracts were dried 
and evaporated. The residue was taken up in chloroform and washed 
twice with water then dried, filtered and concentrated to a solid. 
Bisdethiodi(metbylthio)hyalodendrin was purified by preparative 
t.l.c. (toluene-acetone; 94:6) and crystallised from methylene 
chloride-cyclohexane to give needles, usually 50 mg 1 ^ of medium, 
m.p. 139-140°C (lit.,108 140-140.5°C), M D24 + 63.5° (c, 2.5, CHC13)
(lit.,108 + 64°). Mass, n.m.r. and i.r. spectra were in agreement 
with the literature.*1-0^
8.4 Experimental for Chant eg- 3„
L—Phenylalanine 'Benzyl Ester Hydrochloride (66) — Thionyl
chloride (20 ml, 278 mmol) was added dropwise over 20 min to a
stirred suspension of L-phenylalanine (3.3 g? 20 mmol) in benzyl
alcohol (125 ml) at 5 °C, After heading on a steam hath for 5
the solution was dried and filtered before dry ether was added
to turbidity. On cooling overnight a solid crystallised which
was filtered and dried, (5.22 g, 89.5$), m.p. 188-191 °C.
Recrystallisation from ethanol gave (66) (3.07 g) m.p. 195-196.5
°C (lit.,70 202 °C); vmax>3 300 - 2 500, 1 754, 1 490, 1 230,
750 - 740, and 697 cm-1; £ [(CD ) Soj (60 MHz) 9.30 - 8,55 (3H,
+
m, MH3), 7.35 (5H, s, Ph), 7.25 (5H, s, Ph), 5.15 (2H, s, OCHgPh),
4.50 - 4.10 (1H, m, CHCH2), and 3.40 - 3.00 (2H, m, CHGH^). 
Recrystallisation of the mother liquor yielded more (66) (l„08 g), 
m.p. 19i”192 °C.
N—Benzyloxycarbonyl-L~seryl-L~phenylalanine Benzyl Ester (68) - 
L~Phenylalanine benzyl ester hydrochloride (66) (2.91 g, 10 
mmol) was dissolved in methylene chloride (50 ml) at 0 °G by the 
addition of triethylamine (1.8 ml, 12.5 mmol). R-Benzyloxycarbonyl- 
L-serine (67) (2.39 10 mmol) was added followed by DCC (2.38 g,
11 mmol) and the mixture allowed to stand in the dark for 5 h.
DCU was removed by filtration through a Celite pad and washed 
with methylene chloride. The filtrate was washed with 1M hydro­
chloric acid, water, saturated sodium hydrogen carbonate solution 
and water, then dried, filtered and concentraoed to an oil.
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The residue was dissolved in a small volume of acetone and
the precipitate removed "by filtration. The filtrate was
concentrated to give (68) (3.384 g, 71.1$). Crystallisation
from ethyl acetate — petroleum ether (3sl) and further washing
wdth ether.gave needles (2.36 g, 50$), m.p. 128 - 130 °C (lit.,69
129-130 - 7.31° (o 2.34, Me^NCHO) (lit.,69 - 8.2°),
M d19 - 13«9° (o 1.8, CHC13), R /  0.47? vmax.(GHC13) 1 750 -
1 700, 1 680, and 1 500 cnf1: S 7.42 - 6.88, 7.30 (15H, in, 3 x Ph),
6.90 - 6.80 (1H, m, Do0 exch., NH), 5.80 - 5.60 (lH, hr d, J 7 Hz,
lyj exch., NI-I), 5.14 (2H, hr s, OCHgPh), 5.07 (2H, s, OCHgPh),
4.99 - 4*68 (lH, m, alters on D^O shake to hr t, J 6 Hz, CHCH^Ph),
4*35 - 4.10 (lH, m, sharpens on Do0 shake to ABX, J v + J^v 9*5
c ”  Aa  13a
Hz, CHCH OH), 4 . H  - 3.47 (2H, ABX, 11.5 Hz, 4.0 Hz,
6.0 Hz, sharpens on B^O shake, CHgOH), 3.28 - 2.87 (2H, ABX,
14 Hz, J = JM  6 Hz, CHgPh), 2.70 - 1.00 (lH, hr m, DgO exch.,
OH); m/o. 476 (weak, M), 120 (15$, PhCl^CIMHg), 108 (26, PhCHgOIi), 
107 (17, PhCHgO), 91 (100), 79 (38), 77 (25), 65 (16).
N-Benzyloxycarbonyl-L—serine (67) - N-Benzyloxycarbonyl-
L-serine (67) was synthesised from L-serine hy the method of
o 71
Guttman and Boissonas as crystals (86 0^), m.p. 116—118 C (lit.,
119.5 °c)>[°<]x)20 + 5.2° (c, 1.04, AcOH) (lit.,71 + 5.6°), Rf 0.13 
(ethyl acetate - pet. ether - acetic acid; 20s20;l); vmax#(Nu3°l)
3 550 - 2 400, 3 340- 3 320, 1 690, 1 520, 745 - 725, and 695 cnf1;
6 [(CD3)2SO] (60 MHz) 7*45 (5H, s, Ph), 5.10 (2H, s, OCH Ph), 
4.30 - 3.95 (1H, m, CHCHg), 3.90 - 3.60 (211, m, CHCHg).
L-Seryl-L-phenylalanine (65) - Water (16 ml), followed by 
acetic acid (0.4 nil), was added dropwise at room temperature to 
a stirred solution of N-benzyloxycarbonyl—L-seryl—L—phenylalanine 
benzyl ester (68) (269.5 mS, 0.57 mmol) in ethanol (32 ml).
The solution was hydrogenated for 3 h over 10$ palladium on 
charcoal catalyst (30 mg). The catalyst was removed by filtering 
through a Celite pad which was then washed with water (3 x).
The combined filtrates were concentrated to yield a solid (149 mg) 
which was triturated with chloroform and ether to give (65) (125*4 
mg, 88$), m.p. 218-225 °C (lit.,69 226-227 °C) ,[o<] .p20 + 51*04°
(o. 2.4» AcOH) (lit.,69 + 53.8°), RpA 0.40, O.56, Rp0 0.78;
(Pounds C, 57°00; H, 6.66; N, 10.90. ci2Hl6N2°4 re^uires c> 57.14? 
H, 6.35? N, 31.11$); v ^ 3 600 - 2 200, 3 200, 3 010, 1 680,
FOcLX «
1 570, 1 500, 1 405, 1 015, 745, and 715 - 700 cnf1; & (CF^COOH)
7.82 (1H, br d, J 7.5 Hz, DgO exch., amide NH), 7*53 (3H, br s,
+
D20 exch., NII^ ), 7*50 - 7*10 (5H, m, Ph), 5.30 - 4*90 (lH, m, 
CHCHgPh), 4*82 - 4*45 (1H, m, CHCHgOH), 4*60 - 4.12 (2H, m, 
sharpens on D^O exchange, CH^OH), 3.60 - 3.00 (2H, ABX, J^.
6 Hz, J 8 Hz, JAB 15 Hz, CH2?h);m/e 252 (weak, M), 222 (5$, 
M-CH20), 120 (13, PhCH2CH=NH2), 91 (30), 77 (6), 65 (7), and 60 
(100, H2N=CHCH20H).
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jr:.C4-^ H] Phenylalanine Benzyl Ester Hydrochloride - An 
aqueous solution of phenylalanine ( 500pCi) was added
to L—phenylalanine (165.5 mg, 1 mmol). The resultant solution 
was conoentrated slowly and dried in vacuo overnight. The 
solid was suspended in henz.yl alcohol (7 ml), cooled to 5 °C 
and thionyl chloride (l ml) was added over 20 min. The reaction 
mixture was maintained at 95 °0 for 5 Subsequent work—up
was as described for (66) yielding crystals (264 mg, 91$),
•5 _■}
H activity 448.2 pCi mmol .
H-Benzyloxycarbonyl-L- [3-^0] serine - L- [3-^C] Serine 
(50-pCi) was diluted with L-serine (105 mg, 1 mmol) and converted 
as described earlier to Z-L-[3-^^C]Ser, 196 mg, (82$), activity 
S0.1 pCi mmol
H—Benzyloxycarbonyl-L- IB-1^ ]  seryl-L-[~4-^H]phenylalanine 
Benzyl Ester - N-Benzyloxycarbonyl-L-[3-^C] serine (239 mg,
1 mmol, 41.1 pCi mmol'"1) was coupled with L-[4-^H]phenylalanine 
benzyl ester hydrochloride (291.5 mg, 1 mmol, 405*9 M-Oi mmol ) 
in the presence of DCC (228 mg, 1.1 mmol) and triethylamine 
(0.18 ml) as described above to give, after crystallisation 
and washing, a white solid (268.3 mg, 56.6$), activity
39.3 pCi mmol-1, ^H:1 C 12.1, showing one radioactive band 
on tic, Rp 0.27 (StOAc - CHC13 - BtgNH; 7.5:7.5:0.6) by Panax 
scanning and autoradiography.
L- [3-  ^Gj Sery 1-L- pheny 1 alanine - IT-Ben zy 1 o xy ca.rbony 1—
r 14 i f 3
L- L3~ Cj seryl-lr-[4- K]phenylalanine "benzyl ester (268.3 mg,
—  1
0.56 mmol, 39*3 M-Ci mmol ) was hydrogenated and worked up as 
described earlier to yield a solid, (121 mg, 8$.7$), 14C activity 
38.72 fiCi mmol"’1, 3fl:14C 12.3? RpA 0,40, R ^  O.56, Rp° O.78,
0 .00. A single radioactive product was observed by Panax 
scanning and autoradiography of tic plates. Dilution analysis 
with H-L—Ser-L—Phe-OH (65), H-L-Ser-D-Phe-OH (73) and H-D-Ser- 
lA-Phe—OH (74) showed that the radiochemical. purity was not less 
than S6fo and that not more than 0.2$ .H-L-Ser-D-Phe-OH (73) or 
H-D-Ser-L-Phe-OK (74) was present.
N-Benzyloxycarbonyl-D~serine (77) — H-Benzyloxycarbonyl- 
D—serine (77) was synthesised from D-serine (78) in 90$ yield 
following the same procedure described for the L-enatiomer. 
Physical properties were identical to Z-L-Ser-OH except for 
optical rot at i on, — 4*3° (jc 1.0° AcOH) (lit.,^A - 5*6°)
D-Phenylalanine Benzyl Ester Hydrochloride (79) - 
D-Phenylalanine benzyl ester hydrochloride was synthesised 
in a similar fashion to the L-enanticmer (66) yielding light 
silvery crystals (95$) which were recrystallised from ethanol 
(4756) m.p. 191 - 194 °C.
IT—Benzyloxycarbonrfl—L—seryl—D—phenylalanine Benzy 1 Bster 
(76) - The protected dipeptide (76) was synthesised on an 18
-120-
mmol scale in the same manner described for the enantiomer (75) 
to give, after recrystallisation, a solid (4.17 g, 48.7$), 
having identical physical properties to its enantiomer with the 
exception of optical rot at i o n , - 2.82° (jc, 4.6, CHCl^).
N-Benzyloxycar'bonyl-D-seryl-L-’phenylalanine Benzyl Bster 
M l  - N-Benzyloxycarbony1-D-serine (77) (4.302 g, 18 mmol) 
was coupled with L-phenylalanine benzyl ester hydrochloride 
(66) (5*247 g, 18 mmol) by the j)CC procedure described above 
to give the protected dipeptide (75) (4.663 g, 54*4$)? m.p. 116-
119 °C, R,^ 0 . 4 4 , M ]}19 + 1.9° (0, 4.8, CHCl^); (Pounds C, 67.825 
H, 5.SO: N, 5>88. C27H28H2°6 requires G> 68.07; H, 5*88; 11,5.88$); 
vm^  3 600 - 3 150, 1 740, 1 695, 1 655, 1 550 - 1 530, 1 020,
UlcwL p
760 - 730, and 700 cm"*1; & 7.50 - 6.70, 7*30 (l6H, m, 3 x Ph and 
NH), 5.90 - 5*60 (ill, br d, J 8 I-Iz, I>20 exch., NH), 5*13 (2H, d,
J 2 Hz, OCHgPh), 5.08 (2H, s, OCHgPh), 4*97 - 4*75 (1H, m, 
sharpens on DgO shake, OHCH^Ph), 4*33 - 4.08 (lH, m, sharpens 
on DgO shake, CHCHgOH), 4*05 - 3*48 (211, ABX, sharpens on D^O shake,
JAX 5,5 E7j> JBX 3,4 HZ? JAB 12 HZ? CS20E^  3‘°7 ^2Hj d’ G^ 2Ph^  
and 2.75 ~ 2.25 (1H, br m, D20 exch., OH); m/e, 476 (weak, M),
120 (16$, PhCH2CH-NH2), 108 (55), 107 (43), 92 (22), 91 (100),
79 (77), 77 (55), 65 (25).
L-Seryl-D-phenylalanine (73) - N-Benzyloxycarbonyl-L-seryl- 
])-phenyl alanine benzyl ester (76) (2.8 g, 5.88 mmol) was
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hydro genated for 3 h and worked up as described earlier for the 
LL dipeptide (65) to give a slightly yellow solid, (1.068 g,
72$). Crystallisation from methanol — water (2:1) gave the 
dipeptide (73) as prisms, (652 mg, 440/), m.p. 249 - 252 ° C , M I)20 
v - 29.34° (o 2.9, AcOH), RfA 0.40, RfB O.56, RF° O.78, RpH 0.00
(Pound: C, 57.01; H, 6.58; N, 10.7. c12hioN2(14 requires C, 57*14;
H, 6.35; N, ll.lfl; vmax> 3 500 - 2 250, 3 330, 3 090, 2 130,
1 685, 1 570 - 1 500, 1 410, 1 050, 760 and 710 cm""1; & (CFoC00H)
+ 3 
7.84 (1H, br d, NH), 7.32 (m, NH , Ph), 5.40 - 5.02 (lH, m,
sharpens on D^O shake to ABX, 14 Hz, CHCHgPh), 4.77 -
4.40. (1H, m, CHCHgOH), 4.30 - 3.72 (2H, ABX, J 12.5 Hz, 4.0
Hz, 6.5 Hz, sharpens on DgO shake, CH^OH), 3.70 - 2.92 (2H,
ABX, 14.5 Hz, 9.0 Hz, 5*0 Hz, sharpens on D^O shake,
CH^Ph)5 m/e 252 (weak, M), 222 (5$, M-CHgO), 120 (13), 91 (30),
77 (6), 65 (7), 60 (100).
D-Seryl—L—phcnylalanine (74) — D-Seryl-L-phenylalanine was
synthesised as above on a 2.12 mmol scale to give a triturated 
yield of 75$ an(^- a recrystallised yield of 6l$, m.p. 251-253 °C, 
|o£]p^ + 25.8° (_c, 2.2, AcOH) having identical spectroscopic 
properties to its enantiomer (73).
Benzyloxycarbony1-L-phenylalanine (8l) - A solution of 
L-phenylalanine (8.275 gy 50 mmol) in freshly prepared 2M sodium 
hydroxide (32.5 ml, 65 mmol) was cooled to 0 °C and stirred
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vigorously, Benzyloxy carbonyl chloride (90$; 7.5 ml) and 4M 
sodium hydroxide solution (12.5 ml, 50 mmol) were’ added 
dropwise over a period of 30 min and stirring continued for 
a further 10 min. Excess "benzyloxycarbonyl chloride was removed 
by .ether extraction (3 x). The a.queous solution was cooled 
and acidified to pH 1 with concentrated hydrochloric acid. A 
white solid was precipitated which was filtered, washed and dried 
(14*2 g, 95%>) * Recrystallisation from methylene chloride - pet. 
ether gave (8l) as needles (13«4 g? 90%) m.p. 85-87 °C (lit,,78 
87-89 0C),[o<]D21 + 6.23° (o 2.6, StOH) (lit.,78 + 5.1°); vmax#
3 460 - 2 400, 3 317? 1 705, 1 695, 1 530, 1 270, 740, and 700 
cm*"1; $ 9.55 - -9.10 (III, m, DgO exch., COOH), 7-40 - 7.00 (5H, 
m, CHCH^Ph), 7.28 (5H, s, 0CH_Ph), 5.35 - 5*10 (lH, m, Do0 exch.,
C. T C- C-
UH), 5.06 (2H, s, OGH^Ph), 4.80 - 4.50 (lH, m, CHCH2), 3.20 -
2.90 (2H, m, CH^Ph)•
Benzyloxycarhonyl-D-phenylalanine was similarly prepared in 90$> 
yield.
L-Serine Methyl Ester Hydrochloride (83) - L-Serine (5*25 g,
7950 mmol) was converted by the method of Brenner and Huber ' to 
the methyl ester hydrochloride (83), (7.05 g* 91%) ni.p. I6I-I65 C 
(lit.,80 165-166 °C); v (Hujol) 3 350, 1 740, 1 590, 1 505,
IHctX*
1 250, 1 040, cm"1; & (CP^COOH) (60 MHz) 7*70 (3H, m, ), 4.70 -
4.50 (4H, m, CHCH2), and 4.00 (3H, s, OCI-^ ).
Benzyloxyoarbonyl—L-phenylalanyl—L-serine Methyl Ester (82)
— Benzyloxycarbonyl~L~phenylalanyl-L-serine methyl ester (82) was
D*i *“
synthesised as described by Nicolaides in 70$ yield, m.p. 120- 
122 °C (lit.,81 122-123 °C) (Found; C, 63.28; H, 6.20; N, 6.88. 
C21H24N2°6 requires C, 63.00; H, 6.00; IT, 7.00$); vmax 3 600 - 
3 150, 3 310, 1 745? 1 700, 1 660, 1 540, 1 060, 750 and 700 cm"1 
S 7.50 - 7.00 (lH, m, 1JH), 7.22 (5H, s, Ph), 7.17 (5H, s, Ph), 
5.86 (IK, br d, J 8.0 I-Iz; NH), 5*13 - 4.82 (2H, AB, J 12.5 -
14.5 Hz? OCH^Ph), 4.75 - 4.40 (2H, m, 2 x CH), 3.95 - 3.75 (2H, 
m, CH20H) 3.6? (3H, s, OOH ), 2.50 - 2.25 (lH, br s, BgO exch., 
OH), 3.30 - 2.80 (2H, ABX, J.Y 6.0 Hz, J_v 8.0 Hz, J._ 14 Hz,
AA }5xV A H
CHgPh); m/e 400 (weale, M), 120 (10$, PhGHgCHsNHg), 92 (16), 91
(100), 79,(10), 77 (12), and 65 (l6).
Benzyloxycarbonyl-L-phenylalanyl-L-serine (80) by 
Saponification - 3enzyloxycarbonyl-L-phenylalanyl-L-serine methyl 
ester (82) (l g, 2.5 mmol) was shaken with 2M sodium hydroxide 
(2.52 ml, 5.0 mmol) in methanol (20 ml) for 15 min then acidified 
with acetic acid. The solvent was removed by evaporation and 
the residue was dissolved in sodium hydrogen carbonate solution 
and washed with ether to remove starting material. The aqueous 
solution was cooled, acidified with concentrated hydrochloric 
acid and extracted with methylene chloride. The combined 
organic extracts were dried, filtered and concentrated to give 
(80) (882 mg, 91.4$). Crystallisation from ethyl acetate - ether 
gave a stone coloured solid (80) (88 mg, 9^ -)? m.p. 147—151*5 0
(lit.,75 147-149 °c and76 155-156 °C),[o<]D22 + 0.2° (c_2.1, 
MeoNCB0) (lit.,75 + 44.8° and76 - 2,6°); v 3 700 - 2 400,
1 710, 1 665, 1 535, 1 055, 745 and 700 cm"1;6 [(CD3)2CO] (60 MHz) 
7.30 (10 II, s, Ar), 6.70 - 6.20 (1H, m, D20 exch., Ml), 5.50 - 
4.80 (3H, D20 exch,, C00H,0H,NH), 5.00 (2H, s, OCjyPh), 4.90 - 
4c40 (2H, m,2CH), 4.20 - 3.60 (2H, m, CH OH), 3.15 - 2.85 (2H, 
m, CH2Ph); m/e 386 (weak, M), 148, 120 (FhCH2CH=NII0), 92, 91 
(100$), 79, 77, and 65. .
Recrystallisation of the mother liquor yielded a further 
crop (239 mg, 24.4$), m.p. 142-I48 °C,[cxJi)22 -1.1° (c 2.3,
MegNCHO). The mother liquor was concentrated to a sticky solid 
(555 mg), m.p. 59-61 ^ j M ^ 22 - 15.8° (c 2.0, Me^NCHO),
.Benzyl oxy car "bony 1-L-pheny 1 alanine p-Nitrophenyl Ester (85)
— Benzyloxycarhonyl—L-phenylalanine-p~nitrophenyl ester (85) was
77synthesised as described by Bodanzky and Vigncaud in 71 $ 
yield, m.p. 124*5-126.5 °C (lit.,77 126-126.5 °C), v  3 360,
1 760, 1 697, 1 617, 1 595, 1 528, 1 490, 1 350, and 700 cm"1?
6 (60 MHz) 8.30, 8.15, 7*80 - 6.90 (14K, m, Ar), 5.50 - 5.10 
(1H, m, Mil), 5*15 (2H, s, OCiyPh), 5.00 - 4.70 (lH, m, CHCHgPh), 
3.15 (2H, br d, J 6.5 Hz, CH Ph).
Benzyloxycarbonyl-L-phenylalanyl-L-serine. (80) - Benzyloxy- 
carbonyl—L—phenylananine p-nitrophenyl ester (85) (1*575 g, 3.75 mmol) 
was coupled with L-serine (392.5 mg, 3-74 mmol) as described by
-125-
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Bodanzky et ad. , reacting for 40 h rather than 16 h. An
off white solid was obtained, (610 mg, 42$), rn.p. 150 -154 °C
(lit.,76 155-156 °C, 154 °C s i n t P . M j 20 - 3.3° (o 2.5,•MOgHCHO) 
(lit.,76 - 2.6°).
L-Serine Benzyl ffster p-Toluenesulphonate (87) - L-Serine 
(165 mg, 1 mmol) and p-toluenesulphonic acid (209 mg, 1.1 
mmol) were heated at 100 °C with stirring in benzyl alcohol 
(4 ml) until dissolved. Dry carbon tetrachloride (7 ml) was 
added dropwise and the reaction apparatus set up for reflux 
through a Soxhlet apparatus containing molecular sieves. A 
slight cloudiness developed which disappeared after a few minutes 
boiling. The solution was refluxed for 6 h during which more CCl^
(5 ’ml)- was Ladded, after, rcoolirig dry ether was. added. Cooling for 16 h 
gave an. oil(289 mg, 79$)5 & (CD^D) (60 MHz) 7.75, 7.60, 7.25, 7.10
(Aromatic), 7.32 (s, Ph), 5.20 (s, CHgPh), 4.25 - 3.80 (m, 0HCH^),
2.35 (s, Me). Crystallisation from i-propanol - ether was 
unsuccessful.
D-Serine benzyl ester p-toluenesulphonate -was similarly prepared.
Benzyloxycarbonyl-L-phenylalanyl-L-serine Benzyl Ester (86) - 
Crude L-serine benzyl ester p-toluenesulphonate (87) (1.768 g,
4.82 mmol) was coupled with benzyloxycarbonyl-L-phenylalanine 
(1.441 g, 4.82 mmol) in the presence of DCC (1.099 g, 5*3 mmol) 
and triethylamine (0.915 ml) by the procedure described
previously for (65)* The product was treated with acetone to give 
a yellow oil (2.044 g9 89$) which was taken up in ether and 
cooled for several days to give the protected dipeptide (86)
Tp
as needles, (986 rag, 43/&), Rp 0.40. A sample was recrystallised 
from ethyl acetate — pet. ether (3si) to give needles, m.p. 115- 
118 ° C , M I)20 + 17.3° (o 1.16, CHCl^) (Pound; C, 67.90; H, 5.92;
N, 5*^7* C27H28IT2°6 re!lttires C5- 68.07; H, 5*88; N, 5.88$); vma.£
3 600 - 3 *150, 3 310, 1*737, 1 695, 1 645, 1 540, 1 045, 745, and 
699 cm”"1; & 7.28, 7*23, 7.14 (15H, s, Ar), 7.10 - 6.78 (ill, m,
I)20 exch., NH), 5.60 - 5.40 (lH, hr d, J 8.0 Hz, D20 exch., NH), 
5.14 (2H, s, 0CH2Ph), 4.99 (2H, s, OCHgPh), 4.75 - 4.30 (2H, m,
2-x CH), 4.00 - 3.78 (2H, hr d, CH OH), 3.15 - 2.95 (2H, m,
CHCH Ph), 3.10 - 2.50 (111, hr m, DgO exch., OH); m/e 458 (weak,
K—HgO), 120 (1056), 108 (11), 107 (9), 92 (19), 91 (100), 79 (23), 
7? (23), and 65 (27).
L—Phenylalanyl-L-serine (64) - Hater (28 ml) and acetic 
acid- (0.8 ml) were added dropwise to a stirred solution of 
henzyloxycarhonyl-L-~phenylalanyl-L-serine benzyl ester (86)
(400 mg, O.84 mmol) in ethanol (56 ml). The solution was 
hydrogenated over 10fo palladium on charcoal (40 mg) for 30 min.
The catalyst was removed hy filtration, then washed and the 
filtrate concentrated to an oil at 30 — 40 C. Residual acetic 
acid was removed hy azeotroping with ethanol and the residue 
was triturated with, chloroform to yield (64) as a. solid (233 mg,
■127-
102$), m.p. 121-125 °C (lit.,75 116-125 ° C ) , M ^ °  + 34.8° (ci) ~
2.3, water) (lit.,75 + 30.1°), EL,1 0.38, eJ3 O.65, E ^ 0.62,
*}‘ IF I1
RpH 0.00, (Pound: C, 53.865 H, 6.79; II, 10.25.' . H20
requires C, 53.33; H, 6.6?; N, 10.37$); v , 3 700 - 2 300,max.
1 675, 1 605, 1 525, 1 390, 750, and 700 cm"1; & (CP^COOH) 8.35
+
(1H, hr d, J 7 Hz, amide NH), 7.37 (8H, hr s, Ph, NRj), 5.60 -
4.60 (211, m, 2 x CH), 4.60 - 4.10 (2E, o, CHgOH), 3.70 - 3.15 
(2H, m, CHgPh); m/e 234 (weak, I»l—HgO), 120 (100$), 103 (25), 91 
(73), 77 (16), 73 (45), 65 (16), and 60 (14).
1 A #■* "1A -n
L-[3- CJS erine Benzyl Bster p—Toluenesulphonatc — L— f3— Qj
—1Serine (131.2 mg, 1.25 mmol, 40 gCi ramol ) was dissolved
wi-th jD-toluenesulphonic acid (261.5 mg) in benzyl alcohol (5 ml)
at 100 °C. The procedure described earlier was followed to give
(87) as an oil, (302 ■mg, 66$).
Benzyloxycarhonyl-L- Qi— phenylalanine — Ir- [4-3H]Phsnyl-
— 1 -
alanine (I65 mg, 1.0 mmol, 500 pCi mmol ) was reacted with 
"benzyloxycarbony 1 chloride as described earlier to give (8l),
—  J*
(270.0 mg, 90.3$, H activity 554 PCI ramol ).
B en zy 1 oxy car "bo ny 1—L— (4— phonylalanyl—L— [3— serine
Benzyl lister - L— [3—1^C] Serine benzyl ester p-t oluenesiilptoomate
(330 mg) was coupled with benzylory carbony l-L- |l4-^E]phenylalanine
—I-
(270.0 mg, 0.9 rnraol, 554 (iCi rsmol ) as described previously 
to give, after crystall X Sic* lion from ether, the protected
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dipeptide (86) (350*5 rag*, 82$&), R ^  0.40, Panax scanning and
autoradiography was carried out on the above tic plate revealing
one major radioactive signal at 3L, 0,40 and one minor hand ati?
Bp 0.60.
L— [4~3Hj Phenyl a,l a; y 1-L- r3~^4Cj serine Mono hydrate — 
Hydrogenation of the protected dipeptide, b e n zy 1oxy carhony 1—L— 
[4~^H]phenylalanyl“L“ [3~^^Cjserine benzyl ester (350 mg) was 
carried out as described earlier to give the product (64) after 
trituration (192 mg, 6^,'J‘fo, activity 32,19 [xCi mmol~^, 88^, 
3Hs14C, 13*92), EpA 0.38, RpB 0,65, RpC 0.62, RpH 0.00. A 
single radioactive band was observed on tic by Panax scanning 
and autoradiography. Stereochemical purity was confirmed by 
dilution analysis with L-phenylalanyl-D-serine (90) and D-phenyl— 
alanyl--L-serine (91)® The results showed maximum impurities of 
0.3$ and 0o2$ of the LD- and DL-dipeptides respectively.
Benzyloxycarbonyl-D-phenylalany1-h-serine Benzyl Ester (92)
— L—Serine benzyl ester jp-toluenesulphonate (87) (1.712 g5 4.66 
mmol) was coupled with benzyloxycarbonyl-D-phenylalanine (1.393 mg, 
4.66 mmol) by the DCC method described earlier. A solid product 
was obtained which was triturated thouroughly with ether leaving 
the protected dipeptide (92) (1.04 g, 47^) 0.45 containing
a minor impurity at Rp O.65. A sample was purified for analysis 
by preparative tic and crystallisation from ethyl acetate — pet.
ether (L:l), m.p. 139-141 °G,[c><1.^ + 20.7° (c 0.80, CHG13)
(Founds C, 68*10; H, 5*92; N, 6.12. C27^28*‘2^6 reQ.u^res C,
68.10; II, 5.88; II, 5.88f0); vmaz# 3 470, 3 300, 1 735, 1 715,
1 695, 1 650, 1 540, 1 046, 750, 732, and 695 cm"1; 6 7.29,
7.21 (15H, s, Ar), 6.78 - 6.49 (1H, m, Nil), 5.50 - 5*30 (lH, 
hi* d, J 7 Hz, NH), 5.15 (2H, s, OCiyPh), 5.05 (2H, s, OCHgPh), 
4.70 - 4.30 (2H, in, 2 x CH), 4.00 - 3.57 (2H, rn, CH20H), 3.20 - 
2.98 (2H, m, CHgPh), 1.95 - 1.70 (lH, m, D O  exch., OH); m/e 
476 (weak, M), 210 (10$), 92 (15), 91 (100), 79 (8), 77 (8),
65 (13), 39 (10).
Benzyloxycarbonyl-L~phenylalanyl-D--serine Benzyl Ester 
(93) ~ The synthesis of ■benzyloxycarhonyl-L-phenylalanyl-D-serins 
benzyl ester (93) was carried out as described for the DL-enantiomer 
to yield a crude product in 415s yield. Purification of a, sample 
by tic and crystallisation, as described earlier for (92), gave 
solid (93). m.p. 136.5-140 °C, - 17.9° (o 0.34, CHClj).
The i.r., n.m.r., and mass spectra were identical to (92), (Founds 
Cr 67.82; H, 6.02; N, 6.02. C2^H2gN90^ requires C,68.10; H,
5*88; N, 5.8855).
L-Phe ny1alany1-D-serine (90) - Acetic acid (0.6 ml) and 
1055 palladium on charcoal (50 mg) were added to a suspension 
of b e n z y l osycar bonyl-L-phenylalanyl-D-serine benzyl ester (93)
(504 mg, 1.059 mmol) in ethanol - water (2:1; 100 ml) and
hydrogenated, overnight. The catalyst was removed hy filtration,
then washed with water. The filtrate was concentrated to give
a solid (279 rcg), which was triturated with chloroform and
crystallised from water — acetone to give the dipeptido (90)
(200 mg, 75$), m.p. 215 — 225 °C (with formation of needles,
m.p. 230 - 252 °Ci, dec.),[<*]D20 + 49.80° (c I.96, CF^COOH),
0.38, RpB O.65, R^0 0.62, R ^  0.00, (Found: C, 57.29; H,6.46;
N, 11.03. Cj2Hi6N2°4 reH^ -3?es C, 57.14; H, 6.35; N, 11.11$);
vmax. 3 700 - 2 400, 3 2'fO, 3 0?0, 1 688, 1 625, 1 545, 1 522,
1 422, 1 382, 1 048, 1 032, 750 and 700 cm"1; 8 (CF COOH) 8.32
+
(hr d, J 7 Hz), 7.94 (hr d, J 7 Hz), 7.70 - 7.20 (8H, rn, Ph, NH^),
5.05 - 4.55 (2H, m, 2 x CH), 4.50 - 3-93 (2H, ABX, 12 Hz, J,v
— A/i ilA
4 Hz, JBX 3 Hz, CH^OH), 3.41 (2H, hr d, J 8 Hz, CfigPh); m/e 254 
(weak, M-HgO), 143 (44$, M - H ^ - C ^ ) , 120 (76), 91 (100), 83 (22), 
and 77 (20).
D-Phenylalany'l~L~serine (91) - D-Phenylalanyl-L-serine (91) 
was synthesised in the same manner as its LB-enantiomer (99) 
having identical physical properties with the exception of optical 
rotation.
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Attempted Enzymic Hydrolsis of the Ester (80) — The ester 
(80) was treated with chymotrypsin as described by Halton at al.' 
The starting material failed to dissolve and was recovered* The 
same procedure was followed with pig liver esterase but again 
starting material was recovered*
Attempted Hydrogenation of the Ester (Bo) — The ester 
(80) (100 mg) was dissolved in methanolic hydrochloric acid and 
hydrogenated as described previously* The product showed several 
spots on t.l.c*
-132"
8.5 Experimental for Chapter 4«
L-Phonyl alanine Methyl Ester Hydrochloride (97) - L-Phenyl- 
alanine methyl ester hydrochloride wascsynthesised from L-phenyl~ 
alanine in 90% yield by the method of Brenner and Huber^ as 
needles, m.p. 152-154 °C (lit.,84 159-161 ° c ) , M  19 + 34.40 
(0.4.6, CP C00H), + 35-6° (o 4.0, BtOH)i V (nujol) 1 750,
D IDcLX. #
1 585, 14959 1 232, 730, and 69O cm”1; & (CF COOH) (60 MHz) 7*40 
+
(8H, m, Ph, 1vH3), 4.65 (lH, m, CH), 4.05 (3H, s, OMe), and 3.55
(2H, m, CH Ph).
— 2
D-Phenylalanine Methyl Ester Hydrochloride - D-Phenylalanine 
methyl ester hydrochloride was synthesised as above in 93i<> 
yield with identical physical properties with the exception 
of optical rotation.
N—Benzyloxycarbonyl-L-seryl-h-phenylalanine Methyl Ester
(96) - N—Benzyloxycarbonyl-L-serine (67) (239 mg, 1 mmol) was 
coupled with L-phenylalanine methyl ester hydrochloride (215*5 mS,
1 mmol) by the DCC method described by MacDonald and Slater^1* to 
give an oil (353 nig, 88$). A sample was purified for analysis 
by preparative tic, R^ , 0.26 (StOAc — Pet. ether — HOAc; 20:20s!) 
followed by crystallisation from acetone - pet. ether to give (96) 
as needles, m.p. 75—77 + 15*4° (c_ 1.18, MeOH) (Found:
C, 63,23; H, 5*99; N, 6.90. C2iE24N2°6 r8(3Hires C, 63.00; H, 6.00;
N, 7.00$) v 3 600 - 3 150, 1 745, 1 690, 1 660, 1 550, 1 060, max.
760 - 745, and 705 cm"1; & (60 KHz) 7-50 - 6.30, 7*35 (10H, m,
-133-
Ar), 5.90 (lH. to d, J 7 Hz, exch., NH), 5.10 (2H, s, OCH. Ph), 
5.10 - 4.65 (Hi, m, CH), 4.50 - 3.35 (3H, ra, CH, CHgOH), 3.70 
(3H, s, 0CH3) 3.50 - 3.20 (1H, m, D O  exch., OH), 3.20 - 2.80 
(2H, m, Ciyph); m/e. 400 (weak, M), 162 (12$, PhCH=CHCOOMe), 131 
(5', PhCIi=CHC0), 120 (5, PhCII2CH=M2), 92 (10),91 (100), 79 (6),
77 (B) and 65 (14).
! H—Benzyloxycarbonyl~-D~. seryl -I?—phenylalanine Methyl Ester
(98) - The dipeptide (98) was synthesised as described above 
as a crude oil which was not characterised.
eyclo~(L~Phenylalanyl-h-sery}) (24) - L-Phenylalanine methyl 
ester hydrochloride (2.155 gs 10 mmol) was coupled with H-benzyl- 
oxycarbonyl-L-serine (2.390 g; 10 mmol) hy the DCC method 
previously described to give an oil (2.685 g)• The oil, dissolved 
in methanol (90 ml), was hydrogenated for 5& in "the presence of 
10$ palladium on charcoal (240 mg) end acetic acid (0,1 ml).
The catalyst was removed hy filtering through a Celife pad which 
was washed with methanol. The filtrate and washings were combined 
and concentrated to an oil which was dissolved in a small volume 
of methanol and saturated with ammonia at 0 °C. On standing at 
room temperature overnight, a solid.separated which was filtered 
and washed thouroughly with ether to give (24), (814 mg, 35$ based en 
H-L-Phe-01Ie.HC1), m.p. 237-240 ° C , M ])20 - 95*6° (c, 1.0, BMP),
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showing one spot on tic. Recrystallisation from methanol gave 
(24) (527 mg), m.p. 235-240 °C (decomp.) (lit; 244-246 °C)
[«]D20 - 105° (0 1.0, BI5F) (lit.,3615 - 20.1°), (Pounds C, 61.3;
H, 6.1; N, 11.8. requires C, 61.5; H, 6.0; N, 12.0$)
R/  °*30> V  °-58; v_iax  ^ 3 405, 3 200, 1 670, 1 460, 1 345,
1 075, 761, and 705 cm"*1; £ [(CB^SOj 8.10 - 7-75 (2H, ra, D20 
exch., 2 x KH), 7.40 - 7.02 (5H, m, Ph), 4.82 (lH, t, J 6 Hz,
DgO exch., OH), 4.20 - 3.95 (lH, m, sharpens on DgO shake to 
broad t, + JBX 11 Hz, CHCH^h), 3.80 - 3.58 (lH, m, CHCH^H), 
3.38 - 2.72 (2H, ABX, J B 11 Hz, J 3.5 Hz, J 6.0 Hz, sharpens
on Bo0 shake, CHo0H), 3.08 - 2.99 (211, q, J,,, 6 Ks, J_v 5 Hz,
C. ~~d  A A  JbA
CHgPh); 6 (CP COOH) 8.45 - 8.00 (2E, in, 2 I NH), 7.50 - 7-10 (5H, 
m, Ph), 4.90 - 4.60 (1H, m, CHCH Ph), 4.56 - 4.32 (IE, m, CHCBgOH), 
3.81 - 3.05 (2H, ABX, JAB 12 Hz, J/a 4 Hz, 6 Hz, CH?0H),
3.34 (2H, d, J 5.5 Hz, CHgPh); S (C3 OD) 7.29 (5H, ra, Ph), 4.32 - 
4.20 (1H, m, + JBX 11 Hz, Jcx 1 Hz, CHCHgPh), 3.94 - 3.32 
(1H, dq, J + JBX 9.5 Hz, Jcx 1 Hz, CHCHgOH), 3.57 - 2.82 (2H, ABX, 
11.0 Hz, 3.5 Hz, JM  6.0 Hz, CHgOIl), 3.26 - 3.16 (2H, q,
6.5 Hz, JBX 5.0 Hz, CH2P1i); m/e 234 (175?, »), 204 (21, K-CHgO), 
143 (9, H-C H ), 120 (9, PhCH2CH=KH2), 115 (14), 113 (17), 92 (22), 
91 (100), 85 (22), 77 (7), 65 (12), and 60 (6). Crystallisation
of the mother liquors gave a further crop (100 mg), m.p. 233-240
C (decomp.).
cy clo— ( D—Phony lal anyl-D-seryl) (95) - cyclo-(B-Phe-I)-Ser)
(95) was synthesised as described above on a 10 mmol scale 
to give a solid (666 mg, 28.5$ from II-D-Phe-OMe.HCl) after 
trituration with ether. Recrystallisation from methanol and 
recrystallisation of the mother liquors from methanol gave (95) 
(454 mg), m.p, 235 — 241 °C,K1d20 .f 104° (_c 1.00, BMP), having 
identical spectroscopic and chromatographic properties to (24).
N—13 e n zy 1 o xy c ar b o ny 1 - L- s e ry 1-D-p h e ny 1 al an i n e K e t hy 1 Ester 
iioil- MV-Benzyloxycarbonyl-L-serine (67)’ (2.39 g, 10 mmol) 
was coupled with B-phenylalanine methyl ester (2.155 g, 10 mmol) 
by the normal BCG procedure to give a sticky solid, (2,56 g, 64$) 
a sample of which was purified bjr preparative tic, 0,30 
(StOAc - Pet ether - AcOH; 20s 20? 1), to give the protected 
dip.eptide, m.p. 108 - 112 °C,[C<]B '^:> -- 35*4° (,£ 1.0, CHCl^);
& (60 MHz) 7.35 (5H, s, PhCKgO), 7.55 - 6.80 (6H, m, NH, PhCHgCH)
5.90 (III, br d, J 7 Hz, NH), 5.10 (2K, s, PhCHgO), 5.10 - 4*65 
(1H, m, CHCH ), 4.50 - 3.40 (4H, m, GH, CHgOH), 3.70 (3H, s,
OMe), 3.25 - 2.90 (2H, m, CHgPh)5 m/e 400 (M), 162 (49$, 
PhCH*CHC00Ne), 131 (20, PhCH*CHC0), 108 (51), 107 (41), 91 (100),
79 (74), 77 (68), 65 (26).
cyclo-(L~Phenylalanyl-D-sery 1) (94) - N-Benzylosycarbonyl- 
B— serine (2.39 8, 10 mmol) ana L—phenylalanine methyl ester 
hydrochloride (97) (2.155 8, 10 mmol) were coupled in the normal
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fashion to give the crude protected, dipeptide (2.558 g, 64#) which 
was hydrogenated and cyclised as for the LL—diastereomer. The 
crude solid product was washed thoroughly with ether to give (94)
^721*6 mg, 31$ from H-L-Phe-OMe.IICl) which was recrystallised
from methanol to give cy c 10 - (L—ph e ny lal any 1—D- seryl) (94) a-s 
needles (529 mg, 23$), m.p. 258-268 ° C , M  20 + 11.2° (c 1.0,
DMF), rJ1 0.39, I^ 1 0.62; (Founds C, 6l.7; H, 5-9; N, 12.0.
No0 requires C, 61.5; H, 6.0; N, 12,0$); v 3 480,•j-tc. JLty l. j max.
3 200, 1 685, 1 670, 1 338, 1 108, 1 093, 769, 722, and 707 cm"1;
& [(CD^SO] 8.04 (1H, hr s, D?0 exch., NH), 7,75 (lH, hr s, D O  
excli., FH), 7*21 (511, s, Ph), 4.92 (lH, t, J 5.5 Hz, D20 exch., OH), 
4.26-4.09 (1H, m, JAX+JBX 9 Hz, CHCH2Ph), 3.80-3.35 (2H, m, DQ0 gives 
ABX, J^11.5, -^^4, Jbx3 Hz, CH OH), 3.30-2.80 (3H, m, CiyPh, CHCH^OH) 5 
% (CF.COOH) 8.11 (211, hr s, 2 x Nil), 7.50 - 7.10 (5H, m, Ph),
4.90 - 4c.65 (1H, m, CHCHgPh), 4.32 - 3.93 (2H, ABX, 12 Hz,
3.5 Hz, J 3.5 Hz, CHgOH), 3.53 - 3.14 (3H, m, CHCHgOH and 
CH2Ph); m/e 234 (11$, H), 204 (20, K-CHgO), 143 (6, M - C ^ ) ,
115 (8), 113 (9,), 92 (15), 91 (100), 85 (22), 77 (9), 65 (18).
Crystallisation of the mother liquor gave a further crop (83 mg) 
m.p. 257-264 °C.
oy c1o-(D—Phe ny1an any1-L-s erv1) (100) - cyclo-(D-Phenylalany1- 
L-seryl) (100) was synthesised as ahove and the product had 
identical physical properties with the exception of optical 
rot at ion,^]^^ - 10.2° (_c 1.0, DIuF).
-SL9.1 o -(L- [13- 4C] Phenylalanyl-L-sery 1) — L-fo-^CjPhenyl- 
alanine (lo5 mg, 1 mmol, 100 pCi mmol was suspended in 
freshly distilled 2,2-dimethoxypropane (10 ml),. Concentrated 
hydrochloric acid (1,0 ml) was added dropwise with swirling and 
the solution was stored at room temperature for 24 h. The 
brown solution was concentrated at 30-40 °C to give a brown 
residue. The residue was triturated with ether to yield the 
methyl ester hydrochloride (97) (214.1 mg, 99$), m.p. 155-157 °C 
(lit„,^ 159—161 °C), which was coupled in the previously 
described manner with F-benzyloxycarbonyl-L-serine (239 mg, 1 
mmol) to give a sticky solid (320 mg). Hydrogenation and 
cyclisation gave an off white solid which was washed thoroughly 
with ether to give the product (78.3 mg, 33.5$ from L-phenyl-
alanine, activity, 84.74 l*Ci mmol”1) R 0,10 (CHCH-AcOH;
I9:1), Rp 0.65; Panax scanning and autoradiography of tic plates 
and dilution analysis with inactive stereomers showed that the 
product contained no more than 0,3$ of either the LD- or DL-cyclic 
dipeptides (94) and (lOO).
oyclo-(L- [P~14C]Phenylalanyl-D-seryl) - cyclo-(L- [U-1^CJ 
Phenylalanyl-D-seryl) was synthesised as above to give after 
trituration, a solid, (71 mg, 30$ from L—phenylalanine) 
activity, 45.01 |iCi mmol”1; RpH 0.33, Rp1 0.60. Radioscanning 
and autoradiography of tic plates showed that there was only one 
radioactive band. Dilution analysis revealed that not more than
0.5$ the LL—diasteriomer (24) was present.
cy o1o~(D—P he ny 1 al any 1—D, L- [3-14CQ serv 1) - D,L- (3-14C] Serine 
(116 mg, 1.1 mmol, 100 pCi mmol 1) was converted as previously 
described to N-ben^loxycarbonyl-D,L-£3-14C]serine (190 mg, 72$). 
The sample was diluted to 1 mmol with inactive material and 
converted in the usual manner to the product (49.1 mg, 15$ from 
D,L— serine, 14C activity-, 62.64 pCi mmol 1. Radioscanning and 
autoradiography of tic plates was carried out as above, dilution 
analysis showed that the DLjDD ratio was 68:28 and that not more 
than 0.1$ of the LL-isomer was present in the mixture.
cyclo-(L- [4-^H]Phenylalanyl-L-[3-^4C]seryl) - L-[3~14c]
—1
Serine (110.6 mg, 1.05 mmol, 100 pCi mmol ) was converted 
to N-benzyloxycarbonyl-L-{j3~14C} serine as before (230 mg, 91*4$, 
14C activity, 92.27 pCi mmol”1, 97.2$ of original specific 
activity).
Jj-£4-^HjPhenylalanine (166.0 mg, 1 mmol, 1 mCi mmol 1) 
was converted to L- [4-^pQphenylalanyl methyl ester hydrochloride 
as before (228 mg, 100$).
Z-L-[3-14C]Ser-0H was diluted to 1 mmol with inactive 
compound and coupled with H-L- [4-JpQPhe—OMe.HCl as before to 
give a yellow solid (311 mg) which was hydrogenated and cyclised 
to give an off white solid after trituration, (66.8 rag, 28.6$ 
based on II-L-Phe-OH,'14C activity, 90.405 PCi mmol”1, 98$ of
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reactant^s specific activity), Radiochemical purity was checked 
hy the methods already described. Not more than 0.2# of the 
DL- or LD~isomers, (94) and (100) were present.
Intermediate Trapping Experiment - cyclo-(L-Phenylalanyl- 
L-seryl) (24) (BO mg) was added, in dimethyl sulphoxide (4 ml) 
to a one day old shake culture (l l) of Trichoderma viride.
L-[U-14C_IPhenylalanine (25 pCi) was fed 2 h later. After s. 
further 2 h, the normal work up procedure was carried out.
The aqueous solution, after extraction with chloroform, was extracted 
continuously with ethyl acetate for 3 days. The organic extract 
■was dried, filtered, and concentrated to a brown solid (34 mg,
O.7o3 pCi). Uni abe 11 e d cy cl o~ (L-P he-L~S er) (48*0 mg) was added 
to a sample of the residue (11 mg). The mixture was triturated 
with chloroformthen crystallised to constant activity (0.33 PCi 
mmol”1) with methanol, The activity present in the total 
ethyl acetate extract as cyclo-(L~[U~14C]Phe--h-Ser) was calculated
to be. 0.202 pCi (0.80#).
The aqueous solution vias extracted with ethyl acetate for 
a further 3 days and the procedure described above was repeated. 
cyclo-(L-[U-14C]Phe-L-Ser) (0.12 pCi) (0.5#) was present in the 
extract.
8„6 Experimental for Chapter
Degradation of Gliotoxin “by Basic Hydrolysis — Gliotoxin 
(23.2 mg, 'C activity 0.rJo2 pCi mmol was heated at reflux 
in 10£o sodium hydroxide (7 ml) for 1 h under a stream of 
nitrogen, which, after passage through the apparatus, was "bubbled 
through 211 hydrochloric acid. Steam distillation was carried 
out. for 10 rain, and the distillate was collected in hydrochloric 
acid# The combined acid .solutions were concentrated to a yellow 
film which was solidified by precipitation from methanol— ethyl 
acetate, to give a yellow solid (3.5 rng) R^ O.55 (MeOH - Pet.
1 A
ether - AcOH; lslsO.l), J‘ C activity 0.012 pCi mmol (1,16^)
The hydrochloride salt was dissolved in a minimum of water
arid phenylisothiocyanate (0.02 ml) was added, followed by
concentrated sodium hydroxide solution (l drop). The mixture
was cooled for 3 days by which time crystals had formed. The
solvent was removed by evaporation and the residue dissolved
in methanol - chloroform and applied to preparative tic which
was eluted with EtOAc - Pet. ether (2s5). product was
obtained as an oil which was solidified by scratching, (6 mg,
51$ from gliotoxin), m.p. 109 - 113 C (lit#, 113 C),
R 0.20 (EtOAc - pet. etherj 2;5), 14C activity 2.131 nCi mmol”1 
i)
(0.01%) 5 S (60 MHz) 7.35 (mi ph) ^  3.1 (s, Me).
Anhydrodesthiogliotoxin (3) - Gliotoxin (46.6 mg, 0.143 
mmol) was suspended in dry benzene (10 ml) and stirred
overnight at room temperature with grade II neutral alumina 
(2.03 g). The alumina was removed by filtration and washed 
with hot chloroform (6 x). The combined filtrates were 
concentrated to give a light yellow solid (26 mg) which was 
purified by preparative tic and crystallisation from methanol 
to give (3) as slightly yellow crystals (8 mg, 23 $) m.p. I58-I6O 
°C (lit,,^° 160-161 °C) 0.5 (toluene - acetone; 9:1); vmax
(CHC13) 1 710, 1 675, 1 605, 1 395? 1 355 cm"'1; 6 (60 MHz)
8.60 (1H, d, J 7?7 Hz, indole CH), 7.80 - 7.25 (4H, m, Ar), 6.15 
(1H, d, J 1.5 Hz, olefinic H), 5.25 (lH, d, J 1.5 Hz, olefinic 
H), 3.45 (3H, s, Hlvle); m/e 227, 226, 199, 198, 197? 170, 169?
144, 143, 130, 129, 116, 115? 114? 89, 88, 55, and 54.
Degradation of Gliotoxin to Anhydrodesthiogliotoxin (3) 
and subsequent Ozonolysis (a) — Gliotoxin (52.4 i^ g, activity,
1*1.pCi mmol*"1, ^H: 11.l) was converted to (3) as
described previously, (10 mg, 27*5$>? acivity, 1.21 pCi
mmol 1, 108/6, ^H;1^C 11.2,
The product, dissolved in ethyl acetate, was ozonised for 
30 min at — 25 C. The solvent was evaporated slowly at room 
temperature to give the ozonide which was broken down by steam 
distillation in the presence of zinc. The aqueous distillate 
was collected in dimedone solution and allowed to stand overnight 
resulting in the crystallisation of the dimedone derivative of
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formaldehyde (11.32 mg, 88$) m.p. 139-190 °C (lit., 190-191 °C)
14 • . —1
C activity 0.53 PCi mmol . The derivative was recrystallised
from ethanol - water to give (5.9 mg, 43$) m.p. 190 - 191.5 °C,
Rp 0.72 (EtOAc - Pet. ether; 1:1), 14C activity O.58O pCi mmol""1 
(48$), 3K activity 0.0 pCi mmol"”1.
M  — The degradation of gliotoxin was repeated to give 
anhydrodesthiogliotoxin (10$), 14C activity 0.955 P-Ci mmol’"1 
(105$), 3H:14C 10.7, which was ozonised for 2 min and worked 
up as above to yield the dimedone derivative (44$), m.p. 190- 
191 °C, 14C activity 0.408 pOi mmol"*1 (43$).
Anhydrodesthiogliotoxin (4.9 mg, 14C activity 0.49 
pCi mmol 1, 3H;14C 11.5) dissolved in ethyl chloride was 
ozonised for 10 min at - 2p °C. After the solution had been 
flushed'with nitrogen, dimethyl sulphide (0.02 ml) was added 
and the solution was allowed to stand at — 25 °C for 1 h. The 
temperature x^ as allowed to rise to 0 °G whereupon water was added 
and the flask was allowed to stand at this temperature for 45 
min before standing overnight at room temperature. Steam 
distillation was carried out and the dimedone derivative was 
obtained as before (5.5 mg, 87$) and crystallised to constant 
activity (2,7 mg) m.p. 192-193 °C, 14C activity 0.18 pCi mmol"1
(37$).
Degradation of Gliotoxin derived from cyclo-(L-[U- C]Phe- 
L-Ser) - Gliotoxin (50.72 mg, 14C activity 0.57 ^Ci mmol 1)
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derived from the feeding of c,yclo-(L~[U~1^C] Phe-L-Ser), was 
converted as ahove to anhydrodosthiogliotoxin (3,8 mg, 11$, 
activity 0,570 |iCi mmol”'1, 100$),
Ozonolysis was carried out at — 25 °C for 5 rain and dimethyl 
sulphide used for the work up to give the dimedone derivative of 
formaldehyde (0,5 10$, activity 5*0 x 10*""^  M-Ci mmol*"1)
which was recrystallised (0.15.mg, . activity 1,2 x 10~^ M-Ci 
mmol’"*1),
Dehydrogliotoxin (11) - A solution of gliotoxin (207 nig,
0*635 mmol) in chloroform was heated at reflux in the presence 
of 2,3~dichloro-l,4-hensoquinone (DDQ) for 6 h. The resulting 
phenolic precipitate was filtered and the filtrate concentrated 
to give a residue which was crystallised from chloroform - 
methanol giving (ll) as hrown needles (143 mg, 72$) m.p, I84-I85.5 
°C (lit.,51 185-186 °C), v 3 490, 1 670, 1 610, 1 400, 1 060, 725,
m c2»2c ♦
and. 700 era 5^ m/_e 324 (weak, H) 260 (60^. M—Sg), 243 (35)» 242 
(100,.M-S9-B20), 230 (30, H-Sg-CHgO), 214 (15, K-Sg-HgO-CO), I85 
(13, H-Sg-HgO-CH NCO), 160 (30), 159 (100), 131 (36), 103 (43),
76 (40, CgH~), 64 (45), 56 (35, CHg.-C=HHCBj), with maiastable 
ions at m/e 225, i89.5> 108, 81, and 56.
1,2,3,4-Tetrahydro-6-hydroxy-2-methyl-3-methylene~l,4- 
dioxopyperazino[1,2—a]indole (104) — A solution of dehydrogliotoxin 
(11) (52.5 mg, 0.162 mmol) in acetic acid (5 ml) and acetic
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anhydride (O.I64 ml) was heated at reflux for 3 h, The solvent 
was removed by evaporation and the residue applied to 
preparative chromatography to give the product (104) (42 mg) 
which was crystallised from ethanol — chloroform giving yellow 
needles (24 mg, 61.1%), m.p, 217-219 °C (lit,,91 218-219 °C); 
vmax. 1 68°’ 1 595, 1 58°’ 1 417 - 1 410, 1 380 - 1 350, 1 185, 
775, and 730 cm-1; m/e 242 (100/-, H), 214 (11, H-CO), 185 (18, 
K-CRjHCO), 159 (100), 145 ( 25), 131 (50), 103 ( 70), 102 (15),
76 (80)', 75 ( 20), 56 ( 80, ck2=c-hech3), 55 (35, ce5=c=bch3), 54
(35, CE2=C=C=0)? with met ast able ions at m/e_ 189, 108, 8l, and 56;
S (60 Mz) 10.7 (1H; s, OE), 7*54 (IE, s, indole H), 7-36 -
6.95 (3H, m, Ar), 6,25 (13, d, J 1*5 Hs, CH), 5-35 (1H, d, J
1,5 Hz, CH), and 3*42 (3H, s, HHe)*
112,3,4—Tet rafay dr o-2-aethy 1-1 ,» 3 , 4-trioxopyrazino- 
[1,2a]-indole (5) - Gliotoxin (102,1 mg, activity 1.07 Sddi 
mmol”1, ^Es^C 13,8) was converted to anhyirodestliiogliotoxiii 
(3) as described earlier to give yellow needles (11,2 mg, 1 £5$), 
m.p. 153-156 °C, 14C activity 0.902 |nCi mmol'"1 {91.5$), ^H:1^  
13.6. ,
The product (3), i& acetic acid (15 ml), was stirred at 
room temperature overnight with chromic anhydride solution
(0,44 ml) from a stock solution of chromic anhydride (260 mg) 
in water (10 ml). The reaction was worked mp as described by
—14 5~
°2
Ali jrt ali to yield a crude residue which vjasctriturated with 
methanol then crystallised (3 x) .from methanol — chloroform(l:l) 
to give (5) as an off white solid (2 mg, 18$), m.p. 2o2-264 °C 
(lit. ,^2 262—263 °C), activity 0.0 fiCi mmol activity
15.3 M-Ci mmol’"1 (103$); vm_  1 735, 1 690, 1 400, 1 350, 740
Iilu/jC 0
cm"1; m/e 228 (39$, K), 143 (100), 115 (65), 88 (22), with 
metastahle ions at 92.5 and 67.3.
Glycine Anhydride (lOB) - Glycine (50 g, 670 mmol) was
94converted by the method of Schott et al. to glycine anhydride
(27.81 g, 74$), m.p. 285-300 °C (decomp.) (lit.,112 311-312 °C,
decomp., rapid heating); v _ 3 195 - 3 165, 3  Q50, 1 707 - 1 680,max*
1 470, 1 445, 1 340; era ; m/ e 114 (62$, H), 86 (10, II-CO),
71 (43, il-MGO), 56 (10, K-CH NCO), 43 (42, HUGO).
M-hiacetyl Glycine Anhydride (109) - Glycine anhydride
o(l.0l8 g, 8.93 mmol) was heated at 100 C in acetic anhydride 
(5 ml) for 3 h then cooled to 0 °G and poured onto ice (250 ml).
An oil separated which solidified on stirring and scratching.
The ice-solid mixture was filtered, collected and the ice 
melted to form a solution which was neutralised with sodium 
hydroxide solution. The solution was extracted with chloroform 
several times and the combined organic extracts were dried, 
filtered and concentrated to give a solid which was crystallised 
from ether - pet. ether (60-80 °C) to give the product (109)
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(I.48 g, 84$) m.p, 101—102 C (lit.,11^ 102 °0); v (nuiol)
max, '
1 730 - 1 700, cm ; & (60 KHz) 4,65 (4H, s, 2 x CHg) ,2,.65 ■ (6H, s , 
2xMe); m/e 198 (18$, M), 170 (33, M -00), 156' (21, M+H-CH^CO), 114
(26, H+H2-2CH CO), and 43 (100, CH.CO).
J 3
L-Proline Methyl Ester Hydrochloride - 1-Proline (14*4 g,
0.125 mol) was converted into its methyl ester hydrochloride
79by the method of Brenner and Huber to give an oil (19.6 g,
95$), &. (CD30D) 4.65 - 4*15 (1H, m, CH), 3.85 (3H, s, OCHj),
3.60 - 3.05 (2H, m, NCH ), and 2.70 - 1.75 (4H, m, 2 x CHg).
II-Pyruvoyl-L-proline Methyl Ester (114) — Triethylamine 
(2.4 ml) was added to a suspension of L-proline methyl ester
hydrochloride (3.3 g, 20 mmol) in methylene chloride (80 ml)
at 0 °C. Pyruvic acid (I.76 g, 20 mmol) and DCC (4.12 g, 20 
mmol) were added and the mixture stood at room temperature over­
overnight. The DCU was filtered off through a Celite pad which 
was washed with 1M hydrochloric acid (2 x), viator, saturated 
sodium hydrogen carbonate solution (2 x) and water, then dried, 
filtered and concentrated to give a yellow oil (3.397 g, 84.5$), 
Fractional distillation gave a clear oil (729 mg, 18$). b.p.
72 °C/0.06 mm Hg (lit.,9613 121 °C/0.1 mm Hg), - 87.3°
(jc 1.1, chloroform) (lit.,96l> - 69 ); vmax<> ('thin film) 1 744,
1 725, 1 640, 1 350, cm"1; & (60 KHz) 5.10 - 4.35 (1H? CH),
4.05 - 3.50 (2H, m, MCH2), 3.80, 3.78 (3K, two s, 0CH3), 2.45
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ana 2.43 (3H, two s, CH^CO), 2.60 - I.65 (4H, m, CHCK^CHg);
£}/© 199 (weak, M), 156 (38$, K-CH-^CO), 140 (25, Il-CH^OCO), 128 
(100, M—CH^COCO), and 70 (91).
- ( 2S, 5H) -4,5-Dimet hy 1-3»6-dioxo—5—hy dr oxy—1,2-t rimethyl ene— 
piperazine (115) — A solution of distilled E—pyruvoyl—L—proline
methyl ester (114) (209 mg, l.Op mmol) was cyclised with
96h
methyl amine as described by Lee to give needles (894 mg,
38£), m.p. 135-137 °C (lit.,96’0 145-148 ° C ) , M d20 _ 147.6°
(c 0.5, CHC1,) (lit.,9 - 146°) (Found: C, 54.67; H, 6.91;
II, 13.98. C9®i4K2°3 re<iuires 54.54; H, 7.07; iff, 14.14$);
v 3 280, 1 672 - 1 660, 1 640, 1 100 cm""1; & 5.01 (IE, hr013>X»
s, exch., OH), 4.45 - 4.18 (IE, a, CH), 3.70 - 3-34 (2E, m, 
HCH ), 3.01 (3H, s, iIHe), 2.55 - 1.60 (4H, m ,  CHC^C^), 1.73 
(3H, s, Me); m/e 198 (weak, l), l80 (24, S^-Eyi), 152 (11, H-HgO 
-CO), 151 (11), 124 (62, M-H20-2C0), 95 (13), 74 (11, CH3(0H) 
C=¥MeH), 70(65), 69 (19), 68 (20), 58 (14), 56 (31), 55 (l<»), 
and 54 (46).
( 23 , 5R)-TI4-1^C1 Methyl-3 , 6-dioxo-5-hydroxj/-5-aetliyl-l, 2- 
tyiaethy 1 enepiperazine — Sodium hydroxide (40 mg, 1 mmol) 
was added to an aqueous solution of £ met hy 1 amine
hydrochloride (67.5 ®6, 1 mmol, 250 pCi maol in 2*5 ®1 water).
The solution was heated at reflux for 8 h, and the naethylaiaine 
generated was carried in a stream of nitrogen into a flask
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containing a solution of U-pyruvoyl-L—proline methyl ester (114) 
(199 mg, 1 mmol) in dry dime!hoxyethane (10 ml), cooled to —50 
°C. The reaction flask was stored at 0 °C for 48 h. Methyl- 
amine (10 mmol) was passed into the reaction flask by the same 
procedure and the mixture was left at 0 °C for 5 days. Excess 
methylamine was removed by passing a stream of nitrogen through 
the reaction fixture and into a trap of hydrochloric acid. 
Concentration of the reaction mixture gave a solid residue 
which was crystallised from ethanol - pet. ether to give needles 
(36.3 mg, 18$), 14C activity 171.2 pCi mmol”1 (68.5$), F O.46 
(Acetone - toluene; 2;l), 0.37 (EtOAc - MeOH) 6:1), 0.47
(acetone).
Unlabelled product (115) (40 mg) was added to the mother 
liquor and its crystallisation was repeated to yield a further 
crop of (115) (35 mg, 14C activity 95*3 PCi mmol 1. Radiochemical 
purity of the first crop was tested by Panax scanning, auto­
radiography and dilution analysis and found to be 94.4$. The 
S,S-diasterearner was the only impurity, R^ 0.43 (acetone - toluene; 
2:1), 0.26 (EtOAc - HeOH; 6:1), O.38 (acetone).
(2S)~3,6-hioxo-4-methyl—5-methylene-1,2-trimethylenepiperazine 
(ill) - The hydroxydioxopiperazine (115) (50 mo) was treated 
with anhydrous trifluoroacetic acid (0.5'ml) for 1 min resulting 
in quantitative conversion to the dehydrated product (ill);
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g (CF^COOH) (60 MHz) 5*90 (lH, d, J 2 Hz, exo methylene) 5*15 (lH, 
a, J 2 I-Iz, eco methylene), 4t 65-4.15 (lH, rn, CH), 4.05-3.65 (2H, 
m, HCH2), 3.25 (3H, s, NCH ), and 2.75-1*90 (4H, m, CHCHgCEg).
( 2S, 5H)-3, 6-Hioxo-5—hydroxy-5~methy .1—1,2-trimethylene­
piperazine (116) — N-Pyruvoyl-L—proline methyl esber (114)
(500 mg, 2.5 mmol) was cyclised in the presence of ammonia as
®6b
described by Lee' to give plates (234 mg, 51$), m.p. 194 - 198
°C (decomp.) (lit.,96b 177 °C) jE* ^ 20 - 147.7° (c 0.10, CHC13)
(lit.,96b - 144°) (Found: C, 52.15? H, 6.70; N, 14.98. 
requires C, 52,17; H, 6.52; N, 15.22$) v  ^ (Nujol) 3 200,
„ I OctOC#
3 070, 1 670 - 1 645, cm-1; s [(CD3)2SOj 8.77 (lH, br s, DgO
exch.), 6.43 (1H, br s, D20 exch.), 4.40 - 4.05 (1H, m, CH),
3.60 - 3.10 (2H, m, NCHg), 2.30 - 1.60 (4H, m, CHCHgCHg), and 1.4 
(3H, s, Me); m/e 184 (3$, M), 166 (30, M-HgO), 138 (18, E-HgO 
-CO), 110 (55, M-H20-2C0), 97 (18), 70 (100), 69 (32), 68 (30), 
and 60 (28).
(2S)-3,6-Hioxo-5-methylene-l,2-trimethylenepiperazine
(1127 - The preceding compound (116) (250 mg, 1.36 mmol) was
6b
treated with anhydrous trifluoroacetic acid as described
to yield (112) (87 mg, 38.5$), m.p. slow decomposition (lit.,96°
240 °C) (Found: C, 57.66; H, 6.20; N, 16.71. C8BC10N202 C, 57.83;
H, 6.02; N, 16.87$) v  (llujol) 3 200, 3 080, 1 675, 1 630 cm 1;max.
m/e 166 (80$, M)« 138 (36, M—CO), 13f (17), 110 (100, M—2C0),
82 (16), 70 (29), 69 (12) and 68 (17),
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Ozonolysis of (2S)-3»6-Dioxo-5-methylene-l,2-trimethylene- 
piperazine (112) — A solution of (112) (11.8 mg, 0.071 mmol) 
in ethyl acetate (5 ml) was ozonised and worked up with 
dimethyl sulphide as described previously to give the dimedone of 
formaldehyde (10.0 rag-, 48$), m.p. I9I-I92 °C.
Ozonolysis of (2S)-3.6-Dioxo- [4-14C]methyl— 5-methylene—1,2—
trimethylenepiperazine (ill) - (2S,5R)- [4-14C]Methyl-3,6-dioxo-
5-hydroxy-5-methyl-l,2-trimethylenepiperazine (24.25 mg, 2.79 
-1 \t3 Ci mmol ) was dissolved in trifluoroacetic acid and shaken for 
5 min. The solvent was removed under vacuum. The residue (ill) was 
dissolved in ethyl chloride, ozonised,and worked up with dimethyl 
sulphide as described previously to give the dimedone derivative 
of formaldehyde (19*3 mg, 54$, 0.02 /JCi mmol Recrystallisation 
from methanol-ether gave needles (11.5 mg), m.p. 191—191.5°C,
14C activity 0.01 J L fCi mmol 1.
Attempted Oxidation of the Phenol (104) - The phenol (104)
9 2
(10 mg) was treated with chromic acid as described by Ali et al.
A black solid was obtained which could not be characterised.
92
The phenol (10 mg) was acetylated as described by Ali _et al. 
and treated with chromic acid as above. No simple product could 
be detected.
Attempted Alkylation of NN-Diacet,vl Glycine Anhydride (109)-
The diacetylated anhydride (l09) ^as treated with formaldehyde
95by the method of Gallina and Liberatori . A plastic film was 
obtained which showed several spots on t.l.c.
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8.7 Experimental for Chapter 6.
N—Benzyloxycarbonyl—L—serine Methyl Ester (124) — L-Serine
methyl ester hydrochloride was converted into N-benzyloxycarbonyl—
L-serine methyl ester by the method of Guttman and Boissonas^1
in 80$ yield as an oil. A sample was purified by vacuum
distillation (155 °C, 0,1 mm + 5*75*?(.£ 2.0, chloroform),
[<X] 19 — 10.9° (c 1.6, methanol) (lit.,114 - 13.2°); v r (thin Jj ~~ max.
film) 3 680 - 3 140, 1 760 - 1 680, 1 56O - 1 490, 1 065, 745, 
and 705 cm-1; 8 (60 MHz) 7.40 (5H, s, Ph), 6.20 - 5.65 (lH, m,
DgO exch., NH), 5.15 (2H, s, PhCH 0), 4.70 - 4.30 (lH, m, CHCIIg),
4.05 - 3.80 (211, br d, J 4 Hz, CHgOH), 3.75 (3H, s, 0CH3), 2.75 
(1H,‘ br s, DgO exch., OH); m/e 253 (weak, M), 162 (M-C^H.^), 150, 
108, 107, 92, 91, 79, 77, and 65.
N-Benzyloxycarbonyl-DL-serine methyl ester was similarly 
prepared in 87$ yield.
N-Benzyloxycarbonyl-O-t-butyl—L-serine Methyl Ester (125)
~~ \
— The t-butyl ester (125) was synthesised from H-benzyloxy-
carbonyl-L-serine methyl ester (124) by the method of Callahan
et al. to give an oil which was taken up in pet. ether (80-
100 °C) with.slight warming and decanted from an insoluble oil*
The solvent was removed by evaporation and the residual oil
was taken up again in a minimum of pet, ether (80-100 °C) at,
room temperature. The solution was cooled overnight to give
crystals which were recrystallised as needles (125) (53$), m.p.
41-43 °c (lit.,115 42-44 °C}[<*]DU  + 4.6°(o 1.4, EtOH) (lit.,101
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+ 6.0°),M  11 + 4.0° (c 1.2, MeOH) (lit.,115 + 4.0°); v
v ~ . max.
3 480,- 3 300, 1 750, 1 730, 1 510, 1 395, 1 365, 1 205, 740,
anil 700 cm”15 h (60 KHz) 7.35 (53, s, Ph), 5/65 - 5,40 (lH,
"br d, Nil), 5*15 (2H, s, PhCH20), 4.60 - 4.25 (IE, m, CHCHg),
3.95 - 3,40 (2H, ihBX, 4.0 Hz, JM  3.0 Hz, 3 ^  9.5 Hz, CHCH2),
and 3.75 (3H, s, OMe), 1.10 (9H, s, Bu1)? ra/e 309 (weak, M),
223 (22$), 162 (28), 108 (10), 107 (10), 92 (11), 91 (100), 79 
(15), 77 (10), 65 (12), 57 (37).
N-Benzyloxycarbonyl-O-t-butyl-DL-serine methyl ester was 
similarly prepared in 74$ yield, m.p. 77-79 °C (lit.,11^ 78.5-
79 °c).
N~Benzyloxycar'bonyl--Q~t--'butyl-h-serine (122) - A solution 
of' N—benzyloxycarbonyl-O-t-buiyl-L-serine methyl ester (10.64 g,
34.4 mmol) in 2M sodium hydroxide (34.4 ml) and ethanol (34*4 ml) 
was shaken for 10 min. Acetic s,cid was added to neutrality and 
after removal of ethanol "by evaporation, the residue was taken up 
into a mixture of methylene chloride and water. The aqueous 
layer was separated and extracted with methylene chloride (2 x), 
The combined extracts were dried, filtered and concentrs-ted.
The residue' was then taken up in 10$ sodium hydrogen carbonate 
solution (150 ml). After washing twice with ether (20 ml), the 
aqueous solution was cooled and acidified with concentrated 
hydrochloric acid, then extracted with ether (4 x), The organic 
extracts were dried, filtered and concentrated to an oil which
-153-
solidified after several hours under vacuum (9.472 g. 93$). 
Crystallisation from cyclohexane gave needles (8.65 g, 85.2$), 
m.p. 8l—86 C (lit., 87-87.5 °C); Rp 0.5 (pet, ether — EtOAc- 
AcOH; 28ls0.l),C«3D18 + 18.0° (c 2.4, EtOH) (lit,,101 + 22.7°); 
vmax. 3 435’ 3 300 - 2 800, 1 750, 1 730, 1 685, 1 530, 1 385,
1 365, 1 210, 1 080, 730, and 695 cm*”1; & 11.40 - 11*20 (lH, "br 
s, D20 exch,, COOI-I), 7,37 (5H, s, Ph), 5.90 - 5.55 (lH, m, D20 
eatch., NH), 5.15 (2H, s, PhCHgO), 4-70 - 4.30 (lH, m, CHCH2),
4.05 - 3.45 (211, ABX, JAB 9.5 Hz, 4.0 Hz, 3.0 Hz,, CH OBu*),
1.15 (9H, s, Bu1) • m/e 295 (weak, M), 209 (6$, M+H-CHgOBufc), 148 
(7),.108 (5), 107 (9), 92 (11), 91 (100), 90 (11), 79 (9), 77 (13), 
65 .(25), 59 (15) and 57 (50).
N-Benzyloxycarbonyl-^t-butyl-BL-serine was also synthesised 
by the above procedure yielding an oil (86$),
N-Benzyloxycarbonyl-O-t-butyl-N-methyl-L-serine (128) - 
Methyl iodide (2.5 ml) and sodium hydride (660 mg, 27.5 mmol) 
were added to a stirred, ice cold solution of N-benzyloxycarbonyl- 
O-t-butyl-L-serine (122) (1.475 g» 5 mmol) in dry tetrahydrofuran 
(20 ml). Stirring was continued for 3 ds,ys at 0 °C. The solution 
was decanted from excess sodium hydride and then ethyl acetate 
followed by a few drops of water, were added to the solution to 
destroy suspended sodium hydroxide and hydride. The solvent was 
removed by evaporation and the residue was taken up in a mixture 
of water (100 ml) and ether (30 ml). The organic phase was
separated and extracted with sodium hydrogen carbonate solution.
The combined aqueous extracts were cooled, acidified to pH 3-4
with citric acid and extracted with ethyl acetate. The organic
extracts were washed with water, dried, filtered and concentrated
to .give (128) as an oil (1.51 S', 98$) which showed one spot on
tic, Rp 0,3 (pet. ether - EtOAc - AcOH? 2:1:0.1), M  15 + 4,8°
(c 1*5, CHC1 ), (Pound.: C, 62.25? H, 7-20? N, 4.54. CL ^ Ho.N0>
0 * ±0 3
requires C, 62.13? H, 7.44? N, 4-53$); v .... (CHClJ 3 300 -max. j
2 800, 1 770, 1 730 - 1 69C, 1 395, 1 365, cm-1; & (60 KHz) 9.65 
- 9.25 (IK, br s, DgO exch., COOH), 7.35 (5H, s, Ph), 5.15 (2H, 
s, PhCKgO), 5.00 - 4.55 (1H, m, CHCH^), 3.95 - 3.60 (2H, ra, 
CHgOBu^), 3.03 (3H, s, Me), and 1.15 (9H, s, Bu^)? m/e 309 (weak, 
M), 223 (9$, M+H-CH20But), 148 (8), 92 (15), 91 (100), 77 (9), 65 
(19), and 57 (36).
N—Benzyloxycarbonyl-O-t-butyl—H—methyl-DL-serine was 
similarly prepared as an oil (87$).
H-Benzylox'/carbonyl-O-t-butyl-H-methyl-L-serine Methyl Ester 
P30) - K -Benzyloxycarbonyl-O-t-butyl-H-methyl-L-serine (128)
(3.68 g, 11.9 mmol) was dissolved in ether and a solution of 
diazomethane11  ^ in other was added until a yellow solution was 
observed. The solution was stood overnight and washed with sodium 
hydrogen carbonate solution, dried, filtered, and concentrated- 
to a yellow oil, (3.624 g, 94$), Rp 0.45 (pet. ether - EtOAc*, 4:1). 
A sample was purified by preparative tic to give the methyl ester
(130) as a clear oil, O c ]^21 - 7.6° (c 2.7? CHClJ, (Pound:
C, 63.00; II, 8.01; N, 4.31. Cn JI TJ0r reouiros C, 63.16; H,If 2p )
7.74; N, 4.33$); vr y  (thin film) 3 700 - 3 100, 1 740, 1 695,
1 395? 1 360, 735 and 695 cm"1; & (60 MHz) 7.40 (5H, s, Ph),
5.20 (2H, s, PhGH 0), 4.95 - 4.50 (1H, m, CECH ), 3.90 - 3.50 
(2H, m, GH^OBu^), 3.75 (3H, br s, COOMe), 3.05 (3E, s, Nile), 
and 1.15 (9H, s, Bu*); m/e 323 (weak, M), 237 (20$, M+II-CH 0Bufc)
162 (16), 146 (20), 102.(25), 92 (14)? 91 (100), 65 (10), 59 
(10), 57 (35).
0-t-Budy 1 -IT-metIr; 1-L-serine Kethy1 Ester (129) -■ A solution
of N-hen zy1 oxy car "bony l~0~*b -hut y 1-N~m.et hy1-L- serine methyl ester
(130) (3.454 g, 10.7 mmol) in methanol (100 ml) vas hydrogenated
over 10fo palladium on charcoal for 40 min. The catalyst Has
removed hy filtration through a Celite peri. The filtrate was
concentrated to give the amino 0s t e r (129) (1.9 g, 24/0 7 0*6
(CHC13 - Lie OH - EtgNIT; 10:1:0.01) (Pound: C, 57,1; H, 10,23;
N, 7.29. C H HO, requires C, 57.14; E, 10*05; N, 7.41/0;
7 ±7 o
v (thin film) 3 600 - 3 200, 2 800, 1 740, 1 390, 1 360, and max.x '
1 085 cm"1; & (60 Ms) 3.95 (3H, s, OHe), 3.75 - 3*20 (3H, m,
CHCH2), 2.4-5 (3H, s, Nile), 2.05 (IE, hr s, D?0 exch., Nil), and
1.15 (9E, s, Bu"k).
B e n yy 1 o xy c ar h o ny 1 ■- L~p h e ny 1 zi 1 any l-O-t-hu tyl t hy 1 -- L~ 
serine Methyl Ester (136) - DCC (223 mg, 1.1 mmol) was added •
to an ice cold solution of “benzyloxycarbonyl-L-phenylalanine (8l) 
(299 nig, 1 mmol) and the methyl ester (129) (189 mg, 1 mmol) 
in methylene chloride (10 ml), then the reaction was allowed to 
stand overnight at room temperature. BCU was removed by 
filtration through a Celite pad and the latter was washed with 
methylene chloride. The filtrate was washed with 1M hydrochloric 
acid, water, sodium hydrogen carbonate solution and water, then 
dried, filtered and concentrated to an oil. The oil was taken 
up in a minimum of acetone and a further precipitate of DCU 
was removed hy filtration. Evaporation of the solvent left an 
oil (414 mg, 8&fo) showing one major spot on tic corresponding 
to the product (136), 0.60 (pet. ether - EtOAc — AcOH; 12:6:1)
and one minor spot corresponding to DCU, 0.95)*
A sample of the oil was purified hy preparative tic for 
analysis to give the protected dipeptide (136), [c*] 4- 6.75°
(o 1.14, CHC1-,) (Pound: C, 66.22$ E, 7*08; II, 5*80. C26H34^2°6
requires C, 66.385 H, 7*23; N, 5*96$), vmay# (CHCl^) 8 430,
1 740, 1 720, 1 650, 1 500, 1 395? and 1 365 cm"1; S (oO MHz)
7*35 (5H, s, Ph), 7*25 (5H, s, Ph), 5*85 ~ 5*55 (1H, m, HH), 5*10 
(2H, hr s, PhCH^O) ? 5*20 - 4*60 (211, m, 2 x CH), 3.85 - 3*55 (2H, 
m, CHgOBu"^), 3*70 (3H* s, CQOlle), 3.05 (3H, s, Nlie), 3.20 — 2,80 
(2H, m, CHgPh), 1.15 (9H, s, Bu15).
cyclo~(L-Phenylalanyl-0-t-hutyl-II-methyl-L--seryl) (138) - 
A solution of benzyloxycarbonyl~L-pherylalanyl-£-t-butyl-H-
-157-
methyl-L-serine methyl ester (128) (2.185 g, 4.65 mmol) in 
methanol (100 ml) was hydrogenated for 5 h in the presence of 
10$ palladium on charcoal (220 mg) and acetic acid (6 ml).
The catalyst was removed Tby filtration through a Celite pad, 
which was washed with hot methanol and the filtrate was » 
concentrated to an oil. Residua] acetic acid was removed by 
azeotroping with methanol and the resulting oil was taken up in 
acetone - pet, ether and cooled. Crystals were filtered off 
and washed with ethyl acetate then ether. Recrystallisation 
from ethyl -acetate yielded cyclo- (b-phony 1 al any l-0-.-t—but y 1—If— 
methyl-B-seryl) (139) as cubes (120,2 mg, 8,5^)? m.p. 213—215 
°C, 0.45 (Found: C, 67.30; H, 8.05; II, 9*39* C ^ H
requires C, 67.105 E, 7*89; M, 9 * 2 1 $ ) -  123.8° (c 1.0,
CHClJ; v , 3 270, 1 688, 1 645? 1 100, ?60 - 750, and 7053 max.
cm-1; & 7.25 (5H, m, Ph), 5.88 (IE, br s, HE), 4.45 - 4.28 (IE, 
ABX, JM  + JK  13.5 HZ, CHCHgPh), 3.90 - 3.47 (4H, n), 2 x CHg), 
2.96 (3H, s, Iffle), 2.95 - 2.62 (1H,.ABX, + JBX 25 Hz,
CHCHgOBu^), and 1.12 (9H, s, Bu*); m/e 304 (weak, U), 218 (355&» 
JMWffi OBu*), 127 ( 50), 99 (16, CfcCHOB-A), 91 (100), 65 ( 20), 
57 (100), 56 (25).
The mother liquor, taken up in ethyl acetate — pet. ether 
(lsl), was separated by column chromatography on alumina o (60 g). 
Elution with ethyl acetate - pet, ether (lsl) gave fractions 
containing a solid which was crystallised from acetone — pet, 
ether to give the oyclo-dipeptide (138), (442 mg, 31.3^), m.p.
-158-
133-138 °C,t^J)20 - 149.7° (c 1.4, CHC13), TL^ 0.35, (Founds 
c» 67.32; H, 8.09; If, 9-32. C ^ H  requires C, 67.10; H,
7.89; If, 9.21$); v 3 350, 3 235, 1 680, 1 650, 1 390, 1 365,
llldfAf
1 095, 750, and 700 cm”1; 7.41 - 7,14 (5H, rn, Ph), 5.85 -
5.75 (1H, br s, EH), 4.20 - 3.88 (2H, m, 2 x CH), 3.80 - 3.70 
(2H, m, CH0Ph), 3.55 - 2.98 (2H, AM, J,,r 11 Ha, 3.5 Ha,
~ M m .. Jl&&
JAB 13 Hz, CHgOBa^), 2.99 (3H, s, HKe), and 1.20 (9H, s, Bt^);
& (CD^OD) 7.29 (5H, m, Ph), 4*14 (lH, br i, J 7 Ha, CHCI^ Pfe), 
4.02 (1H, t, J 3 Hz, C3CH OH), 3.81 - 3.31 (2K, AM, jr 3 Hz,
d . —  jfiA
JM  3 Hz, J4B 10 Hz, CH203uX), 3.24 (2E, br d, J 7 Ha, CHgPh),
*fc
3.01 (3H, s, lie), and 1.22 (9K, s, B11 ); ra/e 304 (weak, Iff),
218 (90$, K+H-CKgOBu1), 127 (100), 99 (20), 91 (32), 57 (57)* 
and. 56 (7).
cyolo—(L-Fhenylalanyl—H-mothyl—h-sgpyl) (29) — gyolo- 
(L-Phe-L-(Hlle,03u^)Ser) (138) (99 mg, 0,33 mmol) was dissolved 
in 45^ HBr — AcOH (1-2 ml) over a period of 10 min. Dry ether 
(ca, 50 ml) was added and the contents weres mixed and cooled 
overnight to precipitate a white ©olid which was triturated 
with ether. On exposure to air an oil (160 mg) was formed 
which was applied to preparative tic. The product (29) was 
obtained as an oil which was solidified Ibgr slow evaporation 
from ethyl acetate, then recrystallised from ethyl acetate to 
give fan-lihe crystals (30 mg, 37$»)> sup* X64.5~X6>3 °C, '
-159-
— 127.6 (je,1.0, MeOK); Rp 0.15 (chloroform — methanol — 
diethylamine; 15:1:0.1); (Found: C, 62.60; H,,6.49; N, 11.50. 
^13^16^2^3 r ^E-ires C, 62.90; H, 6.45, N, 11.29$); v 3 300,
1 665, 1 650, 1 090, 750, and 705 cm"1; £ [(CD )?S0] 7-92 (lH, 
to. s, DgO exch., HH), 7.50 - 7.05 (5H, m, Ph), 5.18 (1H, hr t,
J 6 Hz, D20 exch., OH), 4*04 (lH, m, sharpens on D^O shake to 
hr t, J 6.5 Hz, CHCIigPh), 3#8l (lH, m, sharpens on D20 shake 
to hr t, J 3*5 Hz, CHCHgOH), 3*72 - 3.15 (2H, m, sharpens on 
DgO shake to ABX, J^. - 3*5 Hz, 12 Hz, CB^OH), 3*07
(2H, hr d, J 6 H z, CHgPh), 2.86 (3H, s, Me); m/e_ 248 (6fo, M),
218 (100, M-CHgO), 189 (20), 157 (13, H - C ^ ) ,  129 (23, M-PhCII2CH=HH),
I
127 (63, H-CLIL-CJIgO), 120 (12), 99 (25), 91 (64), and 65 (14) 
with metastable ion at 191.5*
cyclo-(L-Phenyl3Janyl-Q-"acetyl-rI-methyl-L-seip/~l) (140) - 
The previous experiment was allowed to stand fob 30 min, then 
worked up as usual. The acetyl derivative was obtained from 
preparative tic. as an oil which was solidified by slow evaporation 
from acetone. The solid was triturated then crystallised from 
acetone, to give the acetyl product (140), (5 mg, 6.0$), m.p.
172 -177 ° G , M I)24 - 141.7*(c 0.6, MeOH), Rp 0.35 (chloroform - 
methanol - diethylamine; 15:1: -l)? (Found: C, 61.75? H, 6.03;
N, 9-46. requires C, 62.07; H, 6.21; N, 9.65$); vmax^
3 250, 1 750? 1 685, 1 640, 1 230, 755? and 710 cm”1; i (CD^D)
-160-
7.35 (5H, br s, Ph), 4.40 - 3.95 (3H, m, CHgOAc, CHCH Ph), 3.63- 
3.41 (1H, AM, + JM  19.5 Hz, CHCH OAc), 3.25-3.05 (2H, m, 
CHgPh), 3.05 (3H, s, Me), 2.05 (3H, s, 0IIe)r m/e 290 (Q%, M),
230 (64, M-CH3COOH), 157 (37), 127 (24, M-C^-CHgOAc), 111 (29), 
91 (100), and 65 (30).
cyclo-( L-P he ny 1 al any l-II-me t hy l-D- s e ry 1) (141) - cyclo-(h- 
Phenylalanyl-O-t-butyl-N-methyl-D-seryl)(139) (80 mg, 0.263 
mmol) was converted as described for (138) into the cyclic 
dipeptide (141), (15 mg), m.p. 159-166.5 °0 and recrystallised 
from methanol - ether - pet. ether (6.3 mg, 9»5$) m.p. 163.5- 
165 ° C , M  22 - 47.8° (c 2.8, MeOH), (Pound: 0, 62.63? H, 6.35?1) 1 —
N, 11.14. c13H16N2°3 reEHires 62.90?. II, 6.455 N, 11.29$);
v 3 380, 3 260, 1 690, 1 645 - 1 630, cm”1; & (CD OD) 7.20 max. s>
5H, s, Ph), 4.38 (1H, hr t, J 5 Hz, CHCHgPh), 3.85 (2H, d, J 
2.5 Hz, CH OH), 3.50 - 3.08 (n, CHCHgOH, CHgPh), 2.83 (3H, s, 
Me); D/e 248 (16$, M), 218 (96, M-CHgO), 188 (28), 157 (20, 
M-C_H?), 129 (30, H—PhCHgCH-NH), 127 (76, M - C ^ -  CHgO), 120 
(18), 99 (25), 91 (100). 
cyclo-(L-LU-1^C]Phen.Tlalan.Tl-H-rae-thyl-h-ser.7l) - L-[jj- C]
—1
Phenylalanine (165.5 mg, 100 pCi mmol ) vias converted as 
previously described into benzyloxycarbcnyl-L-[u-14c] phenylalanine 
(91%9 activity, 83.8 pCi mmol”1)', then coupled with O-t-butyl- 
N-methyl-L-serine methyl ester (129) (l mmol) to give an oil 
(87$). Hydrogenation was carried out as normal to give an oil
-161-
The oil was dissolved in 45$ HBr/AcOH over a 30 min period and 
worked up as usual to give, after preparative tic and crystallisation 
the product (29) as cubes (39 nig, 16$ frogi Z-L-Phe-OH), m.p,
164 - I65 °C, activity 82.78 pCi mmol""1 (98.8$).
The presence of only one radioactive product wes established 
by radioscanning and autoradiography of tic plates rum in 3 
solvent systems and by dilution analysis with unlabelled cycle— 
(L-Phe—L-(NMe)Ser) as diluent.
H—Benzyl0 x,y o ar bo ny 1-0-t-butyl-L-serine t-Butyl Ester (126)
— N-Benzyloxycarbonyl-L-serine (4?78 g, 20 mmol) was converted
101
to (126) by the method' of Callahan et al. to give an oil (5*23 g,
75$); v (film) 3 490 - 3 250, 1 160 - 1 690, 1 500, 1 390, 
max.
1 360, 735, and 695 cm*"1; S (60 MHz) 7*35 (5H- s9 Ph), 5.80 - 
5.40 (1H, m, MH), 5*15 (2H, s, PhCEU), 4*55 - 4*15 (lH, m, CH), 
4.00-3.40 (211, m, CH^Bu1), I.65 (9H, s, COOBu*) and 1.10 (9H, 
s, CHgOBu1); m/e 351 (weak, M), 209 (35$), 148 (25), 91 (100),
57 (68).
O-t-Butyl-H-methyl-DL-serine (132) - A solution of N-benzyl- 
oxycarbonyl—^—t—butyl—H—methyl—BL—serine (535 1*79 mmol) in
methanol (20 ml) and acetic acid (0.1 ml) was hydrogenated for
2 h over 10$ palladium on charcoal (50 mg). The solution was 
filtered and evaporated to give a solid which was crystallised 
from methanol - ether to yield the amino—acid (132) (271 mg,
-162-
86$), m.p. 191—198 °G (sublimation), (Found: C, 54*80; H, 9*5^5 
N, 7*93* Cl8H17N03 requires C, 54,86; H, 9*71; N, 8.00$); vma^  
(Nujol) 3 600 - 2 200, 1 650 - 1 590,- cm"-1; & (CD^OD) (60 MHz)
4.20 - 3.25 (3H, m, CHCH2), 2.75 (3H, s, NMe), 1.25 (9H, s, Bu*); 
m/e .176 (weak, M+l), 175 (weak, M), 102 (45$, M-OBu*), 89 (100, 
M+H-CHgOBu*), 88 (45, M-CHgOBu*'), 74 (64), 57 (100), and 56 (44).
Attempted Hydrolysis of the Ester (125) - The ester (125)
10i
was treated with lithium iodide in diraethylformamide and with 
sodium thiomethoxide in hexamethylphosphoramide.'*'^ Starting 
material was recovered in both experiments and there was no 
evidence for hydrolysis.
Attempted Hydrolysis of the Ester (126) - The ester (126) 
was treated with benzene and jp-toluenesulphonic acid. The product 
was studied by t.l.c. and n.m.r. spectroscopy and found to be 
a mixture of the starting material and two other products of which 
Z-L—Ser-OH was predominant.
Attempted Deprotection of the Butyl Ether (138)- The butyl 
ether (138) was treated, in turn, with benzene and j>-toluene- 
sulphonic acid under reflux, trifluoroacetic acid, and chloroform- 
hydrochloric acid. Starting material was recovered in all these 
experiments. The ether (138) was treated with benzene-concentrated 
sulphuric acid under reflux. The product showed several spots on 
t.I.e.
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